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Abstract
The use of biocatalysis to create chiral centres for chemical pharmaceuticals is 
rapidly becoming a standard industrial technology. Often, the compounds of 
interest are poorly soluble in aqueous solvents leading to the use of organic co­
solvents to deliver substrate into the environment of the biocatalyst. 
Unfortunately these co-solvents can impact negatively on the stability of the 
biocatalyst. Recently, room temperature ionic liquids have been attracting 
interest as potential replacements for organic solvents in such reactions as they 
offer lower toxicity and an increased rate of reaction. This thesis describes an 
original experimental study into the use of ionic liquids with biocatalytic redox 
reactions.
Initially, the stereospecific reduction of 6-Br-p-tetralone to its corresponding 
alcohol (S)-6-Br-P-tetralol was carried out by the yeast Trichosporon capitatum 
MY 1890 and by the bacterium Rhodococcus erythropolis MA7213 using a range 
of ionic liquids chosen on the diversity of their composition. The decrease in cell 
viability of both types of whole cell biocatalyst upon exposure to ionic liquids 
was found to be intermediate to that determined for cells residing purely in 
fermentation media and cells residing in a two-phase mixture of media and 
organic solvent (toluene). For T. capitatum MY 1890 bioconversions, the ionic 
liquid [Emim][TOS] gave a reaction profile comparable to that observed in the 
previously studied water-ethanol system, in terms of overall rate of reaction 
(0.2g(prod)L'1hr'1) and conversion (100% w/w). For bioconversions carried out 
with R. erythropolis MA7213, through use of 20% v/v [Emim][TOS] as a co­
solvent the conversion yield doubled and a four-fold increase in initial rate was 
found compared to the standard ethanol co-solvent.
Subsequent flow cytometric analysis of the R. erythropolis MA7213 in these 
ionic liquids showed that the stability of the biocatalyst was increased in ionic 
liquids, such as [Emim][TOS] and [Oc3 MeN][BTA] accounting for the increased 
rates of reaction and overall conversion observed. The potential for multi 
parameter flow cytometry to be used as a tool for identifying biocompatible ionic
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liquids was demonstrated through the improved oxidation of 1-indanone to 3,4- 
dihydrocoumarin by cyclo-hexanone mono-oxygenase expressed by E. coli 
TOP 10 pQR239 in the presence of 20% v/v [Emim][TOS] with 30% w/w overall 
conversion compared to only 20% w/w overall conversion in the presence of 
10% v/v ethanol.
The ability to perform isolated enzyme catalysed conversions in ionic liquids was 
also investigated. The asymmetric reduction of 6-Br-P-Tetralone to its 
corresponding (S) alcohol was found to be mediated by alcohol dehydrogenase 
isolated from R. erythropolis (ADH RE) and proceeded more favourably in both 
a miscible and immiscible ionic liquid compared to the organic solvent systems 
identified, with initial rate increases of more than two-fold. The ionic liquid 
[BMP][BTI] acting as a co-solvent (20% v/v) yielded 100% conversion of 50 gL'
1 substrate in less than 12 hours (an increase of 25 times over the maximum yield 
from whole cells). This was attributed to a combined effect of increased enzyme 
stability in the ionic liquid and more efficient mass transfer of substrate from the 
ionic liquid phase to buffer compared to toluene. The asymmetric reduction of 
4 ’-Br-2,2,2-trifluoroacetophenone to (R)-4’-Br-2,2,2-trifluoroacetophenyl 
alcohol was also carried out using the ADH RE and was found to be limited to 10 
gL’1 conversion due to toxicity of the substrate on the enzyme in the presence of 
toluene (10% v/v). Using 10% v/v [BMP][BTI] as a co-solvent led to an enzyme 
half life of almost 300 hours at 30°C and complete conversion of 50gL_1 substrate 
in less than 10 hours.
The selection of a suitable ionic liquid for a particular bioconversion appears to 
rest primarily on biocatalyst stability, but is also dependent on solubility and 
mass transfer issues of substrate from the ionic liquid into the aqueous phase. 
The potential of a high throughput ionic liquid selection strategy based on these 
measurements was shown through the use of automated pipetting platforms, 
miniature bioreactors with online monitoring, and microwell compatible devices 
for flow cytometry and spectrometry for biocatalyst stability studies. The 
potential for ionic liquids to be employed in industrial redox bioconversions with 
both whole cell and isolated enzyme biocatalysts has thus been demonstrated.
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flow cytometry analysis was as described in Section 2.8.8.
Figure 5.1 The asymmetric reduction of 6-Br-p-tetralone to (5)-6-Br-p-tetralol 
by alcohol dehydrogenase isolated from Rhodococcus erythropolis (ADH RE) 
and co-factor recycling by the glucose dehydrogenase 103 (GDH 103) mediated 
oxidation of glucose.
Figure 5.2 Comparison of the conversion kinetics of 50 gL'1 6-Br-p-tetralone to 
(5)-6-Br-P-tetralol by ADH RE in the presence of 10% v/v co-solvent: (■) 
[BMP][BTI], ( •)  AmmoEng™ 102, ( A)  toluene (▼) DMSO and (♦) with no co­
solvent (buffer only). Reactions were carried out in Multimax™ miniature 
reactors with 30 mL working volume at 30°C and pH 6.8 ±0.1 as described in 
Section 2.7.2.
Figure 5.3 Effect of co-solvent volume fraction on the conversion of 50 gL'1 6- 
Br-p-tetralone to (5)-6-Br-P-tetralol by ADH RE in a range of co-solvents: (a) 
conversion kinetics (b) residual ADH RE activity (c) residual GDH 103 activity. 
Experiments performed in the presence of: (■) 10% v/v [BMP][BTI], ( •)  20%
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v/v [BMP][BTI], ( A)  50% v/v [BMP][BTI] and (▼) 10% v/v toluene. Reactions 
were carried out in Multimax™ miniature reactors as described in Section 2.7.2.
Figure 5.4 Effect of impeller Reynolds number and dispersed phase volume 
fraction on initial rate of reaction for conversion of 50 gL'1 6-Br-P-tetralone to 
(S)-6-Br-P-tetralol by ADH RE. (a) Conversion kinetics of: (■) 10% v/v 
[BMP][BTI], Re = 450, ( •)  10% v/v [BMP][BTI], Re = 900, ( A)  20% v/v 
[BMP][BTI], Re = 450. (b) Calculated initial rates of reaction. Reactions were 
carried out in Multimax™ miniature reactors as described in Section 2.7.2.
Figure 5.5 Effect of initial ADH RE concentration on the conversion kinetics of 
50 gL '1 6-Br-p-tetralone to (£)-6-Br-P-tetralol (a) Comparison of % conversion 
kinetics at initial ADH RE concentrations of: (■) 0.5 gL'1, (• )  1.0 gL'1, (A)  2.5 
gL'1 and ( T)  5.0 gL'1. (b) Initial rate of reaction against initial enzyme 
concentration. Solid line fitted by polynomial regressions (R2 = 0.996). 
Experiments performed as described in Section 2.7.2.
Figure 5.6 Effect of temperature on the conversion of 50 gL'1 6-Br-p-tetralone to 
(5)-6-Br-P-tetralol at an initial ADH RE concentration of 1 gL'1. (a) Comparison 
of conversion kinetics, (b) residual ADH RE activity, (c) residual GDH 103 
activity at: (■) 30°C (•)  45°C. Experiments were performed as described in 
Section 2.7.2.
Figure 5.7 The asymmetric reduction of 4’-Br-2,2,2-trifluoroacetophenone to 
(R)-4-Br-2,2,2-trifluoroacetophenyl alcohol by ADH RE and co-factor recycling 
by the GDH 103 mediated oxidation of glucose.
Figure 5.8: Comparison of the conversion kinetics of 50 gL'1 4 ’-Br-2,2,2- 
trifluoroacetophenone to (7?)-4,-2,2,2-trifluoroacetophenyl alcohol by ADH RE 
in different co-solvent systems: (a) conversion kinetics (b) residual ADH RE 
activity (c) residual GDH 103 activity. Experiments performed in the presence of 
10% v/v co-solvent: (▲) [BMP][BTI], (•)  AmmoEng™ 102, ( T)  toluene and 
(■) with no co-solvent (buffer only). Reactions were carried out in Multimax™
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miniature reactors with 30 mL working volume at 30°C and pH 6.8 ± 0.1 as 
described in Section 2.7.2.
Figure 5.9: Effect of initial ADH RE concentration on the conversion kinetics of 
50gL‘! 4 ’-Br-2,2,2-trifluoroacetophenone to (/?)-4 ’-Br-2,2,2 trifluoroacetophenyl 
alcohol with 10% v/v [BMP][BTI] co-solvent, (a) Conversion kinetics, (b) 
residual ADH RE activity, (c) residual GDH 103 activity with: (A)  1 gL'1 (•) 
0.5 gL'1 (■) 0.1 gL'1 initial ADH RE concentration. Experiments were performed 
as described in Section 2.7.2.
Figure 5.10: Example of ionic liquid re-use. Conversion kinetics of 4 ’-Br-2,2,2- 
trifluoroacetophenone reduction to (R)-4’-Br-2,2,2-trifluoroacetophenol in the 
presence 15% v/v (■) fresh (•)  recycled [BMP][BTI] as co-solvent. Ionic liquid 
was recovered as described in Section 2.10. Bioconversions were performed in 
pH stats (10 mL working volume) as described in Section 2.7.2.
Figure 5.11 Concentration of 6-Br-p-Tetralone in the aqueous buffer phase of 
Lewis Cell in the presence of toluene with Reynold’s number (■) 1320 (•)  3000 
(A)  4500 and [BMP][BTI] with Reynold’s number (▼) 123 (♦) 250 (+) 430. 
The Lewis Cell was operated as described in Section 2.11.
Figure 6.1 A hierarchical approach towards the systematic evaluation of ionic 
liquids as co-solvents for biocatalysis.
Figure 6.2 Elements used in the automated substrate solubility screen: (a) a 96 
vial plate for automated solubility screening, (b) “Powdemium” solids dispensing 
system for addition of solid substrates. Images reproduced from 
http://www.symyx.com/page.php?id=74.
Figure 6.3 Symyx automated liquid handling platform for addition of liquid 
phases during the initial substrate solubility screen. The platform features 3 plate 
positions with independent heating and magnetic stirring controls, 4 tip arm, and
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32 positions for additives. Image reproduced from 
http://www.svmvx.com/page.php?id=70.
Figure 6.4 Parity plot between manual and automated solubility studies for the 
saturation solubility of 6-Br-P-tetralone in a range of ionic liquids and organic 
solvents. Solid line represents line of parity. Manual and automated solubility 
studies performed as described in Section 2.3 and 6.2 respectively. R2 = 0.953.
Figure 6.5 Automated miniature reactors for evaluation of bioconversion 
kinetics and related mass transfer studies: (a) Multimax™ miniature reactor 
system with 4 independent temperature control chambers and impeller rotational 
speeds, (b) detail of a Multimax™ reactor with pitched blade impeller (di = 24 
mm, OD = 39 mm, ID = 35 mm, h = 74 mm) and pH and temperature probes.
Figure 6.6 Example of online data collection from the Multimax™ system 
shown in Figure 6.5. The screen image shows base addition volumes to the four 
individual reactors. Temperature and pH can be similarly monitored for the full 
reaction course. Experiments were performed as described in Section 2.7.2.
Figure 6.7 Conversion kinetics of 6-Br-p-tetralone reduction by the yeast T. 
capitatum MY1890 in the presence of 20% v/v [Bmim][PF6] in: (•)  250ml 
Erlenmeyer flask cultured in an orbital shaker at 220 rpm (as described in 
Section 2.7.1) and (o) Multimax™ miniature reactor operated at an impeller 
speed of 600 rpm.
Figure 6.8 Illustration of the Guava™ Technologies Easy Cyte microwell based 
flow cytometry studies. The device features forward scatter, side scatter and 3 
wavelength detectors for fluorochromes and can be readily integrated with any 
standard liquid handling robot,
(http: //www. guavatechnologies.com/main/products/easycyte-new. cfm).
Figure 7.1 The coupled substrate recycling of NAD(P)H cofactor during the 
enzymatic reduction of a ketone to alcohol. (Kroutil et al, 2004).
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Figure A.1 HPLC calibration curves for (a) 6-Br-p-tetralone and (b) 6-Br-p- 
tetralol. Samples were analysed as described in Section 2.8.1.
Figure A.2 Sample chromatogram showing separation of 6-Br-p-tetralone 
eluting at 2.7 minutes and 6-Br-P-tetralol eluting at 1.98 minutes. Samples were 
analysed as described in Section 2.8.1 on a short column.
Figure A.3 HPLC calibration curves for (a) 4 ’-Br-2,2,2-trifluoroacetophenone 
and (b) 4 ’-Br-2,2,2-trifluoroacetophenyl alcohol. Samples were analysed as 
described in Section 2.8.1.
Figure A.4 Sample chromatogram showing separation of 4 ’Br-2,2,2- 
trifluoroacetophenone eluting at 5.3 minutes and 4 ’-Br-2,2,2- 
trifluoroacetophenyl alcohol eluting at 3.28 minutes. Samples were analysed as 
described in Section 2.8.1.
Figure A.5 HPLC calibration curves for (a) 1-indanone and (b) 3,4- 
dihydrocoumarin. Samples were analysed as described in Section 2.8.1.
Figure A.6 Sample chromatogram showing separation of 1-indanone eluting at 
5.93 minutes and 3,4-dihydrocoumarin eluting at 4.23 minutes. Samples were 
analysed as described in Section 2.8.1.
Figure B .l Time course of the bioreduction of 6-Br-p-tetralone to (5)-6-Br-p- 
tetralol by the yeast T. capitatum MY 1890 in the presence of 20% v/v (a) 
[Bmim][BF4]; (b) [CABHEM][MeS04]: (■) 6-Br-P-tetralone; ( • )  6-Br- p- 
tetralol; (-) mass balance. Cultivation was performed as described in Section 2.6. 
Bioconversion was performed as described in Section 2.7.1 and the reaction was 
monitored by HPLC analysis as described in Section 2.8.1.
Figure B.2 Time course of the bioreduction of 6-Br-p-tetralone to (*S)-6-Br-p- 
tetralol by the yeast T. capitatum MY 1890 in the presence of 20% v/v (a)
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[Bmim][MDEGS0 4 ]; (b) [Oc3 MeN][BTA]: (■) 6-Br-p-tetralone; ( • )  6-Br- p- 
tetralol; (-) mass balance. Cultivation was performed as described in Section 2.6. 
Bioconversion was performed as described in Section 2.7.1 and the reaction was 
monitored by HPLC analysis as described in Section 2.8.1.
Figure B.3 Time course of the bioreduction of 6-Br-P-tetralone to (S)-6-Br-P- 
tetralol by the yeast T. capitatum MY 1890 in the presence of 20% v/v (a) 
[Bmim][OcSC>4 ]; (b) [Bmim][PF6]: (■) 6-Br-p-tetralone; ( • )  6-Br- p-tetralol; (-) 
mass balance. Cultivation was performed as described in Section 2.6. 
Bioconversion was performed as described in Section 2.7.1 and the reaction was 
monitored by HPLC analysis as described in Section 2.8.1.
Figure B.4 Time course of the bioreduction of 6-Br-p-tetralone to (*S)-6-Br-P- 
tetralol by the yeast T. capitatum MY 1890 in the presence of 20% v/v 
[Emim][TOS]: ( • )  6-Br-p-tetralone; (o) 6-Br- p-tetralol; (-) mass balance. 
Cultivation was performed as described in Section 2.6. Bioconversion was 
performed as described in Section 2.7.1 and the reaction was monitored by 
HPLC analysis as described in Section 2.8.1.
Figure C .l Response of R. erythropolis MA7213 cells to exposure to 10% v/v 
Ethanol. Quadrant HI corresponds to live, polarized cells, H3 corresponds to live 
cells with depolarized cell membranes and H4 corresponds to dead cells. 
Cultivation was performed as described in Section 2.6, bioconversion as 
described in Section 2.7.1 and flow cytometry analysis as described in Section
2 .8 .8 .
Figure C.2 Response of R. erythropolis MA7213 cells to exposure to 20% v/v 
[Bmim][BF4 ]. Quadrant HI corresponds to live, polarized cells, H3 corresponds 
to live cells with depolarized cell membranes and H4 corresponds to dead cells. 
Cultivation was performed as described in Section 2.6, bioconversion as 
described in Section 2.7.1 and flow cytometry analysis as described in Section
2 .8 .8 .
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Figure C.3 Response of R. erythropolis MA7213 cells to exposure to 20% v/v 
[Emim][TOS]. Quadrant HI corresponds to live, polarized cells, H3 corresponds 
to live cells with depolarized cell membranes and H4 corresponds to dead cells. 
Cultivation was performed as described in Section 2.6, bioconversion as 
described in Section 2.7.1 and flow cytometry analysis as described in Section
2 .8 .8 .
Figure C.4 Response of R. erythropolis MA7213 cells to exposure to 20% v/v 
[CABHEM][MeSC>4 ]. Quadrant HI corresponds to live, polarized cells, H3 
corresponds to live cells with depolarized cell membranes and H4 corresponds to 
dead cells. Cultivation was performed as described in Section 2.6, bioconversion 
as described in Section 2.7.1 and flow cytometry analysis as described in Section
2 .8 .8 .
Figure D .l Response of E. coli TOP 10 pQR239 cells to exposure to 20% v/v 
[Bmim][BF4 ]. Quadrant K3 corresponds to live, polarized cells, K1 corresponds 
to live cells with depolarized cell membranes and K2 corresponds to dead cells. 
Cultivation was performed as described in Section 2.6, bioconversion as 
described in Section 2.7.1 and flow cytometry analysis as described in Section
2 .8 .8 .
Figure D.2 Response of E. coli TOP 10 pQR239 cells to exposure to 20% v/v 
[Bmim][MDEGS0 4 ]. Quadrant K3 corresponds to live, polarized cells, K1 
corresponds to live cells with depolarized cell membranes and K2 corresponds to 
dead cells. Cultivation was performed as described in Section 2.6, bioconversion 
as described in Section 2.7.1 and flow cytometry analysis as described in Section
2 .8 .8 .
Figure D.3 Response of E. coli TOP 10 pQR239 cells to exposure to 20% v/v 
[Bmim][0 cS0 4 ]. Quadrant K3 corresponds to live, polarized cells, K1 
corresponds to live cells with depolarized cell membranes and K2 corresponds to 
dead cells. Cultivation was performed as described in Section 2.6, bioconversion
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as described in Section 2.7.1 and flow cytometry analysis as described in Section 
2 .8 .8 .
Figure D.4 Response of E. coli TOP 10 pQR239 cells to exposure to 20% v/v 
[CABHEM][MeS0 4 ]. Quadrant K3 corresponds to live, polarized cells, K1 
corresponds to live cells with depolarized cell membranes and K2 corresponds to 
dead cells. Cultivation was performed as described in Section 2.6, bioconversion 
as described in Section 2.7.1 and flow cytometry analysis as described in Section
2 .8 .8 .
Figure D.5 Response of E. coli TOP 10 pQR239 cells to exposure to 20% v/v 
[Emim][TOS]. Quadrant K3 corresponds to live, polarized cells, K1 corresponds 
to live cells with depolarized cell membranes and K2 corresponds to dead cells. 
Cultivation was performed as described in Section 2.6, bioconversion as 
described in Section 2.7.1 and flow cytometry analysis as described in Section
2 .8 .8 .
Figure D.6 Response of E. coli TOP 10 pQR239 cells to exposure to 20% v/v 
[Oc3MeN][BTA]. Quadrant K3 corresponds to live, polarized cells, K1 
corresponds to live cells with depolarized cell membranes and K2 corresponds to 
dead cells. Cultivation was performed as described in Section 2.6, bioconversion 
as described in Section 2.7.1 and flow cytometry analysis as described in Section
2 .8 .8 .
Figure D.7 Response of E. coli TOP 10 pQR239 cells to exposure to 10% v/v 
ethanol. Quadrant K3 corresponds to live, polarized cells, K1 corresponds to live 
cells with depolarized cell membranes and K2 corresponds to dead cells. 
Cultivation was performed as described in Section 2.6, bioconversion as 
described in Section 2.7.1 and flow cytometry analysis as described in Section
2 .8 .8 .
Figure D.8 Response of E. coli TOP 10 pQR239 cells to exposure to 10% v/v 
toluene. Quadrant K3 corresponds to live, polarized cells, K1 corresponds to live 
cells with depolarized cell membranes and K2 corresponds to dead cells.
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Cultivation was performed as described in Section 2.6, bioconversion as 
described in Section 2.7.1 and flow cytometry analysis as described in Section
2 .8 .8 .
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Abbreviations
[Bmim][BF4 ] 1-Butyl-3-methyl-imidazolium tetrafluoroborate
[Bmim][MDEGS0 4 ] 1 -Butyl-3-methyl-imidazolium-ethy lenglycolmonomethy 1- 
ethersulfate
[Bmim][0 cS0 4 ] 1-Butyl-3-methyl-imidazolium octylsulfate
[Bmim][PF6 ] l-Butyl-3-methyl-imidazolium hexafluorophosphate
[BMP][NTf2] Butylmethylpyrrolidinium
bis(trifluoromethylsulfonyl)imide
[CABHEM][MeS0 4 ] PEG-5 Cocomonium methosulfate
EcoEng™ 21M 1 -Ethyl-3-methyl-imidazolium 2(2-
methoxyethoxy)ethylsulfate
EcoEng™ 212 1 -Ethyl-3-methyl-imidazolium ethylsulfate
EcoEng™ 1111P 1,3-dimethyl-imidazolium dimethylphosphate
[Emim] [TOS] 1 -Ethyl-3-methyl-imidazolium tosylate
[EMP] [ES] 1 -Ethyl-3-hydroxymethyl-pyridinium ethylsulfate
[Oc3MeN][NTf2 ] Methyl-trioctyl ammonium
bis(trifluoromethlylsulfonyl)imide
ADH RE Rhodococcus erythropolis alcohol dehydrogenase
DMF dimethylformamide
DMSO dimethyl sulfoxide
g grams
GDH 103 glucose dehydrogenase 103
HPLC high pressure liquid chromatography
L litres
MTBE methyl tert-butyl ether
Re Reynolds Number
RO reverse osmosis
rpm revolutions per minute
THF tetrahydrofuran
UV ultraviolet
v/v volume per unit volume
w/w weight per unit weight
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1 Introduction
1.1 What is Biocatalysis?
Bioconversions can be defined as ‘selective enzymic modifications of defined 
pure compounds into defined final products’. In a bioconversion at least one of 
the reactants and one of the products will have structural similarity, in contrast to 
fermentation products where the mixture of nutrients provided has little or no 
structural similarity to the microorganisms grown or the result of their metabolic 
activities (Lilly, 1994).
The first significant industrial biotransformations were the steroid 
biotransformations of the 1950s, the first of which was that of Peterson and co­
workers using Rhizopus nigricans:
c o c h 3 C0CH3
Rhizopus nigricans
11-a-HydroxyprogesteroneProgesterone
Figure 1.1 Rhizopus nigricans mediated hydroxylation of progesterone to 11-a- 
hydroxyprogesterone (Peterson et al, 1952).
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Prior to this process being taken up, a series of chemical reactions was required 
to introduce the hydroxyl group at the 1 l a  position, with low yield and low atom 
efficiency. This microbiological process however yielded up to 90% product, and 
was very favourably looked upon in industry. This resulted in a lot of work being 
carried out into discovering more microorganisms capable of selectively 
modifying other steroids. This effort yielded two further processes very quickly; 
the 11 p-hydroxylation of progesterone by Curvularia lunata and the 51- 
dehydrogenation by Corynebacterium simplex (Nobile et al, 1955).
From these initial excursions, biocatalysis has become a standard technology in 
the fine chemicals industry, a fact illustrated by the 134 industrial bioconversions 
being operated around the turn of the century (Straathof et al, 2002). Enzyme 
catalysed reactions have become an essential tool in organic syntheses (Shaw et 
al, 2003). The advantages afforded by biocatalysts such as regio- and stereo­
selectivity of the catalyst (illustrated by the work of Peterson et al, 1952) are 
sufficient to counter the adverse consequences of their employment- primarily 
the much greater cost of using biocatalysts, and so their use is increasing.
The agrochemical and pharmaceutical industries are reliant on biocatalysis to 
provide optically pure compounds in high quantity. Average volumetric 
productivity for bioconversions in the chemical industry has been rated at 15.5 
gL^hr' 1 (Straathof et al, 2002), indicating the success of bioconversion 
optimisation which has occurred to improve the overall performance of 
biocatalysis and to overcome the negative cost aspects of employing biocatalytic
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processes. Of the 134 industrial biotransformations currently being operated over 
50% are in the pharmaceutical sector (Straathof et al, 2002).
The stereo specificity of enzyme reaction systems is seen as the primary 
advantage of using biocatalytic routes. Products containing multiple chiral 
centres are more easily produced using biocatalytic routes since the natural 
specificity negates the need for the multiple protection and deprotection steps 
required in chemical syntheses (Lye et al, 2002).
Further to these reactions that have already been exploited, work is currently 
being done on two new classes of reaction; asymmetric carbon-carbon bond 
formation, which can be done enzymatically through transketolase or aldolase, in 
order to create new chiral centres with high optical purity, and selective 
oxidation reactions. Whole cell systems have been developed where hydroxyl 
groups or oxygen can be inserted at specific positions on complex molecules 
with no requirement for protecting groups (Lye et al, 2002). Such asymmetric 
addition will increase the stereospecificity of enzymes and will reduce the 
problem of low enantiomeric yield.
1.2 Modes of biocatalysis
Bioconversions can be operated in two modes: whole cell, and isolated enzyme. 
In the first case the microbial culture is grown in a fermenter to a defined cell 
density, and the enzyme substrate (reactant) is added. After a set time period, the 
product is recovered from the broth. A number of challenges result from this
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approach, primarily that the product must be separated from the unused broth 
components, and other products of the cells metabolism. Further to this, the 
optimum conditions for the bioconversion may not be the same as the optimum 
conditions for cell growth. This latter problem can be overcome by harvesting 
the cells and charging them into another vessel for the bioconversion (Ballard et 
al, 1983).
However, whole cell systems do offer certain critical advantages. Enzymatic 
redox reactions are highly efficient, and where regio- or stereoselectivity is 
required enzyme routes are often the best choice for an efficient process. The 
redox cycles in the cell require enzyme cofactors to donate or accept electrons, 
and these must be subsequently regenerated to their original state to catalyze 
another reaction, since the concentration of cofactor in the cell is finite (Endo 
and Koizumi, 2001).
In response to the co-factor regeneration problem robust whole cell systems have 
been developed for enzymatic redox reactions requiring a cofactor. The US 
company Eli Lilly developed the whole cell system in which a prochiral ketone is 
reduced to an optically active secondary alcohol, in the presence of the cofactor 
NADH2 (Anderson et al, 1995).
Zygosaccharomyces
rouxii
NADPH NADP
3,4-methylenedioxyacetophenone (S)-(3,4-methylenedioxyphenyl)-2-propanol
Figure 1.2 Whole cell Zygosaccharomyces rouxii dehydrogenase bioconversion (Anderson et al, 
1995).
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The use of isolated enzymes for bioconversions is the ideal solution for 
conversions that do not require cofactors. This approach eliminates the difficult 
task of isolating the desired product from the much more complex mixture of 
compounds in the case of whole cell mediated conversions, such as in the use of 
Pseudomonas putida for the conversion of aromatics to their corresponding cis- 
diols (Ballard et al, 1983).
Recent advances in enzymatic synthesis have led to two potential approaches for 
in situ recycling of co-factor within an isolated enzyme bioconversion. The first 
is a coupled substrate approach where a single enzyme is used to effect the 
desired reduction of, for example, a ketone to an alcohol at the expense of one 
co-factor molecule which is then recycled by the oxidation of, commonly, iso 
propyl alcohol. The second approach is a coupled enzyme approach where 
enzyme A effects the required reaction at the expense of a cofactor molecule and 
enzyme B effects the reaction of a cosubstrate recycling the cofactor. These 
approaches were described by Kroutil and co-workers (2004) and can be seen in 
Figure 1.3.
Enzyme isolation and purification was initially very difficult due to the lack of 
techniques for the large-scale release of enzymes from the interior of cells, so 
that only those enzymes that were secreted into the fermentation broth could be 
isolated, or the limited number of enzymes that could be released intact through 
chemical lysis. The development of a high pressure homogeniser however 
allowed industrial scale access to enzymes found in the cytoplasm, which vastly 
increased the number of enzymes available for use (Hetherington et al, 1971).
33
Chapter 1
(a)
OH
Single enzyme Y
( A D H )  N A D ( p )
N A D ( P ) H
OH
(b)
Enzyme A
NAD(P)NAD(P)H
Cosubstrate Coproduct
Enzyme B
Figure 1.3 The alternatives for the regeneration of the cofactor in isolated enzyme 
bioconversions: (a) co-substrate (b) co-enzyme methods (Kroutil et al, 2004).
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The cost of producing and isolating an intra-cellular enzyme is still too high to 
justify a single use approach (Marin-Zamora et al, 2006). Along with the 
advances in access to intra-cellular enzymes, work was being carried out to 
immobilise water-soluble enzymes into solid forms that could be more readily 
recovered and reused (Hong et al, 2007). Numerous techniques to immobilise 
catalysts were developed which included, for example, the ionic or covalent 
binding of the enzyme to a porous particle (Hou et al, 2007). Similar techniques 
can be applied to whole cells, by entrapping the catalyst in a porous structure 
akin to that used in the case of an isolated enzyme (Petre et al, 1999; Becerra et 
al, 2001; Trelles et al, 2004; Tamalampudi et al, 2007).
A number of process options are consequently available for bioconversions, and 
these decisions have formed the basis for biocatalytic processes for many years.
Enzyme
Immobilised
cellImmobilised
enzyme
+ Product(s)Reactant(s)
Fermentation
Organism
Bioconversion
Figure 1.4 Alternative processing routes for bioconversion processes (Lilly, 1994).
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1.3 Biocatalysis in pharmaceutical synthesis
A critical factor in determining the safety and efficacy of pharmaceutical drug 
products is the chirality of the product, so production of chiral intermediates as 
single enantiomers has become a critical feature of synthesis in the 
pharmaceutical industry (Patel, 2006). In view of the well known advantages of 
biocatalysis relative to chemical synthesis, i.e. the highly enantioselective and 
regioselective nature of enzymes, and the ability to conduct reactions at ambient 
temperatures and atmospheric pressure, biocatalysis is being applied to many 
organic syntheses (Sheldon et al, 2002; Patel, 2004a; Turner, 2004; Faber and 
Kroutil, 2005; Robertson and Bomscheuer, 2005; Ishige et al, 2005). However, 
the application of biocatalysis to the synthesis of pharmaceuticals will be 
focussed upon here.
The process for the production of the HIV-1 protease inhibitor Atazanavir (Bold 
et al, 1998) by Novartis Pharma AG (Basel, Switzerland) includes an asymmetric 
whole cell reduction of an aromatic ketone to chiral alcohol described in Figure 
1.5. The whole cell route yielded the desired 1(5),2(R) enantiomer in 99.4% 
excess and over 90% yield (Patel et al, 2003). In contrast chemical reduction by 
sodium borohydride mainly produced the undesired enantiomer (Xu et al, 2002).
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Boc
Rhodococcus erythropolis 
SC 13845
Figure 1.5 The reduction of a Boc protected ketone to its corresponding (S) alcohol by R. 
erythropolis SC 13845 critical in the synthesis of Atazanavir.
Bristol-Myers-Squibb developed the serotonin 5-HTiA receptor modulator 
Buspirone (Fulton and Brogden, 1997). In this case it was shown that the two 
enantiomers of hydroxybuspirone were effective in treating anxiety but the (S) 
enantiomer was desired as it was cleared more slowly from the blood stream. It 
was found that racemic 6 -acetoxybuspirone could be converted by amano 
acylase 30000 in 46% yield with 96% excess of the desired (5)-6- 
hydroxybuspirone (Hanson et al, 2005a). This is shown in Figure 1.6.
N'
amano acylase 3 0 0 0 0 ^
■CH3
OH
6-acetoxybuspirone (racem ic) (5>6-hydroxybuspirone
Figure 1.6 Reduction of 6-acetoxybuspirone to (5)-6-hydroxybuspirone by amano acylase 30000 
in the synthesis of Buspirone.
37
Chapter 1
A further product developed by Bristol-Myers-Squibb is a tyrosine kinase 
synthesised anti cancer compound requiring 0S)-2-Cl-l-(3-chlorophenyl)ethanol 
as an intermediate. A screen of ~ 100 microbial cultures found that the desired 
enantiomer could be produced with ~73% excess by Hanseula polymorpha SC 
13824 and Rhodococcus globerulus SC 16305. The enzyme from H. polymorpha 
was subsequently isolated and purified to yield the desired alcohol with 1 0 0 % 
excess (Hanson et al, 2005b). The reaction is described in Figure 1.7.
OH
Cl
,CI
6-phosphogluconic acid
Hansenula polymorpha 
ketoreductase cloned in 
E. coli
NADPNADPH
Cl
Glucose-6-phosphate
Figure 1.7 The reduction of 2-Cl-l-3-chloroacetophenone to (S)-2-Cl-(3-chlorophenyl) ethanol 
by a ketoreductase cloned from H. polymorpha.
The microbial reduction of the multi substituted aromatic ketone 2-bromo-4- 
fluoro acetophenone to its corresponding (S) alcohol is a key step in the synthesis 
of potential drugs for the treatment of Alzheimer’s disease (Anderson et al, 
2005). Numerous micro organisms were found through screening from the 
genera Candida, Hansenula, Pichia, Rhodotorula, Saccharomyces, 
Sphingomonas and Baker’s yeast that effected the reduction with a >90% yield
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with the desired enantiomer in >99% excess (Patel et al, 2004b). The reaction is 
described in Figure 1.8.
Microorganisms
Figure 1.8 The reduction of 2-Br-4-F-acetophenone to (S)-2-Br-4-F-acetophenyl alcohol by various 
microorganisms.
Many more examples abound in the literature of the production of single 
enantiomers of drug intermediates in the pharmaceutical industry (Gijsen and 
Wong, 1995; Vicenzi et al, 1997; Patel et al, 1998; Campos et al, 2000; Pamies 
and Baeckvall, 2001; Robertson et al, 2004; Soni and Banerjee, 2005). 
Particularly, the asymmetric reduction of prochiral ketones to chiral alcohols is a 
critical step in the synthesis of such drug compounds (Hummel et al, 2003; 
Hanson et al, 20056; Pollard et al, 2006b). Thus the drive towards more efficient, 
economic biocatalytic processes is critical to the development of more complex 
pharmaceutical products. Some of the recent innovations in biocatalysis to meet 
the industrial needs are discussed in the following sections.
1.4 Biocatalysis in unconventional media
Many of the compounds of commercial interest that have the potential to be 
converted by enzymes or microorganisms are poorly soluble in aqueous media,
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and as a consequence biocatalysis in organic media has been established (Leon et 
al, 1998). Thus many biocatalytic steps run as biphasic systems which often 
comprise a first phase which is aqueous, containing the biocatalyst and a second 
organic phase which is comprised of the solvent and the enzyme substrate.
It has been observed that placing enzymes in anhydrous environments can adapt 
their functionality. In water, numerous lipases, esterases and proteases catalyse 
the hydrolysis of esters to their corresponding acids and alcohols, but in 
anhydrous solvents the same enzymes catalyse transesterification reactions when 
supplied with the appropriate nucleophile, in this case alcohols (Klibanov, 2001). 
The catalytic activity of enzymes in neat organic solvents is much lower than in 
aqueous systems as was demonstrated by Lee and Dordick (2002).
This is not necessarily a problematic limitation. In the cases of a-chymotrypsin 
and subtilisin the specificity constant of a transesterification reaction in 
anhydrous octane exceeds the rate constant without enzyme by 1 0 11 fold; a very 
useful improvement. Further, in hydrous solvents activity can be comparable to 
those in water when coupled with other advantages of organic solvent systems, 
e.g. polyphenol oxidase in octanol containing 3% water retains half of its activity 
in water (Klibanov, 1997).
The use of organic phases in biphasic systems to remove toxic products from 
aqueous phases during bioconversion can have detrimental effects on whole cell 
biocatalysts due to their toxicity (Cruz et al, 2004). However a number of 
Pseudomonas, Bacillus and Rhodococcus strains have been isolated that exhibit
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strong solvent tolerance (de Bont, 1998). These solvent tolerant bacteria will 
allow whole cell biotransformations to be carried out in previously inhospitable 
environments, where substrate solubility may be greatly enhanced potentially 
resulting in very high productivity.
1.5 Ionic liquids
Ionic liquids are liquids composed entirely of ions, that are liquid at, or close to, 
room temperature, have low viscosity, and are ‘easy to handle’ (Sheldon, 2001). 
They have negligible volatility, low flammability, low toxicity, they are liquid 
over a wide temperature range (from -80°C to 200°C), they typically exhibit 
Newtonian rheology and they may be said to have tunable physicochemical 
properties (Roberts and Lye, 2002). This last characteristic has earned ionic 
liquids the accolade of ‘designer solvents’, since their polarity, hydrophobicity, 
and solvent miscibility behaviours can be tuned through the appropriate 
modification of the cation and anion (van Rantwijk et al, 2003).
Generally room temperature ionic liquids are salts of organic cations such as 
tetraalkylammonium or tetraalkylphosphonium, as shown in Figure 1.9. The first 
ionic liquid described was ethylammonium nitrate, which is liquid at room 
temperature, and this was reported in 1914. This was not a true ionic liquid by 
the modem definition as it contained 200-600ppm water. The first example of a 
true, modem ionic liquid was ethylmethylimidazolium tetrafluoroborate (Wilkes 
and Zaworotko, 1992). The corresponding hexafluorophosphate quickly followed
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this (Fuller et al, 1994) and subsequently a plethora of room temperature ionic 
liquids have followed.
Ionic liquids can be prepared by the direct quatemisation of an appropriate amine 
or phosphine, and different anions can be added through anion exchange. 
However, due to the low vapour pressure of ionic liquids they cannot be purified 
through distillation, rather, their production must be closely monitored to ensure 
high purity (Sheldon, 2001).
CATIONS
R1 .
/ N t
R2 I R3 
R4
R1
/ P t
R2 I R3 
R4
R1
R2 R3
+
ANIONS BF4\  PF6-, SbF6', N 0 3\  CF3 S 0 3\  (CF3 S 0 3 )2N’, ArSOf,
CF3 C 0 2’, CF3 S 0 3 CH3 C 0 2', A12 C17'
Figure 1.9 Structures of ionic liquids (Sheldon, 2001).
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The hydrophilicity of ionic liquids can be regulated through the choice of anion 
added to the cation. The ionic liquid [Bmim][BF4 ] is almost completely miscible 
with water but the [PF6 ] salt of the same cation is largely immiscible with water. 
Conversely, the chain length of the R groups of the cation regulates the 
lipophilicity of dialkylimidazolium salts and also of other ionic liquids (Sheldon,
2001).
1.6 Catalysis in ionic liquids
Applications of ionic liquids in catalysis are concentrated in two distinct 
directions; the first is that they replace organic solvents due to their unique 
properties as solvents, and the other is to replace liquid acids due to their variable 
acidities (DeCastro et al, 2000; MacFarlane et al, 2006). Applications of ionic 
liquids in place of organic solvents have taken place for example in dimerization 
reactions (Adams et al, 2000), Heck reactions (Carmichael et al, 1999), Friedel- 
Crafts acylations (Adams et al, 1998) and hydrogenation reactions (Suarez et al, 
1996). Generally it has been found that the reaction rate, conversion and 
selectivity of the catalyst are enhanced in the ionic liquid compared to the 
organic solvent. Currently biphasic reaction systems run as aqueous-organic 
systems with water forming the bulk of the aqueous phase. This system can be 
improved through the use of ionic liquids in place of water. The main 
disadvantage of the traditional system was that catalyst ligands had to be 
modified in order to ensure that the catalyst was soluble in water. The protic 
nature of water also caused many problems which meant that water itself was
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reactive with organometallic catalysts. Ionic liquids, through their inherent 
properties, relieve all of these problems (Zhao et al, 2002).
Ionic liquids have already been used in a number of catalysis reactions, and these 
can be categorised as hydrogen addition or rearrangement reactions, C-C and C- 
O cleavage reactions and C-C or C-heteroatom coupling reactions (Zhao et al,
2002).
Homogeneous hydrogenation has been attempted for some years in a biphasic 
system, with the reaction being catalyzed by transition metal complexes (Joo et 
al, 1999; Heinen et al, 1999). Use of traditional aqueous-organic solvent systems 
presented a significant problem in the necessity to modify the ligands of the 
complex to facilitate water solubility. The catalyst [RuCl2 -(5 )-BINAP]2 -NEt3 can 
be used to catalyze an asymmetric dehydrogenation reaction. The catalyst can be 
dissolved in the ionic liquid [Bmim][BF4 ] without any need for modification and 
used in a biphasic system with isopropanol. The system is capable of 
hydrogenating 2 -arylacrylic acids with enantioselectivities higher than those 
obtained in homogeneous media (Monteiro et al, 1997).
[R u-(S)-BINA P]/H 2/[Bm im ][BF4]/i-PrOH
Figure 1.10 Asymmetric hydrogenation by Ruthenium catalyst in the presence of [Bmim][BF4] 
(Monteiro et al, 1997).
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The post reaction separation is also much simpler in the ionic liquid system, and 
can be achieved through simple decantation. The ionic liquid phase, containing 
the catalyst, can be recycled without significant changes in activity or selectivity 
(Monteiro et al, 1997).
Isomerization is of great industrial importance, and has been done in the past 
through aqueous-organic biphasic systems with limited success; very low 
reaction rates were observed and this was attributed to the poor solubility in 
water of organic substrates. Also the protonation ability of water makes a number 
of the ruthenium and rhodium complex catalysts unstable in such systems. A new 
approach involves the use of ionic liquids based on l-«-butyl-3- 
methylimidazolium salts as non aqueous solvents for rhodium catalysed two- 
phase hydrogenation, isomerisation, and hydroformylation of unsaturated 
substrates. It was identified that catalysts could be immobilised in these solvents 
liquids due to their ionic characters. [Bmim] salts of [SbF6 ], [BF4 ], and [Q 1CI2 ] 
were applied to the hydrogenation of pent-l-ene using the Osborn complex and 
competitive isomerisation was observed in the ionic liquid (Chauvin et al, 1996).
Carbon-carbon bond cleavage reactions are of significance in many industries. 
The cracking of polyethylene is a very important process in plastics recycling, 
and is commonly carried out by pyrolysis, catalytic cracking with acidic 
materials and reactions in supercritical water (Zhao et al, 2002). The process has 
been carried out in the ionic liquid 1 -ethyl-3-methyimidazolium chloride- 
aluminium (III) chloride yielding C3 -C5 gaseous alkanes and branched cyclic 
alkanes all of which are useful feedstocks to a number of processes (Adams et al,
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2000). The low volatility and high stability of the ionic liquid allowed the 
reaction to be carried out at various temperatures and it was observed that the 
products of the reaction differed with the temperature at which it was carried out. 
The product distributions were observed to be independent of the choice of 
cation.
The cleavage of ethers has been investigated in ionic liquids derived from 1,3- 
dialkylimidazolium cations and various anions such as tetrafluoroborate, 
hexafluorophosphate, and heptachlorodialuminate, and the system has been 
shown to hold many advantages over conventional molecular solvents (Green et 
al, 2000). The numerous advantages afforded by ionic liquids through their 
negligible vapour pressure and large liquid range make them an ideal medium in 
which the kinetics of ether cleavage can potentially be enhanced.
o
[Emim][Al2X7]
Figure 1.11 Acylative ether cleavage in the presence of an ionic liquid (Green et al, 2000).
Carbon-carbon coupling reactions have great commercial importance, such as in 
the Friedel-Crafts alkylations and acylations, and the Diels-Alder reactions. In 
the case of the Diels-Alder reaction, its usefulness lies in the high yields
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achievable and the high stereospecificty achievable, which is of particular 
interest in the synthesis of natural products and physiologically active molecules 
(Lee, 1999). The most successful medium in use was based on lithium 
perchlorate-diethyl ether (LDPE) mixtures in which a greatly improved reactivity 
was observed due to the increased internal pressure, and the lithium ion acting as 
a Lewis acid. Diels-Alders reactions have been performed in a range of [Bmim] 
based ionic liquids where similar rate enhancements and selectivities have been 
observed as in LDPE. The advantages of using room temperature ionic liquids 
over LDPE are numerous but most significantly they have no measurable vapour 
pressure, can be recycled, are non-explosive, are stable over a wide temperature 
range and are more convenient to use (Earle et al, 1999).
1.7 Biocatalysis in ionic liquids
Whole cell biocatalytic systems are also capable of being run in ionic liquids. 
The stability of Rhodococcus R312 has been established in the ionic liquid 
[Bmim][PF6 ] as an alternative to the previous toluene water biphasic system. It 
was found that the specific activity of the biocatalyst in the water-[Bmim] [PF6 ] 
was almost an order of magnitude greater than in the water-toluene system (Cull 
et al, 2 0 0 0 ).
The behaviour of the cells in the two systems is of great interest. It was observed 
in the water-toluene system that the cells tended to aggregate and were closely 
associated with the liquid-liquid interface whereas the cells did not aggregate in 
the water-ionic liquid system. This is of great benefit down stream where product
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recovery would be easier, and recycling and reuse of the ionic liquid phase, and 
potentially the biocatalyst, becomes more readily achievable (Cull et al, 2000).
Work has also been done with immobilized baker’s yeast, involving the 
biocatalytic reduction of a ketone to its corresponding alcohol in the ionic liquid 
[Bmim][PF6 ]. In order to prevent the inactivation of the enzyme observed in 
organic solvents the ionic liquid was operated as a [Bmim][PF6 ]-water system in 
the ratio 10:1. The immiscibility of the ionic liquid with water created a biphasic 
system, and was seen to be the closest comparator to an organic solvent- water 
system. The bakers yeast was immobilised by encapsulation in calcium alginate 
beads and methanol was added as an energy source. The coenzyme NADPH is 
necessary for the reduction, but the cell is unable to recycle the cofactor in a non- 
aqueous environment so the reaction is limited by the initial concentration of 
NADPH in the cell (Howarth et al, 2001).
Immobilised Baker's Yeast
NADPH NADP
Figure 1.12 Ketone reduction by baker’s yeast in the presence of [Bmim][PF6] (Howarth et al, 2001).
Other work has also shown the biocompatibility of ionic liquids and their ability 
to support efficient whole cell bioconversion processes. In the case of the whole 
cell biocatalyst L. kefir in the presence of 3 different ionic liquids, [Bmim][PF6 ], 
[Bmim][Tf2N] and [OMA][Tf2N], the cell membrane was found to be stable to
48
Chapter 1
the same extent as in aqueous buffer, whereas in the presence of organic solvents 
such as MTBE membrane integrity was found to fall to less than 10% of the 
original (Pfruender et al, 2004). Further work by Pfruender and colleagues 
showed the importance of good distribution coefficients of the substrate and 
product between the two phases (Pfruender et al, 2006).
It has been known since the early 1980s that enzymes can be used in 
hydrophobic organic solvents, but at the price of a severely reduced reaction rate 
(Klibanov, 2001). However, it subsequently became clear that many lipases, as 
well as some proteases and acylases were so robust that they maintained their 
stability and activity in organic solvent environments (van Rantwijk et al, 2003). 
This much lower activity observed in organic solvents drove the emphasis 
towards extending the methods to ionic liquids.
The first successful isolated enzyme bioconversion in the presence of an ionic 
liquid was the thermolysin mediated synthesis of Z-aspartame, which was carried 
out in the hydrophobic ionic liquid [Bmim][PF6 ] containing 5% v/v water. The 
resulting reaction occurred at 40% of the turnover rate in ethyl acetate 
(Erbeldinger et al, 2000).
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Z-L-Asp-OH
L-Phe-OMe
OH
OMe
COOH
O
[Bmim][PF6], 5% v/v water 
Thermolysin
OMe
N
H
O
COOH
Z-Aspartame
Figure 1.13 Enzymatic formation of Z-Aspartame by thermolysin in the presence of [Bmim][PF6] 
and 5% v/v water (Erbeldinger et al, 2000).
However, the more significant result from Erbeldinger’s work was that the 
enzyme was stabilized by the ionic liquid to a much greater degree than was the 
case in ethyl acetate. In organic solvents enzyme half-life is a function of the 
physical properties of the solvent, but the polar yet hydrophobic property of the 
ionic liquid in question was considered critical in stabilising the enzyme.
Lipases from Candida antarctica have been shown to be active in the ionic 
liquids [BmimJfBFJ and also in another salt of the same cation, [Bmim][PF6 ]. 
Reaction rates in the ionic liquids were similar or better than those observed in 
organic solvents (Lau et al, 2000). However, it was noted from this early work 
involving biocatalysts in ionic liquids that there was some inconsistency in the
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results observed, and this was attributed to impurities resulting from the 
preparation of the ionic liquid. Therefore a purification step was recommended 
prior to use of the ionic liquid (Seddon et al, 2000; van Rantwijk et al, 2003).
The enzyme a-chymotrypsin mediates the trans-esterification of /V-acetyl-L- 
amino acid esters, and the activity of this enzyme has been investigated in the 
presence of five different ionic liquids based on dialkylimidazolium and 
quaternary ammonium cations associated with perfluorinated and bis 
(trifluoromethyl) sulfonyl amide anions at 2% v/v water content at 50°C (Lozano 
et al, 2001; Laszlo and Compton 2001; van Rantwijk et al, 2003). The polarity of 
the ionic liquid environment was found to be sufficient in [Bmim][PF6] and 
[Omim][PF6 ] to negate the requirement of water, which was needed to facilitate 
the reaction. It was found that in these liquids non polar SCO2 was a suitable 
alternative (Lozano et al, 2001).
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Figure 1.14 a-Chymotrypsin mediated transesterification in the presence of [Bmim][PF6] (Lozano 
et al, 2001).
Much of the work in this area thus far has focused upon isolated enzymes, 
particularly lipases (Park and Kazlauskas, 2001; Kaar et al, 2003; Zhao, 2005), 
with relatively few involving oxidations (Hinckley et al, 2002; Laszlo and 
Compton, 2002) or reductions (Eckstein et al, 2004). The work of Eckstein and 
co-workers involved the enantioselective reduction of 2 -octanone by alcohol 
dehydrogenase (ADH) isolated from Lactobacillus brevis in the presence of 
[Bmim][(CF3 S0 2 )2N]. However the initial ketone concentration in this study was 
low at < 1 gL"1. Where co-factor recycling has previously been employed in the 
case of redox bioconversions, it was by the addition of co-substrate. The
Chapter 1
enantioselective reduction of prochiral ketones to alcohols is an important 
reaction in the synthesis of pharmaceuticals (Patel et al, 2004a), but no other 
examples of ketone reductions by isolated enzymes in the presence of ionic 
liquids exist in the literature at the present time.
For biocatalytic applications ionic liquids have been shown to promote improved 
enzyme stability. The lipase Novozym 435 was shown to retain almost 3 times 
the retained activity observed in the presence of hexane after 24 hours incubation 
in the ionic liquid [MMEPHCH3 CO2 ] and twice as much in [Bmim][CH3C02] 
(Zhao, 2005). The activity of thermolysin was retained after incubation in 
[Bmim][PF6] for 144 hours whereas almost half of the original activity was lost 
after similar incubation in ethyl acetate (Erbeldinger at al, 2000). An esterase 
isolated from Bacillus stearothermophilus was found to be greatly stabilized in 
the ionic liquid [Bmim][PF6] with a half life of >240 hours which was a 30 fold 
increase over hexane and 3 times that in methyl tert-butyl ether (MTBE) 
(Persson and Bomscheuer, 2003).
1.8 M ultiparam eter flow cytometry
The response of whole cells to their environment has traditionally been assessed 
by techniques such as manual counts of colony forming units (Quiros et al, 
2007). These measures would therefore count those cells that are capable of 
dividing on the agar surface to which they are attached, but would not count cells 
that are “viable but unculturable” (Hewitt and Nebe von Caron 2001, 
Sachidanandham et al, 2005). This means cells that are capable of metabolic
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activity but are unable to divide. Multi parameter flow cytometry is an emerging 
method capable of detecting such subtle changes in the cellular state of bacteria.
A schematic of the operation of the flow cytometer is shown in Figure 1.15. The 
sample is carried in a fluid known as the sheath fluid, which regulates the system 
pressure and flow rate of material through it. The sample enters the flow cell 
where the stream is focussed to approximately a single cell flow by a focussing 
aperture. Here the sample is exposed to laser light at a wavelength of 488 nm. 
Scattered light from this exposure is detected at two angles: forward scatter in the 
plane of the light and side scatter at right angles to that plane. Emitted light from 
the fluorochromes is also detected at right angles to the plane of the laser. The 
light goes through a series of filters with an increasing wavelength cut off. Each 
of these reflects the light in their respective wave band to a photo multiplier tube 
that leads to a detector. By monitoring shifts in the intensity of reflected light, 
changes in cell characteristics can be determined.
Flow cytometry analysis of a cell population can reveal, at a cell by cell level, the 
physiological condition of a cell population such as cell viability, cell density, 
function or ion density. The parameters under investigation can be tuned 
according to the cell line by employing appropriate dyes that, upon excitation by 
a laser, emit at different wavelengths to allow analysis of multiple parameters per 
cell population in a single run.
54
Chapter 1
\ S s To CELL-SORTING 
or WASTEFILTERS
PMT 1 (RALS) 
PMT 2 (Green)
PMT 3 (Orange)
SAMPLE FLOW
FLOW CELL
SHEATH FLOW
PMT 4 (Red) PMT 5 (N. FALS)
Figure 1.15: schematic describing the operation of a flow cytometer (Hewitt and Nebe von Caron, 
2004).
Flow cytometry is built on the premise that a cell population can be identified 
through a characteristic size and “granularity”- determined through forward and 
side scattering of the laser in the system (Vale-Silva and Buchta, 2006). By 
“gating” this characteristic area and determining base values of fluorescence for 
each of the dyes on those events, changes can readily be identified by shifts in 
these fluorescence intensities.
In this work, two parameters will be determined: membrane potential and cell 
death. Membrane potential is achieved through the maintenance of a charge 
balance across the membrane by potassium/ sodium ion channels. The use of 
ATP by the cell causes 3 sodium ions to be pumped out of the cell and two 
potassium ions simultaneously pumped in resulting in a potential difference 
across the membrane. The maintenance of this potential difference can be taken
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as an indication of the metabolic activity of the cell, since cells not using ATP or 
unable to use it would be unable to maintain the charge imbalance. Membrane 
permeabilisation is not concomitant of depolarization however so membrane 
depolarisation can be taken as an indication of cell stress, and not cell death.
The most common membrane depolarisation dye in the literature is referred to as 
bis-oxonol (BOX) (Amanullah et al, 2003; Onyeaka et al, 2003). However this is 
actually a family of dyes including DiBAC4(3), DiSBAC2(3) and DiBAC4(5) 
with excitation maxima at 490 nm, 530 nm and 590 nm respectively. The most 
commonly used is DiBAC4(3) but all of them operate in the same manner. The 
dyes enter depolarized cells and bind to intracellular proteins or membranes and 
exhibit enhanced fluorescence and red spectral shifts. Increased depolarization 
leads to more influx of the dye and thus an increase in fluorescence. However the 
BOX family of dyes are not suitable for use with gram positive bacteria due to 
the presence of the peptido glycan cell wall (Figure 1.16(b)). The dye DiOC6(3) 
was identified as suitable for determining membrane potential of gram positive 
bacteria (da Silva et al, 2005, Reis et al, 2005).
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Figure 1.16 Graphical depiction of the cell wall of (a) a gram negative bacterium and (b) a gram 
positive bacterium. Images reproduced from
http://student.ccbcmd.edu/courses/bio 141 /lecguide/unit 1 /prostruct/u 1 fig 11 .html
1.9 The model systems used in this work
1.9.1 Reduction o f 6-Br-/3-tetralone to (S)-6-Br-j3-tetralol
Work at the Merck Research Laboratories, NJ, USA identified, through a 
microbial screening program, the yeast Trichosporon capitatum as a suitable 
biocatalyst for the asymmetric bioreduction of 6-Br-P-tetralone to its 
corresponding (S)-alcohol, (<S)-6-Br-p-tetralol (Reddy et al, 1996), shown in 
Figure 1.17.
6-Br-Tetralone (S)-6-Br-Tetralol
Figure 1.17 Asymmetric reduction of 6-Br-P-tetralone to (5)-6-Br-P-tetralol mediated by the 
yeast T. capitatum MY 1890 (Reddy et al, 1996) and R erythropolis MA7213 (Stahl et al, 1997).
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An aqueous system yields a 71.4% enantiomeric excess (ee) of the (5) 
enantiomer. This ee was established with the Trichosporon capitatum, and was 
the best of the range of microorganisms investigated. By using ethanol to a final 
concentration of 5-10% v/v an ee of 93% can be achieved in favour of the (S) 
enantiomer. This is due to the very low solubility of the p-tetralone. The system 
is operated at 28°C with orbital shaking to agitate the mixture. Increasing the 
temperature to 37°C resulted in a higher initial rate of tetralol production, but the 
final titer of tetralol was lower than when operating at 28°C. Further screening 
work identified the gram positive bacterium Rhodococcus erythropolis MA7213 
as another potential biocatalyst for this bioconversion (Stahl et al, 1997).
1.9.2 Reduction o f  4 ’-Br-2,2,2-trifluoroacetophenone to (R)-4’-Br-2,2,2~ 
trifluoroacetophenyl alcohol
Reduction of multi-substituted pro-chiral acetophenones for pharmaceutical 
synthesis has been previously reported with whole cell biocatalysis (Patel et al, 
2004) and by isolated enzymes (Pollard et al, 2006b). In these cases the 
acetophenones were either highly soluble in aqueous media (Patel et al, 2004) or 
the reaction conditions could be manipulated so that the substrate was readily 
converted by the biocatalyst of choice. In the particular case of the reduction of 
4’-Br-2,2,2-trifluoroacetophenone (Figure 1.18) the substrate is soluble in 
aqueous media to concentrations sufficient to drive the reaction but was found to 
have a deactivating effect on the biocatalyst. The application of room 
temperature ionic liquids seeks to address this bottleneck in chiral alcohol 
synthesis.
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(/?)-4'-Br-2,2,2-trifluoroacetophenyl alcohol
NADH NAD'
Gluconic acid Glucose
GDH 103
Figure 1.18 The asymmetric reduction of 4 ’-Br-2,2,2-trifluoroacetophenone to (R)-4-Br-2,2,2- 
trifluoroacetophenyl alcohol by alcohol dehydrogenase isolated from Rhodococcus erythropolis (ADH 
RE) and co-factor recycling by the glucose dehydrogenase 103 (GDH 103) mediated oxidation of 
glucose.
1.9.3 Oxidation o f  1-indanone to 3,4-dihydrocoumarin
The Baeyer-Villiger oxidation of 1-indanone to 3,4-dihydrocoumarin is mediated 
by the gram negative bacterium E. coli TOP 10 pQR239 (Gutierrez et al, 2003). 
The pQR239 plasmid confers cyclohexanone mono-oxygenase (CHMO) activity 
on the E. coli TOP 10 host isolated from Acetinobacter caloaceticus, as well as 
ampicillin resistance useful as a selection marker (Doig et al, 2001). Literature 
data has shown the bioconversion shown in Figure 1.17 proceeds with 
“minimum conversion” in the presence of 10% v/v ethanol (Gutierrez et al,
2003). The potential for ionic liquids to be used to achieve a greater conversion 
is investigated here through the use of flow cytometry to identify potential 
biocompatible ionic liquids.
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E.coli TOPIO pQR239
1-indanone 3,4-dihydrocoum arin
Figure 1.19 The CHMO mediated oxidation of 1-indanone to 3,4-dihydrocoumarin by E. coli TOPIO 
P Q R 2 3 9 .
1.10 Aims and objectives
The application of biocatalysis in pharmaceutical synthesis today is dependent on 
the ability to rapidly screen biocatalysts and process conditions to overcome the 
relatively fast development of comparable chemical processes to produce the 
desired chiral centre (Pollard and Woodley, 2007). Biocatalyst screening is 
relatively simple compared to process screening as it is most often dependent on 
the ability of a given biocatalyst to produce a particular optically active product 
in sufficient excess. This is usually a more important consideration than 
conversion or rate of reaction as these are more readily manipulated through 
engineering parameters such as mixing conditions, co-solvent fraction and 
substrate feeding rates. However, as mentioned previously, the propensity for 
compounds of pharmaceutical interest to be poorly aqueous soluble makes co­
solvents a critical component of process screening, in order to regulate the supply 
of substrate to the environment of the biocatalyst and remove product to drive the 
reaction. In the case of organic co-solvents the log P scale exists to identify 
solvents more likely to support a biocatalyst in it’s active form, but no such scale
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exists for ionic liquids. The primary aim of this thesis is to identify the factors 
critical in selecting a co-solvent for biocatalysis and to rank these factors in order 
of their priority. The specific objectives of this study are summarised below:
• The reduction of 6-Br-p-tetralone to (5)-6-Br-p-tetralol mediated by the 
whole cells Trichosporon capitatum MY 1890 and Rhodococcus 
erythropolis MA7213 will be used to determine the feasibility of ionic 
liquids as co-solvents for biocatalytic reduction. The effect of the ionic 
liquids on the viability of the whole cell biocatalysts will be determined 
and the effects of these changes in viability on the bioconversion 
efficiency.
• The potential for multi-parameter flow cytometry to be used as a tool for 
identifying biocompatible ionic liquids will be assessed. Two strains will 
be investigated: the gram positive bacterium R. erythropolis MA7213 and 
the gram negative bacterium Escherichia coli TOPIO pQR239. The 
selection of ionic liquids will be subsequently tested through the 
oxidative bioconversion of 1-indanone to 3,4-dihydrocoumarin mediated 
by the CHMO expressing E. coli TOPIO pQR239.
• Further to the use of whole cells for Redox bioconversions, the potential 
for ionic liquids to be used as co-solvents in the isolated enzyme 
mediated reduction of 6-Br-p-tetralone to (S)-6-Br-p-tetralol and 4’-Br- 
2,2,2-trifluoroacetophenone to (7?)-4’-Br-2,2,2-trifluoroacetophenyl 
alcohol with in situ co-factor recycling will be assessed. The effects of 
ionic liquids on the stability and activity of the enzyme will be 
investigated and subsequent effects on reaction kinetics.
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• A conceptual framework for the selection of ionic liquid co-solvents for 
biocatalytic applications will be presented. The potential for this system 
to be automated and the units integrated will be assessed.
Finally, as part of the Engineering Doctorate requirements of the University of 
London, a brief appraisal of the Bioprocess Validation and Bioprocess 
Management consequences of the research will be presented.
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2 Materials and Methods
2.1 Chemicals and microorganisms
All chemicals were obtained from Sigma-Aldrich Co. Ltd. (Poole, Dorset, UK), or 
from Merck KGaA (Darmstadt, Germany), and were of the highest purity available. 
The 6-Br-p-tetralone, 6-Br-p-tetralol, T. capitatum MY 1890 and R. erythropolis 
MA7213 were kindly provided by Merck Research Laboratories, Merck & Co. Inc. 
(Rahway, NJ, USA). The E. coli TOPIO pQR239 was kindly provided by Dr J. Ward, 
Depart of Biochemistry, University College London, UK. Ionic liquids were obtained 
from Solvent Innovation (Cologne, Germany) and were of >98% purity. All enzymes 
were procured from Biocatalytics Inc (California, USA).
2.2 Ionic liquid preparation
The hydrophobic ionic liquids were washed with water to remove any soluble 
impurities for whole cell reactions. The removal of, particularly acid, impurities was 
required in order to operate 6-Br-p-tetralone reactions (Chapter 3) between pH 6.5 to
7.0 in the aqueous phase. [Bmim][PF6] was washed with 10 equal volumes of Reverse 
Osmosis (RO) water, with the pH of the final wash being ~6.5. [Oc3MeN][NTf2] was 
washed with 5 equal volumes of RO water, with a final pH of the wash solution close 
to 7. The hydrophilic ionic liquids were used as supplied.
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2.3 Quantification of substrate solubility
500 mg of substrate was weighed into a 1.5 mL HPLC vial and 1 mL of the 
appropriate solvent was added. These were then shaken at 1400 rpm at 30°C on a 
thermomixer (Eppendorf) for 24 hours. After 24 hours the samples were removed and 
allowed to settle before 50 pL was taken and diluted into 950 pL acetonitrile and 
assayed for substrate content by reverse phase HPLC (Section 2.8.1). Aqueous 
solubility curves were generated by taking the appropriate amount of these samples 
and adding to 100 mM KH2 PO4  buffer (pH~7.0) to a total volume of 1 mL. The vials 
were returned to identical conditions as above and allowed to equilibrate for a further 
24 hours. The samples were then allowed to settle before 50 pL was taken and diluted 
into 450 pL acetonitrile in a dead end filter vial to ensure no solids proceeded to 
solute analysis.
2.4 Quantification of substrate extraction
500 pL of ionic liquid was saturated with substrate as described in Section 2.3 and 
undissolved solid removed using a dead end filtration vial. 500 pi of various pure 
organic solvents were then added and the mixture returned to the thermomixer and 
allowed to mix for 3 hours at 1400rpm. For immiscible solvents, a sample of both 
phases was taken, dissolved in acetonitrile and the substrate concentration was 
determined by reverse phase HPLC analysis (Section 2.8.1). Extraction efficiency was 
subsequently determined as the percentage of substrate transferred to the organic 
solvent phase.
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2.5 Enzyme screening
A total of 66 commercially available keto-reductase preparations were used each at a 
concentration of 2 gL'1 in 100 mM potassium phosphate dibasic buffer containing 1.2 
molar equivalents of NADH or NADPH based on the co-factor dependency of the 
enzyme. Substrate (10 gL'1 final concentration) was delivered into the reaction in 10% 
v/v toluene. After 5 hours incubation at 30°C reactions were sampled into acetonitrile 
(to a 1/20 dilution) for reverse phase HPLC analysis (Section 2.8.1), then dried down 
under nitrogen and resuspended in methanol for chiral HPLC analysis (Section 2.8.2).
2.6 Microbial cultivation
T. capitatum MY1890. A frozen suspension of cells stored at -80°C in 25% v/v (final) 
glycerol was thawed at room temperature and used to inoculate a 250 mL Erlenmeyer 
flask containing 50 mL of broth comprising 30 gL'1 glycerol, 25 gL'1 hysoy peptone, 
and 20 gL '1 yeast extract. This had been autoclaved at 121°C for 15 minutes prior to 
use. The culture was aerobically incubated at 28°C on an orbital shaker at 220 rpm. 
Bioconversion was initiated after 36 hours growth.
R. erythropolis MA7213. A frozen suspension of cells stored at -80°C in 25% v/v 
(final) glycerol was thawed at room temperature and was used to inoculate a 250 mL 
Erlenmeyer flask containing 50 mL of autoclaved (121°C for 15 minutes) Tryptic Soy 
Broth (TSB, 30 gL'1). The culture was aerobically incubated at 30°C on an orbital 
shaker at 200 rpm. Bioconversion was initiated after 20 hours growth.
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E. coli TOPIO pQR239: a frozen suspension of cells stored at -80°C in 25% v/v (final) 
glycerol was thawed at room temperature and was used to inoculate a 250 mL 
Erlenmeyer flask containing 50 mL of broth containing 10 gL'1 soya bean peptone, 10 
gL'1 glycerol, 10 gL'1 sodium chloride and 25 gL'1 yeast extract. This was autoclaved 
(121°C for 15 minutes) and prior to use 400 mgL'1 ampicillin was added. The culture 
was aerobically incubated at 37°C on an orbital shaker at 200 rpm. After 3 hours 
cultivation 2.6 gL'1 L(+)-arabinose was added as an inducer of CHMO expression. 
Bioconversion was initiated after a further 4 hours growth.
2.7 Bioconversion kinetics
2.7.1 Whole cell bioconversions
After the appropriate cultivation time for each microorganism the ‘standard’ (or 
control) bioconversion was initiated by the addition of 5 mL of an ethanol solution 
directly to the fermentation flask. In the case of T. capitatum MY1890 (Reddy et al, 
1996), this contained 55 mg of 6-Br-P-tetralone while in the case of R. erythropolis 
MA7213 it contained 22 mg of 6-Br-p-tetralone. Where ionic liquids were employed 
20 mg of 6-Br-p-tetralone in the case of T. capitatum MY1890 and 10 mg in the case 
of R. erythropolis MA7213 was first dissolved in 1 mL of ionic liquid in a glass 
HPLC vial and made up to 4 mL in a sterile 250 mL Erlenmeyer flask. To initiate the 
bioconversion, 16 mL of fermentation broth was added into the ionic liquid. The 
culture was returned to the same incubation conditions (pH ~6.5, 30°C, 200 rpm) for 
the duration of the bioconversion.
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The extent of conversion was monitored by regular sample collection. In the case of 
water miscible, single phase forming ionic liquids, the samples were centrifuged at
13,000 rpm for 5 minutes in a refrigerated benchtop centrifuge and the supernatant 
was taken and stored at 4°C prior to analysis. For water immiscible ionic liquids that 
formed two-phase systems, the samples were similarly centrifuged but the cell free 
ionic liquid phase was taken and diluted in acetonitrile prior to analysis. All 
bioconversions were performed in triplicate.
In the case of 1-indanone oxidation by E. coli TOPIO pQR239 the culture was grown 
for a further 4 hours after induction by L(+)-arabinose (total 7 hours cultivation). The 
cells were then pelleted by centrifugation at 4,000 rpm for 3 minutes. The media was 
removed without disturbing the pellet and the cells were resuspended in 20 mL 100 
mM potassium phosphate dibasic buffer (Cruz et al, 2004). The substrate was pre­
dissolved in 5 mL of appropriate co-solvent such that the final concentration was 0.5 
gL'1. Bioconversion was initiated by the addition of the substrate/co-solvent mixture 
to the cells and the flask was returned to the previous incubation conditions. 
Conversion was monitored by regular sample collection and samples were prepared 
for reverse phase HPLC analysis (Section 2.8.1) as described above.
In the case of miniature bioreactor scale bioconversions with whole cells, T. 
capitatum MY1890 was cultured for 36 hours as described in Section 2.6. The cell 
suspension was subsequently centrifuged at 4000 rpm in a Sorvall centrifuge for 5 
minutes to pellet the cells. The media was removed and the cells were subsequently 
resuspended in 50 mL KH2 PO4  buffer. 16 mL of the resuspended cells were pipetted 
into a Multimax™ miniature bioreactor which contained 4 mL of [Bmim][PF6] with
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6-Br-p-tetralone pre-dissolved to give an overall concentration of 1 gL'1. In parallel, a 
shake flask bioconversion was carried out using the same cell suspension as described 
above. Conversion in both cases was monitored by reverse phase HPLC analysis 
(Section 2.8.1).
2.7.2 Isolated enzyme bioconversions
The initial screening of bioconversions involving a range of co-solvents was carried 
out at 10 mL reaction volume in jacketed, cone shaped pH stats (Mettler Toledo). 500 
mg substrate was added directly to the vessel and the appropriate co-solvent added. 
They were then mixed to dissolve the substrate at 30°C. Mixing of each vessel was by 
a magnetic stirrer bar (d = 10 mm) at high speed. After 1 hour, 7 mL of buffer was 
added with glucose (for co-factor recycling) pre-dissolved to give a final overall 
concentration of 1.5 molar equivalents of substrate. NAD was dissolved in 1 mL of 
buffer to give a final NAD concentration of 1 gL'1, and was added to the vessel. The 
pH was then corrected to 6.8 ± 0 .1 . Once the pH was appropriately adjusted, 1 mL 
further of buffer was added containing ADH RE and GDH 103 to final concentrations 
of 5 gL'1 and 1 gL'1 respectively. Samples of 50 pL were regularly taken to determine 
the extent of conversion by dissolving them into 950 pL acetonitrile in a HPLC vial. 
These were then further diluted 1/10 into acetonitrile and assayed by reverse phase 
HPLC (Section 2.8.1).
Subsequent studies of bioconversion kinetics were performed in miniature 
Multimax™ reactors (Mettler Toledo, Columbia, MS, USA) of 30 mL reaction 
volume fitted with overhead pitched blade impellers (dj = 24mm). The vessel was
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heated by a circulating water jacket and temperature and pH were continuously 
monitored. Reactions were performed as in the pH stat experiments with adjustments 
made for the additional volume.
In both configurations pH in the aqueous phase was controlled by the addition of 2.0 
N sodium hydroxide.
2.8 Analytical methods
2.8.1 Reverse phase HPLC analyses
A Dionex DX 500 HPLC system (Surrey, UK) equipped with a Zorbax RX-C8 
column (4.6mm x 25cm) (Mac-Mod Analytical, Chadds Ford, PA, USA) was 
employed for quantification of the substrate 6-Br-p-tetralone and the product 6-Br-p- 
tetralol. Separation was by isocratic elution using a mobile phase of acetonitrile (50% 
v/v) and acidified water (0.1% v/v 3M phosphoric acid) at a flow rate of 1.0 mL min' 
l. Detection was by UV detector at 220 nm. The maximum coefficient of variance of 
this assay was 3.8%.
A rapid assay was also developed where an Agilent series 1100 HPLC system 
equipped with a Zorbax SB-C18 column (4.6 mm x 50 mm) (Mac-Mod Analytical, 
Chadds Ford, PA, USA) was employed for the separation of 6-Br-p-tetralone and 6- 
Br-p-tetralol by isocratic elution with a mobile phase of 50% v/v acetonitrile and 
acidified water (0.1% v/v phosphoric acid) at a flow rate of 1.0 mL min'1. Detection
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was by UV detector at 220 nm. The assay runtime was 4 minutes with substrate 
eluting at 2.2 minutes and product at 1.6 minutes.
In the case of 4 ’-2,2,2-trifluoroacetophenone an Agilent series 1100 HPLC system 
equipped with a Zorbax SB-C18 column (4.6 mm x 50 mm) (Mac-Mod Analytical, 
Chadds Ford, PA, USA) was employed for the separation of the substrates and 
products. Separation was by isocratic elution by a mobile phase of 60% v/v 
acetonitrile and acidified water (0.1% v/v phosphoric acid) at a flowrate of 1.75 mL 
min'1. Detection was by UV detection at 215nm and the assay runtime was 5 minutes 
with substrate eluting at 1.3 minutes and product at 2.6 minutes. The maximum 
coefficient of variance observed was 4.3%.
For the separation of 1-indanone and 3,4-dihydrocoumarin a Dionex DX 500 HPLC 
system (Surrey, UK) equipped with a Zorbax SB-C18 column (4.6mm x 50mm) 
(Mac-Mod Analytical, Chadds Ford, PA, USA) was employed. Separation was by 
isocratic elution using a mobile phase of acetonitrile (30% v/v) and acidified water 
(0.1% v/v 3M phosphoric acid) at a flow rate of 0.75 mL min'1. Detection was by UV 
detector at 220 nm and run time 10 minutes with substrate eluting at 4.1 minutes and 
product at 5.9 minutes.
2.8.2 Chiral analyses
An Agilent series 1100 HPLC system equipped with a Chiralcel OD-H column 
(Daicel Chemical Industries Limited, USA) was employed for the separation of the 
two enantiomers of 6-Br-p-tetralol using a mobile phase of hexane with 2% v/v IPA
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modifier isocratically at a flowrate of 1.75ml min'1 and detection at 210nm. The 
runtime was 20 minutes with substrate eluting at 9.8 min, the (5) product enantiomer 
at 12.2 min and the (.R) enantiomer at 16.1 min.
A Supercritical Fluid Chromatography system equipped with a Chiralcel AD-H 
column was employed for the separation of the two enantiomers of 4 ’-Br-2,2,2- 
trifluoroacetophenyl alcohol. A mobile phase of supercritical CO2 modified with 4% 
v/v methanol for four minutes was used, which was then increased by linear gradient 
to 40% v/v methanol at a rate of 2% min'1 with a three minute hold at 40% v/v 
methanol (total run time 25 minutes). The assay was run at 35°C and 200 bar pressure 
with a mobile phase flowrate of 1.5 mL min'1. Detection was by UV detection at 215 
nm with the (5) enantiomer eluting at 10.5 and (.R) at 12.2 minutes.
2.8.3 Biomass quantification
Biomass determinations were made off-line for T. capitatum MY 1890 by the 
collection of a 5 mL sample of culture, 1 mL of which was filtered by vacuum 
filtration through a pre-weighed and dried 0.2 pm filter paper. The cake was washed 
twice using equal volumes of RO water and held under vacuum until the filter cake 
became dry. The filter paper and cake were then transferred to a Mettler Toledo AG 
(Greifensee, Switzerland) HG53 Halogen Moisture analyzer and dried at 110°C until 
the weight became constant. The difference between the initial dried filter paper 
weight and the final weight was taken as the dry cell weight in the sample. The 
measurements were taken in triplicate (maximum coefficient of variance observed
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was 14.7%). In the case of R. erythropolis MA7213 and E. coli TOPIO pQR239 
growth was followed by monitoring of absorbance at 600 nm in a spectrophotometer.
2.8.4 Enzyme activity assays
For determination of ADH RE residual activity in the bioconversion studies two 
solutions were made up: solution A containing 2.5 pL p-Cl acetophenone in 7 mL 200 
mM potassium phosphate dibasic buffer (pH~7.2) and solution B containing 24.5 mg 
NADH in 7 mL buffer. 175 pL and 35 pL respectively were added into a single well 
of a 96 well micro titre plate. 10 pL of sample was added to a separate well and the 
assay was initiated by adding 190 pL of the assay solution mixture to the sample. 
Absorbance at 340 nm was recorded every 20 seconds over 2 minutes and plotted. 
The slope of this line compared to a standard of known enzyme concentration gave 
the effective enzyme concentration of the sample. For GDH 103 a single reaction 
mixture was required containing 24.5 mg NAD and 71.9 mg of glucose in 7 mL 
buffer. The samples were analysed as for ADH RE. (Maximum coefficient of variance 
observed was 11.9%)
2.8.5 Viable cell counts
In the case of T. capitatum MY1890 samples were taken at regular intervals once the 
cell culture had been contacted with the ionic liquid. A 0.1 mL sample was taken and 
was diluted through a serial dilution cascade and then 0.1 mL of diluted sample was 
spread on Sabouraud 2% glucose agar plates. The plates were incubated at 28°C for
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48 hours. The number of visible colonies (> 50 ) on the lowest dilution plate was 
recorded as the number of colony forming units.
In the case of R. erythropolis MA7213 and E. coli TOP 10 pQR239 samples were 
taken at regular intervals once the cell culture had been contacted with the ionic 
liquid. Each 0.1 mL sample was taken and was diluted through a serial dilution 
cascade. These diluted samples were then taken and 0.1 mL was spread on LB agar 
plates. The plates were incubated at 37°C for 24 hours. The number of visible colonies 
(> 50) on the lowest dilution plate was recorded as the number of colony forming 
units.
2.8.6 Enzyme half-life studies
Enzyme (1 mg) was dissolved in 900 pL of 100 mM potassium phosphate dibasic 
buffer (pH 6.8) in a HPLC vial and 100 pL of appropriate co-solvent was added. 
These were shaken at 1400 rpm and 30°C on a thermomixer (Eppendorf) and samples 
periodically taken and assayed for enzyme activity as described in Section 2.8.4. Half 
life was determined as the time taken for the activity to reach half that of the original 
activity.
2.8.7 Light microscopy
A 100 pL sample of bioconversion medium was taken and diluted into 900 pL of 
potassium diphosphate buffer (50mM). 10 pL of dilute sample was transferred onto 
the surface of a glass slide and was covered by a glass cover slip. The slide was
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inspected by a Leica MRA2 (Leica Microsystems, Buckinghamshire, UK) upright 
microscope and images taken by a CCD camera (Cohu Inc., Berkshire, UK).
2.8.8 Flow cytometry
Flow cytometric analyses were conducted using a Beckman Coulter Epics XL 
analyser (Beckman Coulter, Buckinghamshore, UK). Stock solutions of dyes were 
prepared as follows: PI was prepared at a concentration of 1 gL'1 in Dulbecco’s 
buffered saline (DBS, pH —7), BOX was prepared to the same concentration in 
DMSO, and DiOc6(3) was prepared to a concentration of 1 mgL'1 in DMSO. All 
solutions were filtered using a 0.2pm syringe filter prior to use.
Culture samples were diluted with DBS such that samples were analysed at a rate of 
~500 events s '1. The appropriate stains were added such that the working 
concentration of PI, BOX and DiOc6(3) were 5 pgmL'1, 10 pgmL'1 and 5 ngmL'1 
respectively. Samples were allowed to incubate for 5 minutes in the presence of the 
dyes prior to analysis. The total number of cells analysed per sample was 50,000 
resulting in a standard error of <0.33%. Any spectral overlap between dyes used 
simultaneously was eliminated through the colour compensation feature of the control 
software. Three replicates were assayed for each sample.
2.8.9 Determining ionic liquid density
A weighing boat was pre weighed and 1 mL of ionic liquid was added using a sterilin 
5 mL pipette to minimise loss of sample due to adherence to the pipette interior. The
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weighing boat and ionic liquid were reweighed and the weight of ionic liquid was 
used to calculate ionic liquid density. Each ionic liquid was tested in triplicate. The 
maximum coefficient of variance observed was 9.4 %.
2.9 Racemic standard synthesis
A chemical reduction of 6-Br-P-tetralone and 4’-Br-2,2,2-trifluoroacetophenone was 
necessary to generate product standards for reverse phase HPLC analysis (Section 
2.8.1). Each substrate was dissolved in ethanol to a concentration of 10 gL'1 and 0.5 
molar equivalents of sodium borohydride was added in a fume hood. The mixture was 
stirred using a magnetic flea for 30 minutes and then concentrated HC1 was added 
drop wise to remove excess hydrogen. The product was then extracted into toluene by 
a half volume extraction and the alcohol isolated by rotary vacuum evaporation of the 
toluene. Product purity was confirmed by reverse phase HPLC (Section 2.8.1).
2.10 Product isolation
2.10.1 (S)-6-Br-/3-tetralol
A simple isolation procedure was feasible whereby the product in the immiscible 
ionic liquid can be separated from the aqueous phase by centrifugation followed by 
three half-volume extractions with toluene from the ionic liquid (~60% w/w average 
extraction efficiency). The product was then isolated from the toluene by vacuum 
evaporation of the solvent
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2.10.2 (R)-4 ’-Br-2,2,2-trifluoroacetophenyl alcohol
In order to isolate the product, this mixture was taken, centrifuged, and the water layer 
removed. The product and remaining substrate was then extracted from the ionic 
liquid layer by 4 washes with diethyl ether until >99% w/w of product was recovered 
(as determined by reverse phase HPLC). The isolated product from the original 
reaction with [BMP][NTf2] was recovered by rotary vacuum evaporation of the 
diethyl ether leaving a viscous oil identified as (7?)-4’-Br-2,2,2-trifluoroacetophenyl 
alcohol by reverse phase HPLC (Section 2.8.1) and SFC analysis (Section 2.8.3).
2.11 Lewis cell operation
The kinetics of the mass transfer of 6-Br-p-tetralone from the ionic liquid 
[BMP][NTf2] and toluene to an aqueous buffer phase (50mM KH2 PO4 ) were 
examined within the Lewis cell. The Lewis cell was designed and constructed as 
described by Lye and Stuckey (2001). The experiments were performed such that the 
Reynolds number (Re) in each phase was equal to ensure comparable hydrodynamics 
on either side of the interface. Reynolds number is defined as:
Re = pNdi2 
P
where N is the impeller speed (s'1) determined using a Lachtron tachometer model 
DT-2236, dj is the impeller diameter (m), p is the liquid density (kgm ') and p is the 
viscosity (PaS). The Lewis cell was operated at 30°C ±0.1 in all experiments and this
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was maintained by a temperature controlled water bath circulating water through the 
vessel jacket. Equal volumes of the two phases had first been equilibrated, in the 
absence of substrate, to ensure that this was the only transferring species. After 
separation, substrate was added to the ionic liquid or toluene phase such that the 
overall concentration for the vessel would be 50 gL'1. The lower phase was then 
funnelled to the bottom of the vessel to avoid wetting the upper half of the cell. The 
upper phase was subsequently added such that the bottom layer was not disturbed. 
Both phases were brought to temperature and samples of each phase taken before the 
impellers were switched on at their pre-set speeds. Each experiment lasted for 4 hours 
and samples of 50 pi were taken each hour for analysis as described in Section 2.8.1.
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3 Whole cell mediated bioreductions of 6-Br-P- 
tetralone*
3.1 Introduction and aims
The chiral alcohol (S)-6-Br-P-tetralol is a key precursor in the synthesis of the 
anti arrythmia drug candidate MK-0499 (Tschaen et al, 1995). Chemical 
reduction of the ketone 6-Br-p-tetralone to its corresponding (S) alcohol yields 
only a 20% enantiomeric excess of the desired enantiomer. Screening of 
microbial libraries identified the yeast Trichosporon capitatum MY 1890 (Reddy 
et al, 1996) and gram positive bacterium Rhodococcus erythropolis MA7213 
(Stahl et al, 2000) that mediated production of the required alcohol at >99% ee. 
These systems use organic solvents as co-solvents for the bioconversion to 
dissolve sufficient quantities of substrate to deliver an efficient process.
The aim of this initial chapter will be to explore the feasibility of performing 
whole cell bioreductions in the presence of ionic liquids. To date, there have only 
been two preliminary reports on whole cell bioreductions with ionic liquids and 
these have focussed solely on baker’s yeast (Howarth et al, 2001; Pfruender et al,
2004), as described in Section 1.7. These studies involved a study of the 
feasibility of performing whole cell bioreductions in the presence of a single 
ionic liquid ([Bmim][PF6]). Broadly, this chapter will investigate the impact of a
* The results presented in this chapter have been published as: Hussain W, Pollard DJ, Lye GJ. 
(2007) The bioreduction of a |3-tetralone to its corresponding alcohol by the yeast 
Trichosporon capitatum MY1890 and the bacterium Rhodococcus erythropolis MA7213 in a 
range of ionic liquids. Biocatal Biotransform 25: 443-452.
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range of ionic liquids on not only the bioreduction, but also the effects of the 
ionic liquid on the whole cell biocatalyst. Specific objectives of this chapter will 
be to:
• Examine bioreductions of 6-Br-p-tetralone mediated by both yeast and 
bacterial cells known to express the same tetralone reductase activity.
• Screen a range of ionic liquids, with varying chemical and physical 
properties, as co-solvents with regard to substrate solubility and 
bioconversion kinetics.
• Attempt to correlate bioconversion performance to ionic liquid physico­
chemical properties and their impact on cell viability.
3.2 Biocatalyst cultivation and standard bioconversion kinetics
In order to confirm the data previously reported for T. capitatum MY 1890 
(Reddy et al, 1996) growth curves were first obtained showing the high cell 
density (~25-30 gL'1) it is possible to achieve with this organism. A typical 
growth curve, obtained from a culture grown in a 250 mL shake flask is shown in 
Figure 3.1 and is comparable to the previously published growth profile for this 
organism given the different scales of culture (Reddy et al, 1996). Growth on 
glycerol containing media is significantly greater than that observed with 
glucose, indicating the preference of the organism for less complex carbon 
sources. For the shake flask culture a final biomass concentration of 26 gL'1 was 
achieved. Bioconversion was initiated after 36 hours growth while the cells were 
in exponential growth phase and metabolic activity is at a maximum.
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The ability to reduce 6-Br-p-tetralone is not exclusive to T. capitatum MY1890 
but to a number of organisms with a broad range of physiologies and properties 
(Stahl et al, 2000). Among these is the gram positive bacterium R. erythropolis 
MA7213 and the growth curve for this strain is also shown in Figure 3.1. The 
total biomass yield is significantly less than for T. capitatum MY 1890, reaching 
a maximum dry cell weight of around 4.5 gL'1. The exponential phase of growth 
for R. erythropolis MA7213 appears to last from around 10 to 24 hours. The 
ideal time to initiate bioconversion is seen to be around 24 hours, when the cell 
density is close to it’s maximum and the cells are still actively growing.
Figure 3.2(a) shows a standard bioconversion time-course for T. capitatum 
MY1890 which was initiated after 36 hours growth by the addition of 10% v/v 
ethanol containing 6-Br-P-tetralone. The bioconversion begins instantaneously as 
reflected by the rapid initial rate of product formation of 70 mg(product)g' 
‘(celljhr'1. The substrate uptake rate is initially even higher at 157 
mg(substrate)g'1(cell)hr'1 as reflected by the deficit in the solute mass balance 
during the initial 3 hours of reaction. This is attributed to the association of 
substrate with the cell surface or its rapid initial uptake and accumulation within 
the cell.
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Figure 3.1 Comparison of growth of (■) T. capitatum MY1890 on 30gL'' glycerol based medium in a 
250 mL shake flask, maintained at 28°C on a shaking incubator (220 rpm), with surface aeration, (A)  
R. erythropolis MA7213 grown on 30 gL'1 TSB in a 250 mL shake flask, maintained at 30°C on a 
shaking incubator (200 rpm), with surface aeration and (•) T. capitatum MY 1890 on 60 gL'1 glycerol, 
in a 23L fermenter maintained at 28°C, agitation at 220 rpm by impeller, with aeration of 6L of air per 
minute and DOT maintained at 30% of initial saturation by control of aeration and impeller speed 
(Reddy et al, 1996). Shake flask cultivation was performed as described in Section 2.6 and biomass 
concentration was determined as described in Section 2.8.3. Error bars indicate one standard deviation 
about the mean.
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By the end of the reaction (after 5 hours) the mass balance closes to 100% as 
expected and complete conversion of the substrate is achieved.
In comparison Figure 3.2(b) shows the standard bioconversion time-course for R. 
erythropolis MA7213, again in the presence of 10% v/v ethanol. As in the case 
of T. capitatum MY 1890, the rate of substrate uptake is significantly higher than 
the rate of product formation giving a similar deficit in the mass balance. 
However the product formation rate remains slow and the final conversion is 
only 14% w/w. This is due in part to the six-fold decrease in cell density in the 
case of the R. erythropolis MA7213 bioconversion compared to T. capitatum 
MY1890. It was found that lysing the cells after the reaction phase was 
completed released the unconverted substrate from within the cell completing the 
mass balance and indicating the substrate was not converted by other enzyme 
activities within the cell.
In both cases, chiral analysis (performed as described in Section 2.8.2) of the 
bioconversion product showed >99% enantiomeric excess in favour of the 
desired (S) enantiomer.
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Figure 3.2 Time course of typical bioreductions of 6-Br-P-tetralone to (S)-6-Br-P-tetralol by (a) the 
yeast T. capitatum MY1890 and (b) the gram positive bacterium R. erythropolis MA7213: (o) 6-Br-P- 
tetralone ; ( • )  6-Br- P-tetralol; (-) mass balance. Experimental conditions were as described in Sections 
2.6 for microbial cultivation and 2.7.1 for the bioconversion.
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3.3 Ionic liquid screening
3.3.1 Physical properties
Prior to studying the activity of the biocatalysts in ionic liquids it was necessary 
to investigate some of the physical properties of the ionic liquids that could have 
an effect on the processing of these liquids at scale. Table 3.1 shows a number of 
the key physical properties for the limited range of seven ionic liquids used in 
this study. The first property is water miscibility, which affects whether the 
system runs as a single phase or a two-phase system. It is clear that miscibility is 
dependent upon the anion/ cation combination. This is exemplified by the ionic 
liquids [Bmim][BF4 ], which is completely miscible with water, while 
[Bmim][PF6] is very hydrophobic and mixes with water only to a limited extent 
(Sheldon, 2001). The choice of monophasic or biphasic system will potentially 
affect the rate of reaction, ease of product recovery and downstream processing.
The density and viscosity of the ionic liquids will affect the ways in which the 
ionic liquids can be mixed in the reaction vessel, and the ease of pumping the 
liquids in industrial scale systems. Generally the published values for the 
viscosities of the pure ionic liquids are many orders of magnitude greater than 
the viscosity of water, the maximum viscosity being that of [CABHEMJfMeSOJ 
at 3 Pas, compared to 9 x 10' Pas. However, during this work it was noted that 
the viscosity of the ionic liquids decreased dramatically upon the introduction of 
even a small amount of water (~1% v/v) to the system. With added water the 
viscosities are greatly reduced becoming much closer to that of water and as such
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do not pose problems for large scale operation. The densities of the pure ionic 
liquids range from 825-1370 kgm'3 which will not pose any significant 
processing issues other than those with higher densities than water will form the 
lower phase in the case of water immiscible ionic liquids.
Literature data concerning ionic liquids has shown they are effective solvents 
dissolving many complex molecules to high titres (Roberts and Lye, 2002). A 
potential advantage of ionic liquids for biocatalysis is the ability to dissolve 
significantly more substrate in the environment of the catalyst than conventional 
solvents. However, as shown in Table 3.1, this benefit could not be realised in 
this work as the 6-Br-p-tetralone substrate proved difficult to dissolve in any of 
the ionic liquids tested at concentrations higher than that achieved with the 
standard ethanol co-solvent.
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Name Ionic Liquid Structure Abbreviation Water
miscibility
Density
k g m 3
Viscosity
PaS
Tetralone 
solubility gL' 1
Media/ Ethanol N/A N/A N/A 1000 0.0001 10.0
1-Butyl-3-methyl-imidazolium
tetrafluoroborate
\  b f 4 [Bmim][BF4] Miscible 1210 0.145 2.1
1 -Butyl-3-methyl-imidazolium- 
ethylenglycolmonomethyl- 
ethersulfate vsti- [Bmim][M DEGS04] Miscible 1060 0.340 3.6
1 -Butyl-3-methyl-imidazolium 
hexafluorophosphate
[Bmim][PF6] Immiscible 1370 0.385 4.33
1 -Ethyl-3-methyl-imidazolium tosyiate o\©/^  °
O
[Emim][TOS] Miscible 930 n/a 6.35
Methyl-trioctyl ammonium 
bis(trifiuoromethlylsulfonyl)imide
C 8H17x + y C e  H17 ,r c
\  /  (CF3S 0 2) 2N
H3C ^
[Oc3MeN][NTO] Immiscible 925 n/a 7.20
1 -Butyl-3-methyl-imidazolium 
octylsulfate
0
(H2C)7H3C— o — s = o  
0
[Bmim][OcS04] Miscible 940 0.874 7.9
PEG-5 Cocomonium m ethosulfate
C i4 H 2 9 v . / -----(( O H [CABHEM ][M eS04] Miscible 825 3.000 4.70
Toluene N/A N/A Immiscible 850 0.00065 >50
Table 3.1 Ionic liquid property table. Tetralone solubility was determined by saturating the ionic liquid with P-tetralone and subsequent HPLC analysis of a diluted sample. Viscosities 
of the ionic liquid are literature values for pure ionic liquids (www.solventinnovation.com). Density was determined independently as described in Section 2.8.9. n/a indicates data not 
available.
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3.3.2 Cell viability upon exposure to ionic liquids
Cell viability, as measured by viable plate counts (Section 2.8.5), may be taken as an 
initial quantitative measure of the response of cellular systems on exposure to ionic 
liquids. The rate of decrease in T. capitatum MY1890 viable cell counts upon 
exposure to various ionic liquids is shown in Figure 3.3(a) and is summarised in 
Table 3.2 (log N/No data). Contact with the ionic liquid at a concentration of 50% 
v/v has a significant effect on the cells for the first 2-4 hours, with as many as 5 log 
reductions in viable cell counts. The effects of all the ionic liquids fall within the 
boundaries formed by media and the two commonly used organic co-solvents 
ethanol and toluene (Figure 3.3(a)). These results indicate that although the ionic 
liquids are to some degree toxic to the cells, they can be less so than typical organic 
solvents used in industrial bioconversions.
A comparison of the T. capitatum MY1890 viability profiles (Figure 3.3(a)) to 
bioconversion kinetics profiles, such as that for ethanol (Figure 3.2(a)), shows that 
despite the rapid loss of cell viability the reaction still proceeds to completion. Plate 
counts are indicative of intact, polarised and metabolically active cells that are also 
capable of cell division. This comparison, then, shows that while there is a large 
reduction in cell viability nonviable cells can still regenerate cofactor and complete 
the reduction over the time scales studied here as has been found for bioconversions 
with conventional solvents. With the measured reductions (>2 log reductions)
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though it would appear to be unfeasible or uneconomic to recover and recycle the 
biocatalyst.
Figure 3.3(b) shows the changes in cell viability in the case of R. erythropolis 
MA7213 and are summarised in Table 3.3 (log N/No data). In general, the gram 
positive bacterium can be seen to be much more tolerant to the presence of ionic 
liquids in comparison to the yeast strain. The ionic liquids tested appear to fall into 
two categories. A number of ionic liquids have very little effect on viable cell 
number over the 8  hours of measurement; single phase forming ionic liquids such as 
[Bmim][BF4 ] and [Emim][TOS] caused log reductions of less than 0.1, along with 
the two-phase forming ionic liquids [Bmim][PF6 ] and [Oc3MeN][NTf2 ]. In contrast, 
ionic liquids such as [Bmim][0 cS0 4 ] caused a much greater decrease in viability in 
a similar way to toluene. The greatly increased stability of Rhodococcus species in 
certain ionic liquids compared to organic solvents is in agreement with earlier 
findings from this laboratory (Cull et al, 2000). In this case however there appears to 
be a closer correlation between measured biocompatibility and bioconversion 
kinetics: those ionic liquids that appeared detrimental to the viability of the cells 
were also poorer co-solvents for the bioconversion.
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Figure 3.3 Viability of (a) T. capitatum MY1890 and (b) R. erythropolis MA7213 in various ionic 
liquids. A shake flask was cultured at 28°C for 36 hours in the case of T. capitatum and for 24 hours at 
30°C for R. erythropolis in a shaking incubator. 5mL of the culture was then taken and contacted with 
5mL of ionic liquid (50% v/v) for 8 hours. Periodically samples were taken and serial diluted in 
phosphate buffer, and the dilutions spread on agar plates. The number of colonies present were counted 
and normalised against a control of 100% media (Section 2.8.5). (•) media control (o) 10% v/v 
ethanol (▼) [Bmim][BF4] (A) [CABHEM][MeS04] (■) [Bmim][MDEGS04] (□) [Oc3MeN][NTf2] (♦) 
[Bmim][OcS04] (0) [Bmim][PF6] (A) [Emim][TOS] (V) 10% v/v toluene.
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3.4 Bioconversion kinetics in ionic liquids
3.4.1 T. capitatum MY1890 bioconversions
Bioconversions catalysed by T. capitatum MY 1890 were carried out using all of the 
ionic liquids shown in Table 3.1 employing a volume fraction of ionic liquid of 20% 
v/v in all cases. Examples of typical reaction profiles are shown in Figure 3.4 (the 
complete set is given in Appendix B) and the results for all ionic liquids are 
summarised in Table 3.2. It can be seen that the highest reaction rate is observed 
with the ionic liquid [Emim][TOS] where the overall rate of reaction is comparable 
to that observed for the standard bioconversion conditions, and the reaction 
approaches completion within 4 hours (Figure 3.4(a)). The initial decrease in the 
solute mass balance is again associated with rapid uptake of substrate into the cells 
but this is subsequently converted to product which partitions out of the cells 
restoring the mass balance.
Considering the rest of the hydrophilic ionic liquids, in the case of [Bmim][BF4 ] the 
reaction was observed to proceed steadily in the presence of the ionic liquid, but 
only to a final conversion of less than 35% w/w. This was surprising since the cell 
viability data (Table 3.2) showed this ionic liquid to be the least harmful to the cells.
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Medium Number of 
Phases
Log(N/N0) Initial Rate 
(mg(prod)g'1(cell) h r'1)
Conversion 
(% w/w)
Standard 1 -3.35 69.8 100
[Emim][TOS] 1 -3.70 50.9 100
[Bmim][BF4] 1 -2.65 2.2 35
[Bmim][0cS04] 1 -3.33 0.7 10
[Bmim][MDEGS04] 1 -4.65 0.5 11
[CABHEM][MeS04] 1 <-5.35 3.3 30
[Bmim][PF6] 2 -4.00 3.1 40
[Oc3MeN][NTf2] 2 -3.65 4.2 60
Table 3.2 Comparison of ionic liquids for the reduction of 6-Br-P-tetralone by T. capitatum MY 1890. 
Cell viability is shown as the log to of the ratio of viable cells in the ionic liquid after 8 hours to the 
viable cells in media and is based on Figure 3.3(a). All bioconversions were carried out at 20% v/v 
ionic liquid or 10% v/v ethanol in the case of the ‘standard’ medium as described in Section 2.7.1. 
Initial specific rate was calculated on the basis of product yield in the first hour. Final conversion is 
shown after 8 hours.
The observed reaction rate of 2.2 mg(product)g‘1(cell)hr' 1 reflects the poor 
conversion, and may be attributed to the association of the ionic liquid with the cell 
membrane preventing effective transfer of substrate into the cell. [Bmim][0 cS0 4 ] is 
another water miscible ionic liquid, which performed most poorly of all the ionic 
liquids tested. In 8  hours, less than 10% w/w conversion was observed (Figure 
3.4(b)). The very low initial rate of 0.73 mg(product)g'1(cells)hr' 1 suggests that the 
ionic liquid caused extensive damage to the cells, as indicated by the logN/No in 
Table 3.2, or that the viscous nature of this ionic liquid (Table 3.1) limited the mass 
transfer of substrate into the cell.
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[Bmim][MDEGS0 4 ] also gave a poor conversion of 1 1 % w/w, but this is almost 
certainly attributed to toxicity of the ionic liquid to the biocatalyst, since a large 
proportion of the substrate was taken up by the cells in the first hour (Appendix B). 
This indicates that mass transfer of substrate into the cell, is unlikely to be a limiting 
factor and failure to convert is likely due to cell death. The final water miscible ionic 
liquid is [CABHEM][MeSC>4 ] which was the most viscous of the ionic liquids 
tested. However, once contacted with the aqueous phase at 20% v/v, the dilution 
effect dramatically reduced the viscosity making it easier to handle. After an initial 
four hour lag phase the reaction proceeded at an initial rate of 3.3 mg(product)g‘ 
^celljhf1 and reached a maximum of 30% w/w conversion. A further point of 
interest with this ionic liquid was that conversion proceeded with a colour change 
from a deep green to dark brown as the reaction progressed. No alteration in the 
quality of the substrate and product was observed based upon the retention times and 
shapes of the HPLC peaks.
Considering the two hydrophobic ionic liquids, [Oc3MeN][NTf2 ] and [Bmim][PF6 ], 
these performed much better on average than the majority of hydrophilic ionic 
liquids in terms of retained cell viability and conversion yield (Table 3.2). This is 
attributed to the bulk of the ionic liquid being physically separate from the cells 
present in the aqueous phase, and so having less direct influence upon the 
biocatalyst. Orbital shaking of the flasks containing the reaction mixture proved 
effective at mixing the two phases; when the shaking was stopped the two phases
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visibly separated after less than a minute. The ionic liquid [Bmim][PF6 ], which has 
been commonly used in chemical catalysis (Sheldon, 2001) also proved effective for 
the bioconversion studied here. It gave a product yield of 40% w/w, at a constant 
rate of 3.1 mg(product)g‘1(cell)hr‘1, indicating the limiting factor is most likely not 
the viability of the biocatalyst but the mass transfer rate of the substrate into the 
aqueous phase. The other hydrophobic ionic liquid [Oc3 MeN][NTf2 ] yielded almost 
60% w/w conversion at an initial rate of 4.2 mg(product)g'1(cell)hr1 (Figure 3.4(c)). 
The rate of product formation again remained approximately constant over the full 8  
hours of the reaction period. The solute mass balance remained close to 100% 
throughout the bioconversion suggesting substrate mass transfer from the ionic 
liquid was probably rate limiting.
It was found that the chirality (determined as described in Section 2.8.2) of the 
product formed in the presence of 20% v/v [Emim][TOS], the best of the ionic 
liquids investigated, was not significantly affected compared to the chirality 
obtained in the presence of 10% v/v ethanol (both >99% ee in favour of the desired 
(S) enantiomer.
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Figure 3.4 Time course of the bioreduction of 6-Br-p-tetralone to (5)-6-Br-P-tetralol by the yeast T. 
capitatum MY 1890 in representative ionic liquids (a) [Emim][TOS]; (b) [Bmim][0cS04]; (c) 
[Oc3MeN][NTf2]: (o) 6-Br-P-tetralone; ( • )  6-Br- p-tetralol; (-) mass balance. Experimental conditions: 
250 mL erlenmeyer flask containing 50 mL of glycerol medium was inoculated with lmL of cell stock 
on 10% v/v glycerol and aerobically incubated on an orbital shaker at 28°C and 200rpm. After 36hr 
bioconversion was initiated by the addition of 16 mL cell culture to 4 mL ionic liquid containing 0.020g 
6-Br-P-tetralone. The culture was returned to the same incubation conditions and the extent of 
conversion was monitored bv HPLC analvsis as described in Section 2.8.1.
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3.4.2 R. erythropolis MA 7213 bioconversion
Bioconversions catalysed by R. erythropolis MA7213 were also carried out using all 
of the ionic liquids shown in Table 3.1 employing a volume fraction of 20% v/v in 
all cases. The cell viability, initial rate of reaction and conversion data are 
summarised in Table 3.3.
Medium
Number
Phases
Log(N/N0)
Initial Rate 
(mg(prod)g'1(cell) hr'1)
Conversion 
(% w/w)
Standard 1 -0.99 4.7 14
[Emim][TOS] 1 -0.09 18.7 28
[Bmim][BF4] 1 -0.07 4.6 11
[Bmim][0cS04] 1 -2.18 9.4 9
[Bmim][MDEGS04] 1 -2.59 1.2 1
[CABHEM][MeS04] 1 -2.35 2.3 3
[Bmim][PF6] 2 -0.13 3.6 7
[Oc3MeN][NTf2] 2 -0.09 15.0 17
Table 3.3 Comparison of ionic liquids for the reduction of 6-Br-P-tetralone by R. erythropolis 
MA7213. Cell viability is shown as the logio of the ratio of viable cells in the ionic liquid after 8 hours 
to the viable cells in media at the start. All bioconversions were carried out at 20% v/v ionic liquid or 
10% v/v ethanol in the case of the ‘standard’ medium. Initial specific rate was calculated on the basis 
of product yield in the first hour. Final conversion is shown after 8 hours.
Of all the ionic liquids tested the highest initial rate of 18.8 mgCproducOg'^celtyhr' 1 
was observed with the hydrophilic ionic liquid [Emim][TOS] with an overall 
conversion of 28% w/w (Figure 3.5). The cells also showed one of the smallest
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decreases in cell viability upon exposure to this ionic liquid. The performance of the 
rest of the hydrophilic ionic liquids varied between 1 - 1 1 % w/w overall conversion 
with the performance showing some correlation to the viable cell count data. Of the 
hydrophobic ionic liquids [Oc3MeN][NTf2 ] gave the best performance with an 
initial rate of 15 mgCproducOg'^celOhr' 1 close to that observed with [Emim][TOS], 
but a lower conversion of 17%. Substrate mass transfer from the ionic liquid phase 
was again likely to be rate limiting.
Although the conversion of 6 -Br-p-tetralone by R. erythropolis MA7213 is 
significantly less than observed in the presence of T. capitatum MY 1890, the initial 
rate of product formation in the presence of 20% v/v [Emim][TOS] is actually about 
4 fold greater than under standard conditions using 10% v/v ethanol (Table 3.3). The 
conversion yield is also doubled suggesting a positive advantage of ionic liquids for 
this particular bioconversion. The cell viability data log(N/No) indicates there is an 
approximately 1 0  fold decrease of cell viability in the presence of ethanol compared 
to [Emim][TOS]. Microscopic observation of the R. erythropolis MA7213 cells 
during bioconversion showed that in the presence of ethanol the cells formed large 
aggregates while in the presence of [Emim][TOS] the cells stayed largely dispersed 
as in fermentation media (Figure 3.6(b)). This aggregation of cells will almost 
certainly result in a mass transfer limitation of substrate into the aggregates as 
reflected by the lower measured initial rates of reaction. In the case of T. capitatum 
MY 1890 (Figure 3.6(a)) no aggregation was observed following bioconversions in 
the presence of either ethanol or [Emim][TOS].
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In summary, comparable reactions between the ionic liquid [Emim][TOS] and 
ethanol were demonstrated with both the gram negative and gram positive cultures, 
T. capitatum MY1890 (Figure 3.2(a), 3.4(a)) and R. erythropolis MA7213 (Figure 
3.2(b), 3.5). The effect of employing the ionic liquid as a co-solvent upon the 
increase in initial rate of reaction was significantly more marked in the case of R. 
erythropolis MA7213 than in T. capitatum MY1890.
3.5 Summary
From the results reported here, it is clear that ionic liquids are feasible media for 
whole cell bioreduction involving co-factors. Comparable or better initial rates and 
final conversions have been observed for both T. capitatum MY 1890 (a yeast) and 
R. erythropolis MA7213 (a gram positive bacterium) in the presence of ionic liquids 
compared to a standard ethanol co-solvent (Tables 3.2 and 3.3 respectively). Ionic 
liquids offer advantages that can be used to improve processes in ways that were not 
possible when using organic solvents, such as the opportunity to use much greater 
proportions of ionic liquid to aqueous media, thereby increasing the overall 
concentration of substrate in the environment of the cell. This is evidenced by the 
fact that much greater proportions of ionic liquid (up to 50% v/v) have been tested 
with the cells and they have remained not only capable of performing the desired 
reaction (Figures 3.4(a) and 3.5), but they also remain viable and able to divide as 
shown by their ability to form colonies on agar plates (Figure 3.3).
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Figure 3.5 Time course of the bioreduction of 6-Br-P-tetralone to (5)-6-Br-|3-tetralol by R. 
erythropolis MA7213 in the presence of [Emim][TOS]: (o) 6-Br-P-tetralone gL'1; ( • )  6-Br- P-tetralol 
gL'1; (-) mass balance. Experimental conditions: 250 mL Erlenmeyer flask containing 50mL of 
Tryptic Soy Broth (30gL'‘) was inoculated with lmL of cell stock on 10% v/v glycerol and was 
aerobically incubated on an orbital shaker at 28°C and 200 rpm. After 24 hrs biotransformation was 
initiated by the addition of 16 mL cell culture to 4ml ionic liquid containing 0.020g 6-Br-P-tetralone. 
The culture was returned to the same incubation conditions and the extent of conversion was 
monitored by regular sample collection.
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Figure 3.6 Light microscope images of (a) T. capitatum MY 1890 (40X magnification) and (b) R. erythropolis MA7213 (100X magnification) after (i) cultivation in 
growth medium (36 hr and 21 hr respectively) and during bioconversions in the presence of (ii) 10% v/v ethanol or (iii) 20% v/v [Emim][TOS] (30minutes after 
bioconversion is initiated). Bioconversions were performed as described in Section 2.7.1 and images were obtained as described in Section 2.8.7.
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This is in contrast to organic solvents where increasing the volume fraction beyond 
10% results in rapid cell death. However the mechanism by which the ionic liquids 
affect the cells and alters the rate of reaction is still unknown: cell viability data and 
substrate solubility do not appear to be sufficient indicators of biotransformation 
performance, for example in the case of R. erythropolis MA7213 the toxic effect of 
the ionic liquid [Bmim][BF4 ] is minimum with a logio(N/No) of -0.07 after 8  hours 
but initial rate and conversion are similar to the standard ethanol system. It is clear 
however that some strains are in general more resistant to ionic liquid exposure than 
others, and that some ionic liquids are more biocompatible than others. No 
predictable relationship has been observed between the properties of the ionic 
liquids used, and the activity and stability data observed, indicating that screening of 
ionic liquids is currently a more viable method for industrial application than 
rational selection. Further work will focus on understanding the effects of ionic 
liquids on whole cell biocatalysts using flow cytometry to gain a better 
understanding of the interaction between ionic liquids and bacterial cells.
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4 Quantifying the impact of ionic liquids on whole 
cell biocatalyst stability
4.1 Introduction and aims
4.1.1 Introduction
In the previous chapter the ability of whole cells of both T. capitatum MY1890 
and R. erythropolis MA7213 was demonstrated for the reduction of 6 -Br-p- 
tetralone to (*S)-6-Br-(3-tetralol in the presence of ionic liquids. The results 
suggested that bioconversion efficiency was, at least in part, related to the 
viability of the whole cell biocatalysts (Section 3.4.1) with ionic liquids 
demonstrating improved biocompatibility compared to a number of common 
organic solvents (Section 3.3.2). Viability was determined from simple plate 
counts after exposure to the ionic liquids. The disadvantages of plate counts are 
that they are only a gross measure of a cells potential to divide and can take up to 
24 hours before viability results can be obtained for some organisms.
4.1.2 Flow cytometry
As described in Section 1.8, flow cytometry analysis of a cell population can 
reveal, at a cell by cell level, the physiological condition of a cell population 
such as cell viability, cell density, function or ion density. The parameters 
investigated for a particular cell line or application can be tuned by employing
101
Chapter 4
appropriate dyes that, upon excitation by a laser, emit at different wavelengths to 
allow analysis of multiple parameters per cell in a single run.
Flow cytometry is built on the premise that a cell population can be identified 
through a characteristic size and “granularity”- determined through forward and 
side scattering of the laser in the system (Vale-Silva and Buchta, 2006). By 
“gating” this characteristic area and determining base values of fluorescence for 
each of the dyes on those events, changes can readily be identified by shifts in 
these fluorescence intensities.
4.1.3 Aims
Flow cytometry is a powerful analytical technique providing a rapid and detailed 
insight into the response of individual cells in a population on exposure to non- 
aqueous solvents. The aim of this chapter is to use flow cytometry to obtain an 
understanding of the response of various types of biocatalyst on exposure to 
ionic liquids. Given the filamentous nature of T. capitatum MY1890 (Figure 
3.6(a)) and the principle of operation of flow cytometry (Figure 1.15) it was not 
possible to study T. capitatum MY1890 using this method. Consequently two 
bioconversions were chosen for this study. The first is the bioreduction of 6 -Br- 
p-tetralone to (5)-6-Br-p-tetralol by the gram positive bacterium R. erythropolis 
MA7213 as described in Section 1.9.1. The second is the Baeyer-Villiger 
oxidation of 1-indanone to 3,4-dihydrocoumarin by the gram negative bacterium 
E. coli TOPIO pQR239 (Section 1.9.3). The pQR239 plasmid confers 
Acetinobacter caloaceticus cyclohexanone mono-oxygenase (CHMO) activity on
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the E. coli TOP 10 host, as well as ampicillin resistance useful as a selection 
marker (Doig et al, 2001). Literature data has shown the bioconversion shown in 
Figure 4.1 proceeds with “minimum conversion” in the presence of 10% v/v 
ethanol (Guttierez et al, 2003). The potential for ionic liquids to be used to 
achieve a greater degree of conversion is investigated here through the use of 
flow cytometry to identify potentially favourable ionic liquids.
1 -indanone
E.coli TOP10 pQR239
3,4-dihydrocoumarin
Figure 4.1 The CHMO mediated oxidation of 1-indanone to 3,4-dihydrocoumarin by E. coli TOP 10 
PQR239.
The specific objectives of this chapter are:
• To establish the use of flow cytometry as a potential high throughput 
method for quantifying the impact of ionic liquids on whole cell 
biocatalyst stability.
• To attempt to correlate the measured response of R. erythropolis MA7213 
and E. coli TOP 10 pQR239 biocatalysts to the structure and properties of 
a range of ionic liquids.
• To establish if there is any relationship between flow cytometry results, 
conventional plate counts (Section 3.3.2) and bioconversion performance.
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4.2 Flow cytometry analysis and reference conditions
4.2.1 R. erythropolisMA7213
The first whole cell biocatalyst selected for investigation using flow cytometry 
was R. erythropolis MA7213 (Section 1.9.1) and suitable dyes were sought for 
identifying membrane polarization and cell membrane permeabilisation (Section 
1.8). Propidium iodide (PI) is a double stranded DNA stain very commonly used 
for identifying cell membrane permeabilisation (Lehtinen et al, 2004; Looser et 
al, 2005; Baatout et al, 2006; Bemey et al, 2007; Saegeman et al, 2007). PI 
cannot pass through an intact cell membrane to stain the DNA inside a cell so 
only cells not metabolizing or controlling their internal environment will be 
positively stained (Amanullah et al, 2002).
Membrane polarization is achieved through the maintenance of a charge balance 
across the membrane by potassium/ sodium ion channels. The use of ATP by the 
cell causes 3 sodium ions to be pumped out of the cell and two potassium ions 
simultaneously pumped in resulting in a potential difference across the 
membrane. The maintenance of this potential difference can be taken as an 
indication of the metabolic activity of the cell, since cells not using ATP or 
unable to use it would be unable to maintain the charge imbalance (Nebe-von- 
Caron et al, 1998). Membrane permeabilisation is not concomitant of 
depolarization however so PI will not be able to pass through the membrane and 
stain the DNA of stressed cells only, and it has been shown that stressed cells can 
recover (Baatout et al, 2006).
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The most commonly used membrane depolarisation dye in the flow cytometry 
literature is bis-oxonol (BOX) (Amanullah et al, 2003; Onyeaka et al, 2003) and 
this was the first dye investigated. Due to the gram positive nature of R. 
erythropolis MA7213, and hence the presence of a peptido-glycan cell wall 
(Koch, 2003), BOX was unable to penetrate the cell wall on depolarization. It 
was found that only through lengthy heat shock treatment of the cell population, 
with an associated breakdown of the cell wall, was the BOX able to penetrate the 
cell. This is clearly unsuitable. Similarly Rhodamine 123 (Rhl23), which 
operates under the same premise as BOX (Amanullah et al, 2003), was also 
unsuitable. The alternative dye, DiOC6(3), was identified through the flow 
cytometry literature and was found to be a suitable dye for identifying 
depolarization of R. erythropolis MA7213 (Reis et al, 2005). Contrary to the 
mode of action of BOX and Rhl23 this dye stains a polarized cell membrane but 
is unable to penetrate a depolarized one.
Based on the use of PI and DiOC6(3) the reference condition plot for R. 
erythropolis MA7213 is shown in Figure 4.2(a). This indicates >99% live, 
metabolically active cells (quadrant HI) approaching the end of the exponential 
growth phase after cultivation for 21 hours in Tryptic Soy Broth (30 gL'1). The 
expected progression of flow cytometry counts upon contact with a detrimental 
co-solvent is from quadrant HI, representing polarized, live cells, to H3 
representing live cells with depolarized membranes and finally to H4 
representing cells with permeabilised membranes.
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4.2.2 E. coli TOPIOpQR239
The parameters to be investigated for this strain are again membrane polarization 
(as an indirect indicator of metabolism) and membrane permeabilisation as 
indicated by the PI DNA stain. The bis-oxonol dye (DiBACs) unsuitable for R. 
erythropolis MA7213 analysis was found to be applicable here for the gram 
negative E. coli cell. Based on the use of PI and BOX the reference plot for cells 
in their standard medium at the end of the exponential phase of growth is shown 
in Figure 4.2(b). In this case there are >98% of the cells in quadrant K3, 
indicating cells negative for both PI and BOX being live and polarized. The 
expected progression for the flow cytometry counts is from quadrant K3 to K1 
indicating live depolarized cells and finally the permeabilised cells will occupy 
quadrant K2. Quadrant K4, indicating PI positive but BOX negative results will 
be occupied by DNA in cell debris pockets that appear within the forward and 
side scatter parameters indicated due to the already very small size of E. coli 
cells.
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Figure 4.2 Flow cytometry density plots under reference conditions, (a) PI/DiOC6(3) staining of early 
stationary phase R. erythropolis MA7213 cells. Quadrant HI corresponds to live, polarised cells, H3 
corresponds to live cells with depolarised membranes and H4 corresponds to dead cells, (b) PI/BOX 
staining of stationary phase E. coli TOP 10 pQR239 cells. Quadrant K3 corresponds to live, polarised 
cells, K1 corresponds to live cells with depolarised membranes and K2 corresponds to permeabilised 
cells. Arrows indicate the expected progression of the cell population after exposure to damaging solvents 
In both cases, a sample of the cells in media was taken and diluted into Dulbecco’s Buffered Saline (DBS) 
prior to flow cytometry analysis as described in Section 2.8.8.
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4.3 Effects of co-solvents on R. erythropolis MA7213
4.3.1 Flow cytometry analysis o f  R. erythropolis MA7213
The effects of the organic and ionic liquid co-solvents investigated in Section
3.4.2 were analysed further by flow cytometry. Results obtained for all the ionic 
liquids studied are shown in Appendix C and only representative ones will be 
described here. Figure 4.3(a) shows the progressive effect of exposure to 10% 
v/v ethanol, the standard solvent for the bioconversion of interest (Reddy et al, 
1996) on the cell population. It can be seen that the cells begin to depolarize 
relatively quickly, <1.5 hours, in the presence of this solvent but that the majority 
of the cells, about 75%, remain viable after 5 hours exposure. However, only 7% 
of the cells have polarized membranes upon immediate exposure to the solvent 
indicating the cells come under stress through the presence of the ethanol. The 
cell membranes remain intact and are able to survive in this environment as the 
proportion of dead cells does not vary significantly over the time course. The 
membrane in the majority of cells remain intact (as indicated by the 
characteristic forward and side scatter values) and so membrane bound proteins 
and enzymes are likely to operate successfully.
In contrast Figure 4.3(b) shows the effect of the ionic liquid [Emim][TOS] (20% 
v/v) on the cell population which appeared to be the most biocompatible ionic 
liquid of all those tested. Over 99% of the cells are seen to remain viable with 
polarized and non-permeabilised membranes throughout the time course of the 
experiment. By comparison Figure 4.3(c) shows that the ionic liquid
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[Bmim][0 cS0 4 ] is highly toxic to the cells. Greater than 99% of cells were 
found to have permeabilised membranes within 30 minutes of exposure and 
100% were in this state at the times shown in Figure 4.3.
4.3.2 Correlation o f  flow cytometry data with viable plate counts
Viable cell counting on plates (by determining colony forming number as 
described in Section 2.8.5) is a much cruder measure of cell population state 
compared to flow cytometry which picks up more subtle changes in cell 
physiology. It was hypothesized here that the colony forming unit count 
determined through plate counting is equivalent to polarized, live cell counts 
identified through flow cytometry i.e. cells in quadrant HI of Figure 4.2(a). This 
is because cells must be live and metabolizing to form new colonies on plates 
while stressed or permeabilised cells would be unable to go through cell division.
Figure 4.4 shows a parity plot comparing colony forming unit counts (Section 
3.3.2) against live polarized cell counts determined here through flow cytometry.
In general there is a positive linear correlation between the two measurements 
confirming the proposed hypothesis. However the correlation coefficient is only 
98%. This is due to the nature of the co solvents and their modes of action as the 
data is skewed to the upper and lower data ranges respectively. Solvents 
displaying intermediate effects on the cells were relatively rare.
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Figure 4.3 Response of R. erythropolis MA7213 to exposure to various miscible and immiscible co-solvents, (a) 10% v/v ethanol (b) 20% v/v [Emim][TOS]
(c) 20% v/v [CABHEM][MeS04]. Quadrant HI corresponds to live, polarised cells, H3 corresponds to live cells with depolarised membranes and H4 
corresponds to permeabilised cells. Experiments performed as described in Section 2.8.8.
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Figure 4.4 Parity plot comparing the percentage of live, polarised cells and viable cell plate counts after 
cell exposure to 10% v/v ethanol. Experiments performed as described in Sections 2.8.5 and 2.8.8. Solid 
lined fitted by linear regression (R2 = 0.985).
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It should also be remembered that flow cytometry only provides percentages of 
cells in a certain quadrant from the total number of whole cells it initially identifies 
due to their characteristic forward and side scatter patterns. Flow cytometry will not 
take into account grossly deformed cells that lose their characteristic forward and 
side scatter measures or those cells completely broken down to debris. However 
such effects will only impact on data in the lower range of measurements. Overall 
there does appear to be a positive correlation between flow cytometry results and 
plate count measurements suggesting flow cytometry can be used as a high 
throughput measure of the whole biocatalyst stability.
4.3.3 Correlation o f flow cytometry data and bioconversion efficiency
Figure 4.5 shows the corresponding bioconversion data for R. erythropolis MA7213 
in the presence of the co-solvents identified in Figure 4.3 along with overall 
conversion and initial rate data for the reduction of 6 -Br-p-tetralone to (5)-6-Br-p- 
tetralol. As suggested by the flow cytometry data in Figure 4.3, the cells in the 
presence of 20% v/v [Emim][TOS] remain viable and are able to convert the ketone 
at an initial rate of 20 mg(prod)g‘1(cell)hr' 1 to a final conversion of 28% w/w. This is 
in contrast to 1 0 % v/v ethanol as a co-solvent where only 14% w/w conversion was 
achieved at a lower initial rate of 5 mg(prod)g'1(cell)hr'1. This is in line with the flow
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cytometry data in Figure 4.3(a) which shows a much lower proportion of viable cells 
in quadrant HI compared to [Emim][TOS]. Finally, the flow cytometry data also 
successfully predicts the lack of conversion and negligible rate of reaction in the 
presence of 20% v/v [CABHEM][MeSC>4 ] where the cells were shown to be rapidly 
permeabilised (Figure 4.3(c)). Overall the results indicate that flow cytometry is a 
potential tool for rapidly identifying ionic liquids giving high rates of reaction as 
well as high biocompatibility. This is perhaps to be expected for oxidative reactions 
where the cells must retain metabolic activity in order to be able to recycle the 
necessary co-factors.
4.4 Flow cytometry analysis of E. coli TOPIO pQR239
4.4.1 Characterisation o f 1-indanone bioconversion
In order to determine the optimum time for induction of CHMO expression and 
bioconversion initiation, an understanding of the growth kinetics of this whole cell 
biocatalyst is required. The E. coli TOPIO pQR239 was cultured in shake flasks and 
a growth curve was obtained as shown in Figure 4.6.
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Experiments were then carried out to determine the optimum point for induction 
with L(+)-arabinose by performing 10% v/v ethanol bioconversions with cells 
induced at different points and determining which yielded the most product. The 
results of this induction study are shown in Table 4.1, showing the ideal time for 
induction is between 2 and 4 hours. Consequently the system was subsequently 
induced at 3 hours and bioconversion initiated after 7 hours cultivation in all 
subsequent experiments.
Induction Time 
(hrs)
Conversion
(% w/w)
0 3
1 9
2 18
3 19
4 19
5 14
6 9
7 1
Table 4.1. Summary of data to the determine optimum time for induction of E. coli TOPIO pQR239 
culture to maximize conversion of 1-indanone. Induction was carried out as described in Section 2.6. 
Bioconversion was initiated after 7 hours total culture as described in Section 2.7.1.
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Figure 4.5 Comparison of (a) conversion profiles of 6-Br-P-Tetralone to (5)-6-Br-P-Tetralol in the 
presence of (•) 20% v/v [Emim][TOS] (■) 10% v/v ethanol (A) 20% v/v [CABHEMJfMeSO,*] (b) 
initial rates of reaction and conversion of these reactions. Microbial cultivation was carried out as 
described in Section 2.6, and bioconversion was subsequently performed as described in Section 
2.7.1.
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Figure 4.6 Growth profile of E. coli TOPIO pQR239 on modified LB media in a 250 mL Erlenmeyer 
flask over 8 hours at 37°C in a shaking incubator operating at 200 rpm with surface aeration. Microbial 
cultivation was performed as described in Section 2.6 and biomass analysis as described in Section 
2.8.3. Error bars indicate one standard deviation about the mean.
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A further parameter of interest is substrate solubility (as described in Section 3.3.1), 
both in pure co-solvent ( 1 0 0 % v/v) and subsequent solubility in the aqueous phase 
upon initiation of bioconversion. The solubility results are summarised in Table 4.2. 
As was observed in the case of 6 -Br-P-tetralone, solubility of 1 -indanone in the ionic 
liquid is less than in the organic solvent, with ethanol and toluene solubility of 
indanone both over 700 gL'1. Conversely, the highest solubility with ionic liquids is 
in AmmoEng™ 102. Of the 2 ionic liquids identified in the flow cytometry analysis 
of R. erythropolis MA7213, 1-indanone solubility is around 350 gL' 1 in both at 
100% v/v, with the hydrophilic [Emim][TOS] conferring 2.2 gL' 1 on the aqueous 
phase at 20% v/v and the hydrophobic [Oc3MeN][NTf2 ] conferring around 0.3 gL' 1 
on the aqueous phase at 2 0 % v/v ionic liquid.
4.4.2 Flow cytometry analysis ofE.  coli TOPIOpQR239
Figure 4.7 shows the flow cytometry analysis of E. coli TOPIO pQR239 in the 
presence of 10% v/v ethanol, 20% v/v [Emim][TOS] and 20% v/v 
[CABHEM][MeS0 4 ]. Results obtained for all the ionic liquids studied are shown in 
Appendix C.
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Solvent Substrate Solubility (gL'1)
(% v/v) 10 20 50 100
EcoEng™ 212 1.37 2.48 8.53 248
[Bmim][PF6] 0.41 0.43 0.7 313
AmmoEng™ 102 2.86 4.87 12.96 456
[Bmim][OcSC>4] 1.91 3.19 7.99 295
AmmoEng™ 120 1.92 3.81 9.37 446
[Oc3MeN][NTf2] 0.32 0.34 1.72 331
[Emim][TOS] 1.21 2.19 8.75 ■»362
[Bmim][BF4] 1.40 2.57 5.43 273
[CABHEM][MeS04] 2.18 2.36 5.25 192
[BMP][BTI] 0.30 0.31 0.32 301
Table 4.2 Summary of 1-indanone solubility at various co-solvent volume fractions. In the case of 10-50% 
v/v co-solvent the solubility recorded is that in the aqueous buffer phase. In the case of 100% co-solvent the 
solubility shown is the saturation substrate solubility in the co-solvent Experiments were performed as 
described in Section 2.3.
118
Chapter 4
In the presence of 10% v/v ethanol (Figure 4.7(a)) around 50% of cells become 
permeabilised in the first half an hour increasing to over 80% within 2 hours. 
However, contrary to this behaviour in the presence of 20% v/v [Emim][TOS] 
(Figure 4.7(b)) approximately 45% of cells remain polarized with intact membranes, 
with approximately 30% depolarized inside the first half hour, changing to 38% 
polarized with intact membranes and 60% with permeabilised membranes in 2 
hours. In the case of [CABHEM][MeS0 4 ] (Figure 4.7(c)) approximately 90% of 
cells become permeabilised within the first 10 minutes indicating the much greater 
toxicity of this ionic liquid to these cells.
Figure 4.8 shows the flow cytometry data obtained for E.coli TOPIO pQR239 in the 
presence of the hydrophobic, two-phase-forming ionic liquid [Oc3MeN][NTf2]. As 
expected, the partitioning of the solvent appears to have a protecting effect on the 
cells as the toxic components of the ionic liquid partition much more slowly into the 
aqueous phase, and washing of the ionic liquid removed many of the soluble 
impurities before use (Section 2.4). The bar chart in Figure 4.8(b) shows the intact 
cell population is maintained at 50-60% throughout the analysis. Also, the gradual 
depolarization and subsequent death of the cells can be more readily tracked in this 
“slower” system.
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It can be seen that in the case of permeabilised cells multiple “sub-populations” of 
cells become apparent with different characteristic fluorescences. The presence of 
these sub-populations is an artifact of the use of cell stocks to produce seed cultures 
rather than colonies from plates. Although the sub populations are clearly apparent, 
they do not affect the validity of the results as they are plasmid carrying cell 
populations with CHMO expression as evidenced by their ampicillin resistance.
Overall in the case of E. coli TOPIO pQR239 the flow cytometry data indicates 
[Emim][TOS] and [Oc3MeN][NTf2] as single phase forming and two phase forming 
biocompatible ionic liquids respectively.
4.4.3 E.coli TOPIOpQR239 bioconversion kinetics
The bioconversion kinetic data for the oxidation of 1-indanone to 3,4- 
dihydrocoumarin by E. coli TOPIO pQR239 is summarised in Figure 4.9. Table 4.2 
summarises the calculated initial rates of reaction and biocatalyst half life as 
calculated from the flow cytometry data in the presence of a range of co-solvents. 
Conversion in the presence of ethanol reaches around 20% w/w within five hours at 
an initial rate of around 0.07 g(prod)L'1hr'1.
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Figure 4.7 Response of E. coli TOPIO pQR239 cells to exposure to various miscible co-solvents, (a) 10% v/v ethanol (b) 20% v/v [Emim][TOS] (c) 
20% v/v [CABHEM][MeS04]. Quadrant K3 corresponds to live, polarized cells, K1 corresponds to live cells with depolarized cell membranes and K2 
corresponds to dead cells. Microbial cultivation was performed as described in Section 2.6 and flow cytometry analysis as in Section 2.8.8.
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Figure 4.8 (a) Response of E. coli TOPIO pQR239 to the immiscible co-solvent [Oc3MeN][BTA] present at 20% v/v. Quadrant K.3 corresponds to live, 
polarized cells, K1 corresponds to live cells with depolarized cell membranes and K2 corresponds to dead cells, (b) Bar chart of relative cell number of live 
polarized (red), live depolarized (green) and dead (blue) cells over time. Microbial cultivation was performed as described in Section 2.6 and flow cytometry 
analysis as in Section 2.8.8.
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Many of the ionic liquids examined performed significantly worse than this with no 
conversion detected with 3 of them (Table 4.3). Of all the ionic liquids tested 
[Bmim][BF4 ] behaves most similarly to ethanol, whereas the hydrophobic ionic 
liquid, [Bmim][PF6] performs significantly worse than its hydrophobic counterpart 
[Oc3MeN][NTf2], This is despite a similar “half-life” as determined through flow 
cytometry and a slightly greater aqueous solubility at 20% v/v co-solvent. This 
indicates that there is another factor besides biocatalyst stability and substrate 
solubility affecting bioconversion kinetics. This is most likely to be mass transfer 
efficiency as this is the factor that was seen to be likely to limit the 6-Br-P-tetralone 
conversions with hydrophobic ionic liquids in Section 3.4.
4.4.4 Biocatalyst stability and carbon chain length
Based on the results discussed in Section 4.4.2 there appears to be an initial 
correlation between the size of the carbon chain of the anion of an ionic liquid and 
its apparent biocompatibility with the E. coli TOP 10 pQR239 biocatalyst. Observing 
the flow cytometry output of various salts of butyl methyl imidazolium as shown in 
Figure 4.10, it appears to be the case that increasing the size of anion increases the 
toxicity of the ionic liquid to the cells. However further study is required to verify 
this initial observation.
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Co-Solvent Initial rate 
(gL'hr*1)
Conversion 
(% w/w)
tl/2
(hr)
[Bmim][BF4] 0.03 16 0.25
[Emim][TOS] 0.11 30 1
Ethanol 0.07 19.6 0.15
[Bmim] [MDEGS04] 0 0 <0.1
[Bmim][PF6] 0.01 4 2
[C ABHEM] [MeS04] 0 0 <0.1
[Oc3MeN][NTf2] 0.12 28.3 >2
[Bmim] [OCSO4 ] 0 0 <0.1
Table 4.3 Summary of 1-indanone oxidation data by E. coli TOP 10 pQR239 in the presence of 20% v/v 
co-solvent in the case of ionic liquid co-solvents and 10% v/v in the case of ethanol, ti/2 indicates the 
time required for 50% of cells to become depolarized and permeabilised as measured by flow 
cytometry. Bioconversions were performed as described in Section 2.7.1. Flow cytometry analysis was 
carried out as described in Section 2.8.8.
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Figure 4.9 Comparison of conversion profiles of 1-indanone to 3,4-dihydrocoumarin by E. coli TOP 10 
PQR239 in the presence of: (■) [Bmim][BF4] (•) [Emim][TOS] (A) Ethanol (▼) [Bmim][MDEGS04] 
(♦) [Bmim][PF6] (+) [CABHEM][MeS04] (x) [Oc3MeN][NTf2] (*) [Bmim][0cS04]. Cultivation was 
carried out as described in Section 2.6 and bioconversions were performed at volume fractions of 10% 
as described in Section 2.7.1.
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Figure 4.10 Changes in apparent toxicity of ionic liquids to E. coli TOPIO pQR239 with anion size. Flow 
cyometry plot is 30 minutes past exposure in all cases. Experiments were performed at ionic liquid 
volume fractions of 20% and flow cytometry analysis was as described in Section 2.8.8.
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4.5 Summary
The use of flow cytometry to quantitatively examine the biocompatibility of both 
ionic liquid and organic co-solvents to both whole cell gram positive and gram 
negative biocatalysts has been shown. Analysing membrane potential and cell 
membrane permeability appear to be good indicators of the overall state of the 
biocatalyst and give a better indication of bioconversion potential than traditional 
colony forming unit counts.
Flow cytometry has been demonstrated as a tool for successfully estimating the 
biocompatibility of an ionic liquid. There is also an initial indication that flow 
cytometry will predict the bioconversion efficiency given a particular whole cell 
biocatalyst and co-solvent combination. However, more data is needed to show this 
conclusively.
In general, a hierarchy of biocompatibility can be established of immiscible ionic 
liquids, followed by immiscible organic solvents and then miscible solvents of both 
types. As expected, gram positive cells are more “solvent tolerant” than gram 
negative cells, and the mode of toxicity of ionic liquids appears to follow the trend 
of depolarization of cells (i.e. breakdown of cell metabolism) followed by cell death.
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There also appears to be some initial correlation between ionic liquid structure and 
biocompatibility.
For both of the whole cell biocatalysts examined flow cytometry was successfully 
used to identify both biocompatible ionic liquids and those ionic liquids that have a 
high degree of toxicity towards the biocatalyst. For the reduction of 6-Br-P-tetralone 
to (S)-6-Br-p-tetralol the ionic liquid [Emim][TOS] was identified through the flow 
cytometry screen and was used to double conversion of the ketone at a significantly 
higher rate. In the case of the 1 -indanone oxidation a number of ionic liquids were 
identified two of which gave improved conversions at higher initial rates compared 
to the conventional ethanol co-solvent.
The great potential of flow cytometry, however, lies in the relative speed and ease of 
operation compared to traditional viable cell counts. In the cases examined here 
samples could be taken from the bioconversion, run on a standard flow cytometer 
and the results obtained in around 10 minutes per sample. The time taken for 
analysis could be decreased further through the use of automated samplers allowing 
32 samples to be loaded and processed at once. As will be described in Chapter 6 
there are now also flow cytometers commercially available capable of operating
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with standard micro titre plates which open up the possibility of truly high 
throughput biocompatibility analysis.
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5 Isolated enzyme bioreductions of ketones*
5.1 Introduction and aims
The reduction of 6-Br-p-tetralone to (5)-6-Br-p-tetralol by whole cell 
biocatalysts in the presence of ionic liquids has been successfully demonstrated 
in Chapter 3. The reactions are limited to 2 gL'1 initial substrate concentration 
however due to substrate toxicity to the biocatalyst beyond this concentration. 
Such low initial substrate concentrations are not sufficient for industrial 
application of biocatalysis to chiral alcohol synthesis. Isolated enzyme systems 
can provide processes with the desired substrate concentrations of 50-100 gL'1 
(Pollard and Woodley, 2007). The issue of co-factor regeneration in this case has 
been resolved by the availability of coupled enzymes such as formate 
dehydrogenase or glucose dehydrogenase that recycle the required co-factor such 
that its availability does not limit the reaction (Kroutil et al, 2004; Pollard and 
Woodley, 2007). An added benefit of isolated enzyme systems is the amenability 
of such processes to rapid development which is a priority in early 
pharmaceutical process development (Pollard and Woodley, 2007).
The challenge with respect to isolated enzyme mediated synthesis is the same as 
for whole cells; the need to provide large quantities of substrate into the aqueous 
system, through the use of non-aqueous solvents, is traded off with the inhibitory 
effects of these solvents on the biocatalyst. The aim of this chapter is to
* The results presented in this chapter have been submitted for publication as: Hussain W, Pollard 
DJ, Truppo M, Lye GJ. (2008) Enzymatic ketone reductions with co-factor recycling: 
improved reactions with ionic liquid co-solvents J  Mol Catal Enzym in press.
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determine the feasibility of carrying out isolated enzyme bioreductions of 6-Br- 
p-tetralone with coupled enzyme mediated co-factor recycling in the presence of 
ionic liquid co-solvents. Key objectives of the work presented in this chapter are 
to:
• Determine the effects of ionic liquid co-solvents on enzyme stability.
• Characterise bioconversion kinetics in a range of ionic liquid and other 
co-solvents.
• Determine the feasibility of product recovery from ionic liquids.
• Characterise the limiting factors to reduction reactions involving ionic 
liquids.
5.2 Biocatalyst identification
A library of 66 commercially available enzyme preparations for ketone 
reductions was tested against the 6-Br-p-tetralone substrate in an automated 
screen (Section 2.5) and a selection of the results is presented in Table 5.1. It can 
be seen that the (5) enantiomer of interest can be synthesized with excellent 
selectivity by four of the enzymes each with 100% ee. In contrast, the (.R) 
enantiomer does not appear to be so readily formed. When considering the 
screening data, the enantio-selectivity of the enzyme is generally deemed more 
critical than the conversion as the latter can be more readily manipulated through 
altering some of the engineering parameters when performing the conversion. It 
was found that the alcohol dehydrogenase isolated from Rhodococcus 
erythropolis (ADH RE) was an effective catalyst for the reduction of interest
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(Figure 5.1), with a >99% enantiomeric excess of the desired (S) enantiomer. 
The ADH RE system was chosen for further investigation as it was isolated from 
the same species previously studied in Chapter 3 (R. erythropolis). Glucose 
dehydrogenase 103 was selected as the co-enzyme used for co-factor recycling.
Enzyme Conversion (% w/w)
Product ee
(%)
KRED1 100.0 24.4
KRED4 25.9 54.7
KRED7 22.7 27.9
KRED8 98.9 -37.1
KRED9 42.3 13.3
KRED10 30.9 55.1
KRED11 98.5 29.4
KRED26 100.0 100
KRED27 100.0 -71.8
KRED28 100.0 -71.5
KRED29 69.6 -43.2
KRED30 92.3 6.4
KRED31 47.7 35.6
KRED exp-A1A 25.7 41.9
KRED exp-A1 B 100.0 -43.2
KRED exp-A1 C 100.0 -45.1
KRED exp-A1D 100.0 -40.8
KRED exp-A1 E 74.1 -18.4
KRED exp-A11 33.3 30.3
KRED exp-A1J 83.8 9.3
KRED exp-A1 L 68.7 78.3
KRED exp-A1P 99.1 100
KRED exp-A1T 73.8 -30.0
KRED exp-A1 U 50.0 93.5
KRED exp-A1V 36.3 33.3
ADH RE 99.5 100
KRED NADH 102 100.0 100
Table 5.1. Summary of conversions and product ee of enzymes identified from a screen of 66 ketoreductase 
preparations for the reduction of 6-Br-p-tetralone to (S)-6-Br-p-tetralol (Figure 5.1). Product ee was calculated 
for the (S) enantiomer. Enzyme nomenclature is as supplied by the manufacturer 
(http://www.biocatalytics.com/kred.html). Experiments were performed as described in Section 2.5.
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Br
6-Br-P-tetralone
Gluconic acid
ADH RE
pH~6.8, T=30°C
N A  A D 4
kOH
Br
Glucose
GDH 103
Figure 5.1 The asymmetric reduction of 6-Br-P-tetralone to (S)-6-Br-P-tetralol by alcohol dehydrogenase 
isolated from Rhodococcus erythropolis (ADH RE) and co-factor recycling by the glucose dehydrogenase 
103 (GDH 103) mediated oxidation of glucose.
5.3 Substrate solubility screen
One of the primary issues in generating economically viable biocatalytic 
processes is in effectively charging large titres of substrate to the reaction system 
(Rozzell, 1999). The compounds of interest are usually sparingly soluble in 
aqueous systems (<1 gL*1) so the use of a co-solvent is required to boost the 
delivery of the substrate to the catalyst. In the case of 6-Br-p-tetralone aqueous 
solubility was found to be very low at less than 0.1 gL'1. Increasing the substrate 
charge is often achieved through the use of organic solvents that can act as 
reservoirs of substrate and/or product confining them away from the catalyst 
until required. The use of solvents in the system however is often detrimental to 
the catalyst, so using higher volume fractions of solvent to increase substrate 
delivery further becomes impossible due to inhibition of the biocatalyst (Kim et 
al, 2007). The processing issue becomes a trade off between the need for
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effective, concentrated substrate delivery and the need to prolong the activity of 
the biocatalyst.
A variety of conventional organic solvents with a range of miscibilities with 
water and polarities were initially screened for solubility of 6-Br-p-tetralone, and 
some of these are shown in Table 5.2. Solvents with higher polarities, such as 
methanol, ethanol and iso-propyl alcohol, were found to have relatively poor 
solubility of the substrate (<75 gL'1), whereas lower polarity solvents dissolved 
the substrate much more readily. Of these, toluene, DMSO, THF and DMF were 
found to dissolve the substrate to >500 gL'1 in the pure solvent. The partitioning 
of solute to the conjugate aqueous phase however was much weaker, with only 
toluene delivering >1 gL'1 substrate to the aqueous phase at 10% v/v co-solvent 
fraction. Even at much higher volume fractions these non-polar solvents failed to 
deliver >5 gL'1 substrate to the aqueous phase.
The 11 ionic liquids screened gave solubilities of the same order of magnitude as 
polar organic solvents, though solubility levels were often greater than 100 gL'1 
(Table 5.2). There was no readily discemable difference in behavior between the 
miscible and immiscible ionic liquids. However, in delivery of substrate to the 
aqueous phase there was a marked contrast between the behavior of ionic liquids 
compared to organic solvents and between water miscible and water immiscible 
ionic liquids. In general the use of ionic liquids resulted in the partitioning of 
much higher quantities of substrate to the aqueous phase compared to organic 
solvents (Table 5.2). Two of the AmmoEng™ salts and [Bmim][BF4 ] for 
example delivered ~5 gL"1 substrate to the aqueous phase at 10% v/v co-solvent
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Co-solvent Structure Solubility Aqueous solubility (;fL' )
(gL'1) 5% 10% 20% 50%
[Emim][TOS] 46 3.44 3.09 1.25 11.78
AmmoEng™ 110 e\ ® /  °  
N
MtS E^t
64 0.36 0.49 0.63 4.07
[EMP][ES]
(@P0H B.SO-,N
k
65 0.39 0.74 1.67 9.66
EcoEng™ 21M 86 0.97 0.55 3.06 6.89
[Bmim][PF6] £F6 105 0.17 0.18 0.23 0.32
EcoEng™ 212 EtOSOj\s/ 121 2.04 0.54 1.30 6.06
AmmoEng™ 102
’•“ w — K _VA Etos°!'
126 3.49 5.97 18.62 29.78
AmmoEng™ 120
R X R M e O S O j
126 4.01 10.76 19.26 55.90
EcoEng™ 111 IP 138 3.04 1.16 2.77 32.20
[Bmim][BF4] 139 0.41 4.97 1.82 62.94
[BMP][NT£2] N(CF3S02)2 164 0.03 0.21 0.14 0.80
DMSO
0
I
/ \  HjC CHj
>500 0.22 0.53 0.95 1.50
THF Q >500 0.20 0.32 0.74 3.78
Toluene 6 >500 2.15 LOO 1.58 4.60
DMF
\ 
_
 
°K
X >500 0.30 0.63 0.81 5.27
Table 5.2 6-Br-P-tetralone solubility in a library of ionic liquids and selected solvents. Solubility refers to the saturation 
solubility of substrate in 100% v/v co-solvent. Aqueous solubility refers, in the case of miscible co-solvents to the 
equilibrium saturation concentration of substrate in the co-solvent mixture. In the case of immiscible co-solvents 
aqueous solubility refers to the equilibrium saturation concentration of substrate in the conjugate aqueous phase. % 
values refer to the volume fraction of co-solvent to buffer.
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fraction compared to less than 1 gL'1 for other ionic liquids and for the organic 
solvents considered.
As ionic salts, ionic liquids possess a much higher polarity than the organic 
solvents described (Carmichael and Seddon, 2000; Reichardt, 2004) and so are 
able to dissolve this poorly aqueous soluble substrate more readily in the 
presence of water. The two immiscible ionic liquids, [BMP][NTf2] and 
[Bmim][PF6] show poorer aqueous substrate solubility than even the organic 
solvents. This indicates that substrate mass transfer from these co-solvents will 
potentially be an important factor in determining their efficacy to deliver 
substrate in the aqueous phase containing the biocatalyst.
5.4 Effect of ionic liquids on enzyme stability
The other issue of interest from the standpoint of bioprocess design is enzyme 
activity. The ADH RE identified in Section 5.2 and GDH 103 were subsequently 
screened in a library of ionic liquid and organic co-solvents for enzyme stability. 
Measured half-lives of ADH RE and GDH 103 are summarized in Table 5.3 
when determined at 10% v/v co-solvent volume fraction.
ADH RE appeared stable at 30°C in the presence of up to 20% v/v DMSO for 48 
hours, with only 30% loss of activity. In contrast, toluene was much more 
detrimental with less than 5% residual activity after 48 hours in the presence of 
10% v/v co-solvent.
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Co-solvent Structure Half-life, ti/2 (hours)
ADH RE GDH103
None 78 128
[BMP][NTf2] N (C F 3S 0 2) 2 266 >300
[Bmim][PF6]
£ F ‘
135 220
AmmoEng™ 102
^  —oh EtOSOj"
‘/ v Y Y T
12 >300
AmmoEng™ 110 E\ ® ^ ( ~ ^ r 0H c r  
M/ \ ,
77 >300
AmmoEng™ 120
O
r .------ A  MeOSOj-
0
40 170
[Emim][TOS]
\ © /
82 41
[Bmim][BF4 ]
\  b f 4 
\ © / ^  '
45 239
EcoEng™ 212 E I O S O jWJ 147 >300
EcoEng™ 111 IP \ n A A m /  M e 2 P 0 < 
\ © /
182 108
EcoEng™ 21M 22 97
[EMP][ES]
© T  E.OSO, 
N
k
144 27
Toluene
0 ^ ch>
10 5
THF r\ D <3 25
DMSO
O
II
h 3c  c h 3
231 34
Table 5.3 Half life of alcohol dehydrogenase isolated from Rhodococcus erythropolis (ADH RE) and glucose 
dehydrogenase 103 (GDH 103) in a range of co-solvents (10% v/v) at 30°C and pH 7. None represents 100% 
v/v 100 mM potassium phosphate dibasic buffer. Experiments were performed as described in Section 2.6.
Chapter 5
This is in contrast to enzyme in 100% buffer (pH 7.0) where 65% of the original 
activity was retained after 48 hours. Seven out of the eleven ionic liquids 
screened (Table 5.3) offered an advantage toward the stability of both ADH RE 
and GDH 103 compared to the organic solvents tested. In particular the 
immiscible ionic liquids [BMP][NTf2] and [Bmim][PF6] where 80% and 78% 
original activity was maintained respectively over 64 hours compared to only 
57% activity retention in buffer. This is in contrast to AmmoEng™ 102 and 
EcoEng™ 21M where >95% enzyme activity was lost after just 15 hours.
5.5 Bioconversion of 6-Br-P-tetralone to (5)-6-Br-P-tetralol
Bioconversions in the presence of all the ionic liquids listed in Table 5.3 were 
subsequently performed in pH stats (working volume 10 mL) at an initial 
substrate concentration of 50 gL'1 to determine which co-solvent would result in 
the best conversion yield and reaction rate. These pH stat reactors were mixed by 
a magnetic flea, as described in Section 2.7.2, and visual observation of the 
reactions indicated effective mixing of the two-phase systems was achieved with 
good dispersion of the ionic liquid phase into the bulk fluid. A summary of the 
bioconversion data for selected co-solvents is presented in Table 5.4.
The immiscible ionic liquids [BMP][NTf2] and [Bmim][PF6] performed the best 
of all the co-solvent systems analyzed. Enzyme stability in the presence of these 
two co-solvents is good with residual ADH RE activities after 24 hours of 43% 
and 28% respectively (Table 5.4). The steady state aqueous solubility of the 
substrate from [BMP][NTf2] and [Bmim][PF6] to the conjugate aqueous phase
138
Chapter 5
was measured at 0.21 gL'1 and 0.18 gL'1 respectively which is much lower than 
for the miscible co-solvent systems. However, the complete conversions and 
high initial rates of reaction achieved in the presence of these co-solvents suggest 
enhanced mass transfer rates of substrate from these ionic liquids as a possible 
factor. The use of 10% v/v toluene as an immiscible co-solvent significantly out 
performed all the other organic co-solvent systems studied in terms of conversion 
(Table 5.4, Figure 5.2), and the residual ADH RE activity was similar to 
[BMP][NTf2]. In addition to this, the solubility of the substrate after 
equilibration in the aqueous phase is 1 gL'1 suggesting the rate of reaction should 
be greater than that for [BMP][NTf2]. However the rate is almost one third that 
of [BMP][NTf2], indicating the solute mass transfer rate may be lower from the 
toluene phase.
Co-solvent Initial rate 
(g(prod)L'1h r 1)
Conversion 
(% w/w)
Residual ADH 
activity 
(%  w/w)
Substrate
solubility
(gL-1)
None 3.1 100 74 0.1
rBM Pl[N Tf2] 14 100 43 0.2
[Bmim][PF6] 14 98.5 28 0.2
AmmoEngTN* 102 12 100 9.4 6.0
[Emim][TOS] 6.5 89.0 51 3.1
[Bmim][BF4] 9 99.5 38 1.2
EcoEng™ 111 IP 1.2 38.5 66 1.3
Toluene 5.8 100 41 1.0
DMSO 2.3 58.4 42 0.5
THF 2 24.9 0.8 0.3
DMF 3.6 95.8 7.6 0.6
Table 5.4 Summary of initial reaction rates, conversion, residual ADH RE activity and substrate solubility 
in the ionic liquid screen for the reduction of 50 gL'1 6-Br-P-tetralone to (5)-6-Br-P-tetralol (Figure 5.1). 
All experiments were performed in the presence of 10% v/v co-solvent as described in Section 2.7. In the 
case of miscible co-solvents substrate solubility refers to the equilibrium saturation of substrate in the co­
solvent mixture. In the case of immiscible co-solvents substrate solubility refers to the equilibrium 
saturation concentration of substrate in the aqueous phase.
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Despite a low aqueous solubility of 6-Br-p-tetralone (<1 gL'1) the reaction 
carried out with no co-solvent (at an added initial amount of substrate equivalent 
to 50 gL'1) goes to completion within 24 hours at an initial rate of 10.1 g(prod)L' 
lhr'1 (Figure 5.2). The residual ADH RE concentration after this time was 74% 
w/w (Table 5.4). Visually, the reaction is seen to begin as a two-phase system of 
aqueous buffer and solid substrate but as product is synthesised an immiscible oil 
phase is formed. It is suggested that the dispersed oil and solid phase enhance the 
mass transfer rate of substrate into the aqueous phase yielding the full conversion 
observed in 24 hours. The presence of dispersed solid phases in particular is 
known to enhance gas-liquid mass transfer coefficients in bioreactors (Littlejohns 
et al, 2007). The initial rate of reaction in the presence of [BMP][NTf2] is still 
greater than with the buffer (which have comparable aqueous solubilities) 
suggesting that the mass transfer improvements of substrate from the 
[BMP][NTf2] to the aqueous phase are greater than the effects of the 
enhancements brought about through the presence of the product oil and solid 
phases.
In the case of miscible ionic liquid co-solvents, the 10% v/v AmmoEng™ 102 
co-solvent system yielded 100% w/w conversion with an initial rate of 12 
g(prod)L'1hr'1 (Table 5.4, Figure 5.2). Residual ADH RE activity was only 10% 
of the initial value as the enzyme has been shown to have a very short half life in 
the presence of this co-solvent (Table 5.3). However the solubility of the 
substrate is boosted to 6 gL'1 facilitating more rapid reactions.
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In summary, while there does appear to be a correlation between bioconversion 
efficiency and parameters such as enzyme activity, aqueous substrate solubility 
and solute mass transfer efficiency there is still a need to carry out a screen of 
reaction conditions. Based on the data available reliably predicting which 
conditions will give the highest rates and yields is not currently feasible. For 
example, the ionic liquid [Emim][TOS] provides an aqueous solubility of 3.1 gL'
1 (Table 5.4) and ADH RE half life is around 80 hours (Table 5.3) in the 
presence of 10% v/v co-solvent, but conversion is limited to <90% w/w at a 
much lower initial rate of 6.5 g(prod) L^hr'1 when compared to [BMP][NTf2].
5.6 Effect of volume fraction
For immiscible co-solvents the volume fraction of the dispersed phase will 
determine the total amount of substrate that can be dissolved in the system and 
the interfacial area available for mass transfer. In the case of [BMP][NTf2], the 
best ionic liquid found in Section 5.5, there appears to be no readily discemable 
difference in rate or conversion between 10% and 20% v/v volume fractions 
while at 50% v/v the measured rate is approximately 60% that of the lower 
volume fractions (Figure 5.3).
Normally mass transfer would be expected to be better at the increased co­
solvent volume fraction (Cesario et al, 1997). Interestingly the enzyme stability 
data shows that there is no significant difference in the rate of ADH RE or GDH 
103 degradation between the three systems (Figures 5.3(b) and 5.3(c)). This 
apparent disparity in reaction rate at high volume fraction may be due to the
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influence of the viscosity of the ionic liquid as the viscosity of the pure ionic 
liquid is two orders of magnitude greater than that of water (9x1 O'2 PaS). All 
three ionic liquid concentrations were operated at the same stirrer speed (1000 
rpm) yet the mass averaged viscosity varied 2-3 fold across the experiment 
resulting in a 50% change in the Reynolds number. The Reynolds number is an 
engineering parameter indicating the degree of turbulence within a system and is 
based on the ratio of inertial forces to viscous forces due to agitation. It is 
defined as Re = pNdj /p where p is the mass averaged system density, N is the 
impeller speed, di is the impeller diameter and p the mass averaged system 
viscosity.
5.7 Effect of impeller Reynolds Number
The effect of Reynolds number on the conversion was further examined at 
Reynolds numbers of 450 and 900 as determined by the minimum and maximum 
impeller speeds achievable on the lab scale equipment (Section 2.7.2). Figure 5.4 
shows the conversion profiles for two 10% v/v [BMP][NTf2] co-solvent 
systems, one at a Reynolds number of 450, the other at 900, and a 20% v/v 
[BMP][NTf2] co-solvent system with a Reynolds number of 450. As expected, at 
a fixed co-solvent fraction and in a heterogeneous reaction system that is mass 
transfer limited doubling the Reynolds number doubles the initial rate of 
reaction. Likewise at a fixed Reynolds number doubling the co-solvent fraction 
leads to a corresponding increase in the measured rate of reaction due to an 
increase in the area available for solute mass transfer. These results confirm that
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mass transfer is the limiting factor for the ionic liquid bioconversions studied in 
this work.
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Figure 5.2 Comparison of the conversion kinetics of 50 gL'1 6-Br-P-tetralone to (5)-6-Br-P-tetralol by 
ADH RE in the presence of 10% v/v co-solvent: (■) [BMP][NTf2], (•) AmmoEng™ 102, (A)  
toluene (▼) DMSO and (♦) with no co-solvent (buffer only). Reactions were carried out in 
Multimax™ miniature reactors with 30 mL working volume at 30°C and pH 6.8 ±0.1 as described in 
Section 2.7.2.
143
Chapter 5
100-
90-
co
12<D>coO
200 10 15 255
Time (hors) (b)
£
>
o
CO 50- LU
Q
<  30-
- I  20- 
'( / )
Q) 1 0 -
200 5 10 15
Time (hours)
100
COo
2 0 -
10 -
15 205 100
Time (hours)
Figure 5.3 Effect of co-solvent volume fraction on the conversion of 50 gL'1 6-Br-P-tetralone to (S)-6~ 
Br-P-tetralol by ADH RE in a range of co-solvents: (a) conversion kinetics (b) residual ADH RE activity 
(c) residual GDH 103 activity. Experiments performed in the presence of: (■) 10% v/v [BMP][NTf2], 
(•) 20% v/v [BMP][NTf2], (A) 50% v/v [BMP][NTf2] and (▼) 10% v/v toluene. Reactions were 
carried out in Multimax™ miniature reactors as described in Section 2.7.2.
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Figure 5.4 Effect of impeller Reynolds number and dispersed phase volume fraction on initial rate of 
reaction for conversion of 50 gL'1 6-Br-P-tetralone to (5)-6-Br-P-tetralol by ADH RE. (a) Conversion 
kinetics of: (■) 10% v/v [BMP][NTf2], Re = 450, (•) 10% v/v [BMP][NTf2], Re = 900, (A) 20% v/v 
[BMP][NTf2], Re = 450. (b) Calculated initial rates of reaction. Reactions were carried out in 
Multimax™ miniature reactors as described in Section 2.7.2.
145
Chapter 5
5.8 Effect of enzyme concentration
Due to the high cost of enzyme preparations, industrial enzymatic processes are 
rarely run such that mass transfer is the limiting factor. Enzyme concentration is 
a more restrictive constraint (Pollard et al, 2006a) and so was also examined. At 
a fixed Reynolds number of 450 and 10% v/v [BMP][NTf2] co-solvent, various 
initial ADH RE concentrations (0.5-5.0 gL'1) were used to determine the enzyme 
concentration at which mass transfer becomes rate limiting (GDH 103 
concentration was maintained at 0.5 gL'1 for all experiments). As expected 
increasing initial enzyme concentration increases the rate of reaction and the time 
to complete conversion is reduced. The results, shown in Figure 5.5, indicated 
that solute mass transfer first becomes rate limiting at an initial ADH RE 
concentration of ~2 gL'1.
5.9 Effect of temperature on conversion kinetics
It was shown that the ADH RE stability at 40°C was not significantly different 
from stability at 30°C (Table 5.3). Consequently, the 1 gL'1 initial ADH RE 
experiment originally described in Section 5.8 was compared to a similar 
experiment run at 45°C. From Figure 5.6(a) it can be seen that the initial rate of 
reaction was much greater (approximately double) at the higher temperature but 
this rate diminished sharply after 2 hours due to a much more rapid decrease in 
ADH RE activity at this higher temperature.
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Figure 5.5 Effect of initial ADH RE concentration on the conversion kinetics of 50 gL'1 6-Br-p-tetralone 
to (5)-6-Br-P-tetralol (a) Comparison of % conversion kinetics at initial ADH RE concentrations of: (■) 
0.5 gL'1, (•) 1.0 gL'1, (A) 2.5 gL'1 and (T)  5.0 gL'1. (b) Initial rate of reaction against initial enzyme 
concentration. Solid line fitted by second order polynomial regression (R2 = 0.996). Experiments were 
performed as described in Section 2.7.2.
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Figure 5.6 Effect of temperature on the conversion of 50 gL'1 6-Br-P-tetralone to (S)-6-Br-|3- 
tetralol at an initial ADH RE concentration of 1 gL'1. (a) Comparison of conversion kinetics, (b) 
residual ADH RE activity, (c) residual GDH 103 activity at: (■) 30°C (•) 45°C. Experiments were 
performed as described in Section 2.7.2.
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This apparent disparity between the stability data observed between enzyme in 
buffer and co-solvent in vials (in thermomixers) and the reaction vessel is 
attributed to the harsher mixing conditions in the reaction vessel.
5.10 (S)-6-Br-|$-tetralol recovery
A study of the partition coefficient for 6 -Br-p-tetralone between [BMP][NTf2] 
and various organic solvents showed that toluene gave the best extraction of 
product from the ionic liquid. A simple isolation procedure was feasible 
whereby the product in the immiscible ionic liquid can be separated from the 
aqueous phase by centrifugation followed by three half-volume extractions with 
toluene from the ionic liquid (~60% w/w average extraction efficiency). The 
product was then isolated from the toluene by vacuum evaporation of the solvent 
yielding 8 8 % w/w product with an enantiomeric excess of >99% in favour of the 
desired (S) enantiomer.
5.11 Acetophenone reduction
5.11.1 Introduction
A further example of an asymmetric ketone reduction to which biocatalysis is a 
desirable route of formation is the reduction of 4’-Br-2,2,2-trifluoroacetophenone 
to (R)-4’-Br-2,2,2-trifluoroacetophenyl alcohol. The reaction is described in 
Figure 5.7. Reduction of multi-substituted pro-chiral acetophenones for 
pharmaceutical synthesis has been previously reported with whole cell
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biocatalysis (Patel et al, 20046) and by isolated enzymes (Pollard et al, 20066). 
In these cases the acetophenones were either highly soluble in aqueous media or 
the reaction conditions could be manipulated so that the substrate was readily 
converted by the biocatalyst of choice. In the particular case of 4 ’-Br-2,2,2- 
trifluoroacetophenone the substrate is soluble in aqueous media to concentrations 
sufficient to drive the reaction but was found to be inhibitory towards the 
biocatalyst. The application of room temperature ionic liquids is investigated 
here to address this bottleneck in chiral alcohol synthesis.
OH
ADH RE
pH~6.8, T=30°C
B r'
4'-2,2,2-trifluoroacetophenone
CF.
Br
(ft)-4'-2,2,2-trifluoroacetophenyl alcohol
NADH NADh
Gluconic acid Glucose
GDH 103
Figure 5.7 The asymmetric reduction of 4’-Br-2,2,2-trifluoroacetophenone to (R)-4-Br-2,2,2- 
trifluoroacetophenyl alcohol by ADH RE and co-factor recycling by the GDH 103 mediated 
oxidation of glucose.
5.11.2 Biocatalyst identification
Enzymes suitable for the reduction of 4 ’-Br-2,2,2-trifluoroacetophenone to (R) 
4 ’-Br-2,2,2-trifluoro phenyl ethanol (Figure 5.7) were initially identified by
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screening the substrate against the commercially available ketone reduction 
library used in Section 5.2. Enzymes yielding both product enantiomers were 
found. The alcohol dehydrogenase isolated from Rhodococcus erythropolis 
(ADH RE) gave the desired (R) enantiomer with an enantiomeric excess (ee) > 
99% while the ketoreductase KRED 101 gave the (S) enantiomer. Both of these 
enzymes used a second enzyme, glucose dehydrogenase 103 (GDH 103), to 
regenerate the cofactor (NADH).
5.11.3 Bioconversion o f  4 ’-Br-2,2,2-trifluoroacetophenone to (R)-4’-2,2,2- 
trifluoroacetophenyl alcohol
All bioconversions were investigated at an industrially relevant initial substrate 
concentration of 50 gL'1. For bioconversions in buffer (Figure 5.8(a)) or with 
10% v/v of miscible organic co-solvent such as methanol, DMSO or THF only 
10% conversion was achieved. This was not due to the low solubility of the 
substrate as the solubility in buffer alone is > 6  gL'1. Rather, the poor conversion 
was due to rapid deactivation of both enzymes as shown by the activity profiles 
for ADH RE and GDH 103 in Figure 5.8(b) and 5.8(c) respectively. Separate 
enzyme stability studies in buffer with 10 gL' 1 substrate (the aqueous solubility 
limit) showed an enzyme half life of < 2  hours which is severely reduced 
compared to enzyme stability measured in buffer only where the half life is 78 
hours for ADH RE and >300 hours for GDH 103 (Table 5.3). Biphasic systems 
with organic solvents gave some improvement to conversion as for example up 
to 20% w/w conversion in the presence of 10% v/v toluene (Figure 5.8(a)). The 
toluene acted as a reservoir for the substrate so the aqueous substrate
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concentration the enzymes were exposed to was lowered to around 4 gL'1. As 
shown in Figure 5.8(b) and 5.8(c) the presence of 10% v/v toluene reduced the 
deactivation on the enzyme such that a low level enzyme activity was detectable 
even after 24 hours.
Bioconversions in the presence of ionic liquid such as the immiscible 
[BMP][NTf2] showed rapid reaction rates with complete conversion of an initial 
50 gL' 1 substrate concentration in less than 10 hours (Figure 5.8(a)). The use of 
AmmoEng™ 102 also led to improved reactions. The calculated initial rate of 
reaction with no co-solvent was approximately 3 g(prod)L'1hr' 1 which almost 
doubled in the presence of 10% v/v AmmoEng™ 102 to 5.5 g(prod)L'1hr' 1 and 
doubled again to 12.3 g(prod)L'1hr' 1 in the presence of 10% v/v [BMP][NTf2], 
In the presence of a number of ionic liquids, especially [BMP][NT£2], the ADH 
RE half-life was markedly improved as shown in Table 5.3, and its residual 
activity was less affected by the presence of substrate as shown in Figure 5.8(b). 
A total of four of the ionic liquids tested gave conversion improvements over the 
best organic co-solvent tested and three of these significantly protected the 
enzyme from the inhibitory effects of the substrate (Table 5.5).
In Section 5.4 it was seen that the presence of some ionic liquids enhanced the 
stability of ADH RE. Among these was the ionic liquid [BMP][NTf2]. In the 
presence of this ionic liquid at 10% volume fraction the half life of ADH RE 
increased to 266 hours and that of GDH 103 to >300 hours. This is in contrast to 
buffer alone where half life of the ADH RE and GDH 103 was 78 and 128 hours 
respectively. The increase in enzyme stability in the presence of [BMP][NTf2]
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however is not sufficient to account for the large increases in initial activity 
observed in Figure 5.8(a), suggesting a further enhancement of other physical 
parameters may be in operation such as that observed for the 6 -Br-p-tetralone 
substrate in Section 5.4.
Co-solvent Initial rate 
(gCpro^L^hr1)
Conversion 
(% w/w)
Residual ADH 
activity 
(% w/w)
Substrate
solubility
(gL 1)
None 3.1 5.6 0 6.5
rBMPirNTf2 1 12 100 40 5.1
[Bmim][PF6] 11 99.6 47 3.8
AmmoEng™ 102 5.5 75.8 4 14
[Emim][TOS] 2.5 46.1 46 8.2
[Bmim][BF4 ] 0.1 0 0 6.3
EcoEng™ 111 IP 0.1 0.8 0 11
Toluene 6.1 20.8 1 8.2
Table 5.5 Summary of initial reaction rates, conversion, residual ADH RE activity and substrate 
solubility in the ionic liquid screen for the reduction of 50 gL'1 4’-Br-2,2,2-trifluoroacetophenone to 
(/?)-4’-Br-2,2,2-trifluoroacetophenyl alcohol (Figure 5.7). All experiments were performed in the 
presence of 10% v/v co-solvent as described in Section 2.7. In the case of miscible co-solvents substrate 
solubility refers to the equilibrium saturation of substrate in the co-solvent mixture. In the case of 
immiscible co-solvents substrate solubility refers to the equilibrium saturation concentration of 
substrate in the aqueous phase.
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Figure 5.8: Comparison of the conversion kinetics of 50 gL'1 4’-Br-2,2,2-trifluoroacetophenone to (/?)-4’- 
2,2,2-trifluoroacetophenyl alcohol by ADH RE in different co-solvent systems: (a) conversion kinetics (b) 
residual ADH RE activity (c) residual GDH 103 activity. Experiments performed in the presence of 10% v/v 
co-solvent: (A) [BMP][NTf2], (•) AmmoEng™ 102, (T)  toluene and (■) with no co-solvent (buffer only). 
Reactions were carried out in Multimax™ miniature reactors with 30 mL working volume at 30°C and pH 6.8 
±0.1 as described in Section 2.7.2.
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5.11.4 Effect o f  enzyme concentration
Experiments in which the initial ADH RE concentration was reduced from 1 gL' 1 
to 0.5 gL' 1 (GDH 103 concentration was also reduced to 0.5 gL'1) still allowed 
for 100% w/w conversion of 50 gL' 1 4 ’-Br-2,2,2-trifluoroacetophenone to Cft)-4’- 
Br-2,2,2-trifluoroacetophenyl alcohol within 24 hours. The use of 0.1 gL' 1 ADH 
RE, although found to be feasible, resulted in too low a rate of reaction to give 
full conversion within the lifetime of the enzyme in the system. In this case 
enzyme concentration became the limiting factor as evidenced by the linear 
conversion rates through the majority of the reaction course.
5.11.5 Ionic liquid re-use
In order to investigate ionic liquid re-use a 0.25 gL' 1 ADH RE, 50 gL' 1 initial 
substrate concentration and 15% v/v [BMP][NTf2] experiment was performed at 
30°C in a pH stat (as described in Section 2.6) for ~28 hours, converting ~95% 
w/w 4 ’-Br-2,2,2-trifluoroacetophenone to alcohol. In order to isolate the product, 
this mixture was taken, centrifuged, and the water layer removed. The product 
and remaining substrate was then extracted from the ionic liquid layer by 4 
washes with diethyl ether until >99% w/w of product was recovered (as 
determined by reverse phase HPLC). It was apparent by eye that some of the 
ionic liquid had been absorbed into the diethyl ether layer so fresh ionic liquid 
was added (~0.25 mL giving a total ionic liquid volume of 1.5 mL) to replenish 
the system.
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A second bioconversion (shown in Figure 5.10) in which the recovered ionic 
liquid was used with fresh enzyme was then performed under the same reaction 
conditions and compared to a simultaneously run fresh ionic liquid experiment. 
The recovered ionic liquid profile mirrored the fresh ionic liquid profile very 
well, but the rate always remained slightly lower than in the fresh ionic liquid 
case. In the case of the recovered ionic liquid 85% w/w conversion was achieved 
compared to 92% w/w conversion in the case of fresh ionic liquid.
5.11.6 (R)-4’-Br-2,2,2-trifluoroacetophenyl alcohol recovery and yield
The isolated product from the original reaction with [BMP][NTf2] was recovered 
by rotary vacuum evaporation of the diethyl ether leaving a viscous oil identified 
as (i?)-4’-Br-2,2,2-trifluoroacetophenyl alcohol by reverse phase HPLC (Section
2.8.1) and SFC analysis (Section 2.8.3). The overall yield of recovered product 
was 85% w/w with an ee of >99% in favour of the desired (R) enantiomer.
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Figure 5.9: Effect of initial ADH RE concentration on the conversion kinetics of 50gL'* 4’-Br-2,2,2- 
trifluoroacetophenone to (/?)-4’-Br-2,2,2 trifluoroacetophenyl alcohol with 10% v/v [BMP][NTf2] co-solvent, (a) 
Conversion kinetics, (b) residual ADH RE activity, (c) residual GDH 103 activity with: (A) 1 gL'1 (•) 0.5 gL'1 
(■) 0.1 gL'1 initial ADH RE concentration. Experiments were performed as described in Section 2.7.2.
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Figure 5.10: Example of ionic liquid re-use. Conversion kinetics of 4’-Br-2,2,2-trifluoroacetophenone 
reduction to (/?)-4’-Br-2,2,2-trifluoroacetophenol in the presence 15% v/v (■) fresh (•) recycled 
[BMP][NTf2] as co-solvent. Ionic liquid was recovered as described in Section 2.10. Bioconversions 
were performed in pH stats (10 mL working volume) as described in Section 2.7.2.
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5.12 Lewis cell mass transfer study
The suggestion of improved substrate mass transfer observed in the 10% v/v 
[BMP][NTf2] system for the ADH mediated reduction of 6 -Br-P-Tetralone to 
(S)-6 -Br-P-Tetralol (Section 5.5) was investigated further in a Lewis Cell, as 
described in Section 2.10 (Lye and Stuckey, 2001). A Lewis Cell provides a 
constant and defined interfacial area between two immiscible liquid phases and 
allows for accurate determination of changes in solute concentration in the two 
phases over time under controlled hydrodynamic conditions. Theoretically, 
operation of the cell requires equal Reynold’s numbers between the two phases 
(Lye and Stuckey, 2001). However, due to the large differences in density and 
viscosity between the ionic liquid and buffer, and mechanical limitations of the 
Lewis Cell available it was not possible to achieve equal Reynold’s numbers in 
each phase. Consequently experiments were run based on varying the ionic 
liquid phase Reynold’s number (from 120 to 430) while keeping that of the 
aqueous phase constant at 430. Despite these limitations, the results shown in 
Figure 5.11 indicate a clear advantage in mass transfer of 6 -Br-P-tetralone from 
[BMP][NTf2] to buffer compared to transfer of the substrate from toluene to 
buffer, even at much reduced Reynold’s number for the ionic liquid system, 
given the equilibrium concentrations from each ionic liquid phase shown in 
Table 5.2. These results confirm a much enhanced increase (more than 5-fold) in 
substrate mass transfer rate from ionic liquid to buffer compared to toluene. 
However, the reason for this enhancement is currently unclear.
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Figure 5.11 Concentration of 6-Br-P-Tetralone in the aqueous buffer phase of Lewis Cell in the 
presence of toluene with Reynold’s number (■) 1320 (•) 3000 (A ) 4500 and [BMP][NTf2] with 
Reynold’s number (T ) 123 (♦) 250 (+) 430. The Lewis Cell was operated as described in Section 2.11.
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5.13 Summary
The asymmetric reduction of industrially relevant quantities of prochiral ketones 
to their corresponding alcohols in the presence of ionic liquid as a co-solvent and 
with coupled enzyme regeneration of co-factor has been demonstrated. In the 
reactions studied here the ionic liquid was found not to alter the enantiomeric 
selectivity of the enzyme.
Use of an immiscible ionic liquid, in particular [BMP][NTf2], led to dramatic 
improvements in reaction performance. In the case of the reduction of 4 ’-Br- 
2 ,2 ,2 -trifluoroacetophenone the initial rate of reaction in the presence of 1 0 % v/v 
[BMP][NTf2] increased to 12 g(prod)L'‘hr 1 with 100% w/w conversion in 24 
hours (Figure 5.8(a), Table 5.5). The highest rate achievable with organic 
solvents was with 1 0 % v/v toluene where only 2 0 % w/w conversion was 
achieved in 24 hours at an initial rate of ~ 6  g(prod)L'1hr' 1 (Table 5.5). Thus, the 
use of ionic liquids as co-solvents not only improved the rate of reaction but 
resulted in a previously infeasible reaction becoming potentially industrially 
viable. In the case of the reduction of 6 -Br-p-tetralone use of ionic liquids led to 
more than a two-fold increase in initial rate of reaction to 14 g(prod)L‘1hr' 1 in the 
presence of 10% v/v [BMP][NTf2] and [Bmim][PF6 ] (Table 5.4). This is in 
contrast to 10% v/v toluene where the initial rate of reaction was 5.8 g(prod)L‘ 
‘hr' 1 and buffer only where the initial rate of reaction was just 3.1 g(prod)L'1hr' 1 
(Table 5.4).
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Recovery of the products from the ionic liquids has also been shown to be viable, 
with little loss in yield and purity. In the case of [BMP][NTf2] separation of the 
ionic liquid from the aqueous phase where the enzyme resides, proved feasible 
by centrifugation where a protein precipitate layer forms between the two phases. 
Extraction of the product from the ionic liquid into organic solvent was rapid and 
subsequent isolation of the product by rotary vacuum evaporation is a standard 
technique.
Half life increases to > 250 hours for ADH RE and to >300 hours for GDH 103 
at 30°C in the presence of 10% v/v [BMP][NTf2] have also been shown. 
Previous work on ADH from Lactobacillus brevis showed increases of half life 
to 50 hours under similar conditions in the presence of [Bmim][(CF3 S0 2 )2N] 
(Patel et al, 2005). Rates of reaction have also been vastly improved with >95% 
w/w conversion of 50 gL' 1 substrate achieved in less than 8  hours in both cases 
studied here.
Based on the current results and the few examples in the literature (Park and 
Kazlauskus 2001; Laszlo et al, 2002; Hinckley et al, 2002; Kaar et al, 2003) , 
there does not at present appear to be a rational way to select ionic liquids for 
biocatalytic processes based upon their structure or functional groups. Screening 
of a limited range of ionic liquids has been shown to be effective in a number of 
cases (Roberts at al, 2004; Lozano et al, 2006; Zhang et al, 2006). A 
representative library of ionic liquids can be readily formed for most 
applications. Of the eleven ionic liquids screened here for the 6 -Br-P-tetralone 
conversion (Section 5.4), five gave rates and conversion equivalent or better than
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those of the best organic solvent screened. In the case of the 4 ’-Br-2,2,2- 
trifluoracetophenone reduction (Section 5.10.3) four ionic liquids gave 
improvements over the best organic co-solvent but critically they all facilitated 
much greater conversion over organic solvents and buffer. Important factors in 
ionic liquid selection appear to be solubility of substrate in the aqueous phase of 
heterogeneous phase systems, mass transfer rates of substrate from immiscible 
ionic liquids into the aqueous phase and biocatalyst stability in the aqueous/ co­
solvent mixture.
The enhanced mass transfer of substrates from the ionic liquid [BMP][NTf2] 
alluded to in Sections 5.4 and 5.10.3 have been shown through Lewis Cell 
analysis of the [BMP][NTf2] system in comparison to toluene. Under conditions 
of fixed interfacial area between the two liquids mass transfer from 
[BMP][NTf2] to buffer was clearly superior to mass transfer from toluene to 
buffer.
The issues of substrate solubility, biocatalyst stability and mass transfer have 
been examined in this work. The influence of ionic liquids on enzyme activity 
appears to be the most critical followed by the inter-related effects of mass 
transfer substrate solubility. A strategy for the high throughput screening of ionic 
liquids for biocatalytic applications should centre upon these three factors and is 
described in Chapter 6 .
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6 A systematic approach to the high throughput 
screening of ionic liquids as co-solvents for 
biocatalysis
6.1 Introduction and aims
In the previous chapters both whole cell (Chapter 3) and isolated enzyme 
(Chapter 5) ketone reductions have been shown to be feasible in a range of ionic 
liquids. In both cases efficient bioconversions for a number of substrates and 
biocatalysts were achieved by evaluating a relatively small range of ionic liquids 
(Tables 3.1 and 5.2). A number of common process design considerations were 
identified including substrate solubility, biocatalyst stability and the relative rates 
of bioconversion and solute mass transfer in the case of water immiscible ionic 
liquids.
The success of the screening approach, and the present inability to relate ionic 
liquid structure or properties to bioconversion efficiency, suggests that for the 
industrial uptake of ionic liquids a systematic, high throughput approach to ionic 
liquid evaluation is required. Building upon the earlier experimental results, the 
aim of this chapter is to outline and exemplify a systematic approach to ionic 
liquid selection and how it can be implemented. The specific objectives of this 
chapter are to:
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• Outline a systematic approach to ionic liquid evaluation for biocatalytic 
applications.
• Describe methods for automated solubility studies and establish the 
congruence of automated methods to manual .
• Describe the use of such automated platforms for biocatalyst and co­
solvent screening.
• Describe larger scale methods for determining rate of reaction and 
conversion data.
6.2 A systematic approach to ionic liquid selection
The vast array of enzymes and co-solvents for potential biocatalytic application 
requires a robust and verifiable method for screening. Any screening method 
needs to be rapid, small scale and preferably automated to allow research groups 
to establish product formation rates, chirality, ideal co-solvent (if any), substrate 
solubility and biocatalyst kinetics at relatively low cost. The use of larger scale 
bio-reactor mimics would also be required to subsequently establish process 
parameters relating to phase mixing and mass transfer.
Based upon the earlier findings in this study Figure 6.1 illustrates a proposed 
hierarchical approach to the systematic evaluation of ionic liquids as co-solvents 
for biocatalysis. It also indicates the scales of operation and the nature of the 
equipment that could be used at each stage. While the emphasis is on ionic 
liquids the same elements may be applied to any organic co-solvents.
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Proposed hierarchy. Equipment and scale
Choose representative 
range of ionic liquids.
Can a suitable biocatalyst be 
identified in promising ILs?
Is substrate solubility within 
acceptable range?
Scale-up studies & 
manufacturing analysis.
Can initial bioconversions 
be established?
Can optimised 
bioconversions give 
required metrics?
• Automated liquid and powder 
handling systems 
• Microtitre plates (1 mL)
Automated liquid and powder 
handling systems 
• Microtitre plates (1 mL)
Automated miniature bioreactors 
Miniature stirred reactors (30 mL)
• Lab scale reactors 
• Stirred reactors (1 L)
Figure 6.1 A hierarchical approach towards the systematic evaluation of ionic liquids as co-solvents for 
biocatalysis.
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6.3 Automated solubility screen
The first experiments performed within the proposed framework relate to 
determination of the solubility of the substrate in a wide range of ionic liquids. 
To demonstrate this aspect of the approach a microwell platform capable of 
dispensing both solids and liquids was used to prepare microwell plates 
containing 250mg of the desired substrate 6 -Br-p-tetralone (Figure 6.2). A 
microtitre plate containing 96 miniature glass vials (max volume 1.5 mL per 
well) was taken by the robotic arm and was placed on the integrated weighing 
platform. A shield then came up to surround the plate and protect it from any air 
disturbances during solids dispensing and the weight measurement. To fill each 
well the robotic arm then picked up a hopper from a defined position, prefilled 
with the solid substrate required, and added a defined amount to each vial. Solids 
could be dispensed to an accuracy of ±0 . 2  mg.
The powder filled block was then moved to the liquid handling station (Figure 
6.3). Here, solvent was taken from 32 possible positions and added to the pre­
dispensed solids in each well as required. A particular issue with the use of 
automated liquid handling systems with ionic liquids is the high viscosity of 
some pure ionic liquid phases. To overcome this problem specific “viscous tips” 
were used on the platform allowing more accurate aspiration. The aspirate and 
dispense speeds were then minimised to allow sufficient time for take up of the 
required volume of ionic liquid. However, even with these factors taken into 
account, the very viscous ionic liquids, such as [CABHEMJfMeSCL] were still 
not aspirated accurately.
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(a)
(b)
Figure 6.2 Elements used in the automated substrate solubility screen: (a) a 96 vial plate for 
automated solubility screening, (b) “Powdemium” solids dispensing system for addition of solid 
substrates. Images reproduced from http://www.symyx.com/page.php?id=74.
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Figure 6.3 Symyx automated liquid handling platform for addition of liquid phases during 
the initial substrate solubility screen. The platform features 3 plate positions with 
independent heating and magnetic stirring controls, 4 tip arm, and 32 positions for 
additives. Image reproduced from http://www.symyx.com/page.php?id=70.
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To fully overcome this problem, a “wait” step of 10 seconds was added while the 
tips were still submerged in the fluid to allow complete take up of the required 
ionic liquid volume. Use of glass vials rather than plastic multi-well plates allows 
for use of a full range of solvents as well as magnetic stirring ensuring good 
mixing of two phases. There is also the advantage that the vials are available for 
individual visual inspection which is not possible with rigid plates.
Once liquid dispensing was complete, the plate was covered using a rubber plate 
seal and the substrate-co-solvent mixture was left to stir on the magnetic 
platform for 24 hours using a 5 x 2 mm magnetic flea in the base of each well. 
After mixing the whole plate was centrifuged to take all the solids to the bottom 
and 50pl of the liquid was removed automatically and diluted in 950pl 
acetonitrile. This was subsequently diluted again 1:4 with acetonitrile before 
analysis of the dissolved substrate concentration by reverse phase HPLC (Section
2.8.1). The results obtained with the automated solubility screening system were 
compared to the manual solubility screen performed as described in Section 2.3.
The results shown in Figure 6.4 indicate a good agreement between automated 
and manual solubility studies. The three outlying points are identified as the ionic 
liquids [BMP][NTf2], [Bmim][BF4 ] and AmmoEng™ 120 all of which have 
relatively high viscosities. Further manipulation of the pipetting regime would be 
required to account for high viscosities as the automated system currently under 
predicts the substrate solubility.
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Figure 6.4 Parity plot between manual and automated solubility studies for the saturation 
solubility of 6-Br-P-tetralone in a range of ionic liquids and organic solvents. Solid line 
represents line of parity. Manual and automated solubility studies performed as described in 
Section 2.3 and 6.2 respectively. R2 = 0.953.
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6.4 Automated biocatalyst screen
The second element of the proposed framework relates to the identification of an 
appropriate biocatalyst, either whole cell or isolated enzyme, that is able to 
selectively transform the substrate of interest (Figure 6.1). This could be carried 
out using a similar robotic platform as was described in Section 6.3, and a 
possible method is described in Section 2.5. Product yield and enantiomeric 
excess can be determined for a library of biocatalysts in less than 24 hours (Table
5.1), and an appropriate biocatalyst identified.
6.5 Automated quantification of bioconversion kinetics
Having identified a suitable biocatalyst that acts on the substrate of interest in 
perhaps a small range of ionic liquids the next step of the framework is to gain 
more insight into the factors that influence bioconversion kinetics. As shown in 
Figure 6.1, these relate first to understanding the biocatalyst stability in the 
selected ionic liquids and later the relationship between the substrate mass 
transfer biocatalyst activity.
Analysis of the reaction kinetics of biocatalysts in the identified solvents was 
carried out in the Multimax™ miniature reactors (Figure 6.5). In this system, 
four reactors can be operated each with individual control of pH, temperature and 
rotational speed of the mixing shaft. The vessels have a liquid capacity of 50 mL 
with working volumes of 25-30 mL. Control of pH and temperature is dynamic 
via the pH and temperature probes visible in Figure 6.5(b). The associated
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software monitors and records data for all the variables and this data is available 
via a graphical user interface (Figure 6 .6 ) or via export to a Microsoft Excel 
format for ease of subsequent analysis.
In the case of isolated enzyme bioconversions, the GDH 103 co-factor recycling 
system used with both 6 -Br-p-tetralone (Figure 5.1) and 4’-Br-2,2,2- 
trifluoroacetophenone (Figure 5.7) results in a decrease in pH of the aqueous 
phase due to the formation of gluconic acid from glucose. In this case, base 
addition to the reaction can be used to estimate on-line the initial rate of reaction 
and subsequent conversion.
The use of these automated miniature reactors is also likely to give a better 
indication of bioconversion kinetics in larger scale stirred reactors. In Chapters 3 
and 4 whole cell bioconversions were routinely carried out in Erlenmeyer flasks 
mixed on a shaking incubator. The potential for much better mixing to eliminate 
any potential mass transfer limitations in these systems was demonstrated in the 
Multimax™ reactors (Figure 6.7). In the 20% v/v [Bmim][PF6 ] system reported 
in Section 3.4.1 with the yeast T. capitatum MY 1890 acting as the biocatalyst it 
was postulated that this system was mass transfer limited due to the linear 
increase in product concentration over time.
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(a)
(b)
Figure 6.5 Automated miniature reactors for evaluation of bioconversion kinetics and related 
mass transfer studies: (a) Multimax™ miniature reactor system with 4 independent temperature 
control chambers and impeller rotational speeds, (b) detail of a Multimax™ reactor with pitched 
blade impeller (dj = 24 mm, OD = 39 mm, ID = 35 mm, h = 74 mm) and pH and temperature 
probes.
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Figure 6.6 Example of online data collection from the Multimax™ system shown in Figure 6.5. The screen 
image shows base addition volumes to the four individual reactors. Temperature and pH can be similarly 
monitored for the full reaction course. Experiments were performed as described in Section 2.7.2.
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Figure 6.7 Conversion kinetics of 6-Br-P-tetralone reduction by the yeast T. capitatum MY 1890 
in the presence of 20% v/v [Bmim][PF6] in: (•) 250ml Erlenmeyer flask cultured in an orbital 
shaker at 220 rpm and (o) Multimax™ miniature reactor operated at an impeller speed of 600 
rpm. Cultivation was performed as described in Section 2.6 and bioconversion as described in 
Section 2.7.1.
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As shown in Figure 6.7 the initial rate of reaction with mechanical agitation is 
around 7 fold greater than in the shaker flasks. However, conversion is minimal 
after approximately 4 hours indicating that the more intense mixing regime may 
have an adverse effect on the ability of the cells to perform the bioconversion.
The mass averaged Reynold’s number in this experiment was only 115 indicating 
a laminar regime, but this value comes about as a result of the much greater 
viscosity of the ionic liquid over water (0.352 Pas), and a higher density (1400 
k g m '). However, as the biocatalyst resides only in the buffer phase, the 
relatively high rotational speed may have had an adverse effect on the biocatalyst 
stability. In summary, it has been shown that the use of a mini reactor system can 
be used to rapidly determine biotransformation kinetics with minimal human 
input while reducing any potential mass transfer limitations.
6.6 Analysis of biocatalyst stability
As described in Section 4.4.3 there is a strong relationship between biocatalyst 
stability in ionic liquids and the ultimate bioconversion performance. 
Consequently high throughput methods to evaluate whole cell biocatalyst 
stability are included as part of the framework (Figure 6.1) to help in the 
identification of a suitable biocatalyst. In Chapter 4 the utility of flow cytometry 
for the study of biocatalyst stability was demonstrated and it was mentioned that 
microwell plate based flow cytometry devices are now available.
In the case of isolated enzyme systems stability can already be monitored using a 
high throughput plate based assay via spectrometry as described in Section 2.8.4.
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This system monitors the accumulation or consumption of the co factor NADH 
at a wavelength of 340nm. By comparing the rate of change in intensity to a 
standard concentration of enzyme an effective enzyme concentration can be 
determined over time during exposure to different ionic liquids.
For whole cells, however, the state of the biocatalyst has been measured 
specifically via multi parameter flow cytometry as described in Chapter 4. 
Recently, Guava™ Technologies have commercialised the EasyCyte flow 
cytometer system specifically for use with multi well plates as shown in Figure 
6.8. Experience from our laboratory has shown that multiparameter analysis can 
be carried out rapidly (less than a minute per sample) on multiple biocatalyst 
samples using this device hence no specific studies were required here to confirm 
this element of the proposed framework.
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Figure 6.8 Illustration of the Guava™ Technologies Easy Cyte microwell based flow 
cytometry studies. The device features forward scatter, side scatter and 3 wavelength 
detectors for fluorochromes and can be readily integrated with any standard liquid handling 
robot, (http://www.guavatechnologies.com/main/products/easycyte-new.cfm).
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6.7 Summary
In this Chapter a systematic approach to the identification of suitable ionic 
liquids as co-solvents for biocatalysis is described. This is centred upon 
determining aqueous solubility of substrate from the co-solvent, biocatalyst 
stability in the presence of co-solvent and substrate, and screening for 
biotransformation kinetics. Each of these processes has been shown to be readily 
automatable in multi well formats or miniature stirred reactors to allow screening 
of multiple conditions in parallel.
The saturation solubility of substrates into ionic liquids and solvents can be 
accurately ascertained through an automated process of weighed addition of solid 
substrate, co-solvent addition and agitation under temperature controlled 
conditions. Parameters such as the aspiration and dispensing speed of the liquid 
handling platform can be manipulated to take into account the particular 
properties of viscous materials like ionic liquids in order to improve 
measurement accuracy.
Biocatalyst and solvent screening is currently a standard technology for organic 
solvents in the case of whole cells (Stahl et al, 1997) and isolated enzymes 
(Pollard et al, 2006b; Truppo et al, 2006), and the inclusion of ionic liquids into 
such screening approaches provides a valuable addition to the range of process 
options that can be considered. Through the manipulation of liquid handling 
conditions described in Section 6.3 it is possible to accurately and reproducibly
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dispense ionic liquids for analysis of bioconversion kinetics in a multiwell 
format.
Having identified biocatalysts and co-solvents further investigation of the 
biocatalyst stability and bioconversion kinetics must be carried out in larger scale 
devices of a similar geometry to pilot and manufacturing scale vessels. Here the 
biocatalyst can be exposed to a hydrodynamic environment more typical of that 
like to be present in a large scale system. The Multimax™ miniature bioreactor 
system with temperature and pH control and online monitoring has been shown 
to be ideal for this kind of analysis in the case of isolated enzymes (Section 
5.10.3). Other products are now coming on to market for whole cell work which 
would allow analysis of both cell growth and bioconversion kinetics in a single 
vessel (Gill et al, 2007).
The work presented in this chapter have thus built upon the experimental studies 
described in Chapters 3, 4 and 5. A number of key engineering parameters for 
ionic liquid selection were identified and a hierarchical approach to ionic liquid 
process design was proposed (Figure 6.1). It has also been shown that the 
experiments required at each stage of ionic liquid evaluation can be readily 
automated allowing for high throughput, parallel experimentation.
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7. General discussion and commercial issues
7.1 General discussion
The use of room temperature ionic liquids as co-solvents for biocatalytic redox 
reactions, in both whole cell and isolated enzyme conversions, has been 
successfully demonstrated in this work The main factors concerning their 
implementation were the solubility of the substrate in the co-solvent mixture, the 
stability of the biocatalyst in the presence of the co-solvent and the mass transfer 
efficiency of the transfer of substrate and product to and from the aqueous phase 
in the case of two-phase forming co-solvents.
One of the primary advantages of ionic liquids cited in the literature is that they 
are good solvents capable of dissolving large quantities of substrate (Cull et al, 
2000; Roberts and Lye 2002; Mateus et al, 2003; Roberts et al, 2004). In this 
work it has been found that this is not always the case for certain types of 
substrate. Table 5.2 shows that of the ionic liquids screened some have 
significantly lower solubility of 6-Br-p-tetralone than common organic solvents 
such as toluene, THF or DMSO. However, when considering the supply of 
substrate to the environment of the biocatalyst, which resides in the aqueous 
phase, ionic liquids are generally superior to the organic solvents mentioned in 
Table 5.2. This is attributed to the higher polarity of the ionic liquids, with 
polarities generally in the range 0.7-0.8 relative to water, compared to solvents 
such as toluene with polarity of ~0.1 relative to water. In the case 4’-Br-2,2,2- 
trifluoroacetophenone, the substrate solubility in buffer alone was already quite
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high (~6 gL'1) but use of ionic liquids such as AmmoEng™ 110 and EcoEng™ 
1111P doubled the substrate solubility in the co-solvent mixture at equilibrium 
(Table 5.5).
The stability of the biocatalyst in the presence of the co-solvent under 
consideration is an important consideration in co-solvent selection. In the case of 
T. capitatum MY1890 stability of the biocatalyst was markedly affected by the 
presence of any co-solvent (Table 3.2). Two to three log reductions in viable cell 
numbers were recorded within eight hours by colony forming unit counts (Table
3.2). The effect of ionic liquid co-solvents, in general, was intermediate to that 
observed in the presence of common organic solvents such as ethanol or toluene 
compared to media only (Figure 3.3). There was no marked difference observed 
between single phase forming ionic liquids and those immiscible with water 
forming two phases. This is contrary to general observations for two phase 
systems where partitioning of the solvent away from the biocatalyst in the 
aqueous phase promotes stability (Cao et al, 2004). In the case of R. erythropolis 
MA7213 the effect of co-solvents was generally less pronounced as expected for 
Gram positive bacteria (Harrop et al, 1992). Some single phase forming ionic 
liquids such as [Emim][TOS] and [Bmim][BF4 ] exhibited biocatalyst stabilities 
superior to the cells residing in buffer only (Table 3.3). Both of the water 
immiscible ionic liquids tested, [Bmim][PF6] and [Oc3MeN][NTf2] similarly 
conferred some degree of greater stability on the gram positive biocatalyst 
compared to buffer only. In the case of immiscible co-solvents the apparent 
stabilising effect can be attributed in part to the removal of all soluble 
contaminants in the ionic liquid through washing prior to use (Section 2.2). In the
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case of miscible ionic liquids the mechanism of stability conferred by the co­
solvent mixture is currently unknown.
This quantification of whole cell biocatalyst stability based on colony forming 
unit counts relies upon the ability of cells to divide and form colonies on agar as 
a sign of their viability (Nebe-von-Caron et al, 1998). Although some degree of 
congruence was shown between the number of viable cells determined by this 
method and bioconversion kinetics, the speed and rate of bioconversion observed 
suggests that despite the apparent stress the cells are exposed to, their ability to 
carry out the bioconversion does not appear to have been affected (Section 
3.3.2). Other work (Cruz et al, 2004) in whole cell bioconversions has shown the 
efficacy of whole cell biocatalysts at carrying out selected bioconversions after 
being removed from growth media, washed and resuspended. This indicates that 
viability, as measured through an ability to divide is not required for effective 
bioconversion, but an active cellular metabolism is.
The use of multi parameter flow cytometry described in this work facilitates 
discrimination of the effect of co-solvents on whole cell biocatalysts (Chapter 4). 
As described in Section 1.8, cells undergo a period of stress, known as 
depolarisation, prior to cell death where the cellular metabolic pathways begin to 
break down. After ATP breakdown has ceased, the presence and efficacy of 
membrane bound proteins does not necessarily cease, indicating a possible 
mechanism for the continued bioconversions observed. The parity between 
viable cell counts as determined through colony forming unit counts and flow 
cytometric determination of live polarised cell populations (Figure 4.4) indicates
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the depolarised cells, which form a significant proportion of the cell number as 
determined through flow cytometry analysis could account for the apparent 
disparity between colony forming unit numbers and bioconversion kinetics.
In the case of isolated enzyme bioreductions the use of an immiscible ionic 
liquid, [BMP][NTf2], has been found to lead to a dramatic improvement in 
reaction performance for both of the bioconversions studied in this work (Figures
5.2 and 5.8). This increase in performance is a combination of increased half-life 
of both ADH RE and the GDH 103 co-factor recycling enzyme (Table 5.3) and 
other effects, most notably mass transfer (Sections 5.5 and 5.12). The often 
greatly increased enzyme half-life in the presence of hydrophobic co-solvents is 
attributed to a number of possible mechanisms. Hydrophilic co-solvents have 
been found to strip enzymes of “internally bound” water and soluble components 
of solvents interact electrostatically to adversely affect enzyme activity. In 
contrast, the action of hydrophobic co-solvents such as [BMP][NTf2] seem to 
promote enzyme stability (Zhao, 2005). A more compact enzyme conformation 
resulting from changes of a-helix structures to P-sheet within the protein has also 
been observed with hydrophobic ionic liquids (De Diego et al, 2005) and could 
act to protect the enzyme within a co-solvent system. For the reduction of 4 ’-Br-
2,2,2-trifluoroacetphenone [BMP][NTf2] acted to decrease the inhibitory effect 
of the substrate on the ADH RE. Potential changes in the redox environment 
within a co-solvent solution may also have an effect on the dynamics of the co­
factor binding and transfer within the system (Ichinose et al, 2005; Edegger et al, 
2006). This can subsequently affect the binding and transfer of substrate 
resulting in the kinds of changes in initial rate of reaction observed in this work.
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In a number of cases it has been shown that the use of ionic liquids can improve 
the mass transfer of substrates from the co-solvent phase to the aqueous phase in 
heterogeneous reaction systems. In Section 5.12 it was shown that despite a 
significant difference in Reynolds number the mass transfer of 6-Br-P-tetralone 
from the ionic liquid [BMP][NTf2] into the aqueous buffer phase was much 
more rapid than the transfer of the same substrate from the organic solvent 
toluene into the aqueous buffer phase given the same volume fractions and 
interfacial area (Figure 5.11). Coupled with the increased stability of the isolated 
enzyme biocatalyst observed in Section 5.4 the superior initial rate of reaction 
observed and more rapid overall conversion can be accounted for. A similar 
pattern was observed in the case of the 4 ’-2,2,2-trifluoroacetophenone reduction 
and it is highly likely that the mass transfer of this substrate is generally superior 
from the ionic liquid into the aqueous phase.
These two parameters: biocatalyst stability and mass transfer coefficients appear 
to be the most significant in determining successful application of ionic liquids to 
a process. However, solubility of the substrate is also an important consideration 
as illustrated by the AmmoEng™ 102 data for the two isolated enzyme 
reductions. Despite a poor enzyme stability, with ADH RE half life measured at 
just 12 hours (Table 5.3), the 6-Br-P-tetralone bioreduction proceeds to 100% 
w/w conversion at an initial rate of 6.5 g(prod)L'1hr'1. With such a low enzyme 
half life this would not be expected but the solubility of 6-Br-p-tetralone in the 
co-solvent mixture is enhanced to ~6 gL'1 in the presence of 10% v/v
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AmmoEng™ 102. This higher initial substrate concentration appears to drive the 
reaction to completion at a fast initial rate.
Based on these experimental studies the parameters for successful selection of 
ionic liquid co-solvents have been established. In Chapter 6 a systematic 
framework for the identification and selection of biocompatible ionic liquids has 
been suggested. Automation allows for rapid, parallel screening of parameters 
such as solubility and biocatalyst stability facilitating co-solvent identification 
(Lye et al, 2003). It is critical that this framework includes analysis of reactions 
and reaction conditions as other advantages of ionic liquids such as superior 
mass transfer cannot be readily directly identified through a high throughput 
screening process. However, a rapid method for identifying an appropriate 
biocatalyst, stability of that biocatalyst and substrate solubilities in a range of co­
solvents, and subsequent analysis of rates of reaction and conversion in larger 
scale miniature reactors is a feasible method for process development. The 
automation of all the elements of the proposed framework has been successfully 
demonstrated. The successful use of small libraries of commercially available 
ionic liquids in this work and others (Roberts et al, 2004; Lozano et al, 2006; 
Zhang et al, 2006) overcomes the significant hurdle of the vast numbers of 
potential ionic liquids and their tenability which is antithetic to rapid process 
development.
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The robust, tightly controlled regulatory environment of the pharmaceutical 
sector is a feature of medicine development that must be considered from the 
very beginning of process development. There are a number of potential issues 
surrounding the use of ionic liquids for pharmaceutical drug development that 
must be addressed before they can become a common feature of industrial 
bioconversion processes.
The issues of residual solvents in drug preparations were addressed by the 
Centers for Drug Evaluation and Research (CDER) and for Biologies Evaluation 
and Research (CBER) of the U.S. Food and Drug Administration (FDA) in 1997. 
For the purposes of safety assessment the CDER and CBER have classified 
solvents into three classes:
• Class 1: encompassing solvents known Or suspected to be human 
carcinogens or environmentally hazardous.
• Class 2: solvents that are non genotoxic but possibly cause other 
irreversible toxicity such as neurotoxicity or teratogenecity.
• Class 3: solvents with low potential human toxicity that are known to 
have a permitted daily exposure (PDE) limit of over 50 mg.
Solvents within class 1 are to be totally avoided, class 2 solvents are permitted to 
be used in a limited fashion up to their PDE value with analysis of their impact
1 The inclusion of this section relates to the University of London EngD requirement for 
consideration of the validation implications of the research work performed.
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on health over long term exposure times. Class 3 solvents can be used such that 
their daily intake would be 50 mg or less without justification and above that 
limit up to their PDE with long term exposure studies.
The safety implications of ionic liquids, particularly in humans, is not well 
understood at the moment. Some work has taken place into aquatic models (Zhao 
et al, 2007) which shows that many of the ionic liquids currently in use in ionic 
liquid research are highly toxic: the ionic liquid [Bmim][PF6] has an LC50 value 
of 19.9 and [Bmim][BF4 ] an LC5 0 value of 10.7 to the aquatic Daphnia genus as 
well as poor biodegradability (Wells and Coombe, 2006). Compared to 
methanol, the toxicity of the ionic liquids tested by Wells and Coombe is of the 
order of 104 to 106 greater. This indicates that the safety of ionic liquids needs to 
be of primary concern to the manufacturers and pharmaceutical end users. In this 
work, it was shown that the product of interest could be very effectively 
extracted from the ionic liquid phase using organic solvents but the residual 
concentration of the co-solvent in the product preparation could not be 
determined. Work in this area would also be valuable as it is only residual 
concentrations of solvents in the final formulated product that is covered by the 
FDA regulations mentioned earlier. The toluene used for isolation of 6-Br-P- 
tetralol in Chapter 5 is a class 2 solvent within the FDA classification system 
with a PDE of 8.9 mg day'1.
A further potential regulatory issue associated with ionic liquids is their safe 
disposal. As non volatile ionic salts, ionic liquids are generally very stable over 
wide temperature ranges and they have been shown to be poorly biodegradable
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in their complete form. Development of safe methods for effective disposal of 
ionic liquids are thus of paramount importance at the present time. Recent work 
in this area by Li and co-workers (Li et al, 2007) has shown possible methods 
and mechanisms for the oxidative degradation of imidazolium ionic liquids to 
inert components under mild conditions (50°C and 2.5mM anion concentration). 
Further work is required for other salts to determine generic methods to 
overcome this regulatory barrier to more widespread ionic liquid usage.
Although ionic liquid manufacture is becoming more widespread, and more 
companies are becoming active in ionic liquid manufacture and distribution, a 
consistent supply of good quality ionic liquids is required for FDA approval. 
Issues such as soluble contaminant concentrations and unreacted halide 
prevalence (as found in practice) between batches of ionic liquids must be 
addressed before industrial uses of these valuable solvents can increase.
The primary regulatory barrier to the use of ionic liquids in pharmaceutical 
processes at this time is the lack of safety data for a wide enough variety of ionic 
liquids. The lack of work on suitable models for extrapolation of data to human 
models is also a major concern. The limited data present in the literature appears 
to show that the toxicity of ionic liquids is such that they would be under Class 1 
of the CDER solvent classification system. Effective means of purifying products 
such that no traces of ionic liquid remain would thus be required to overcome 
this regulatory constraint. Analytical methods such as LC-MS would be required 
to accurately quantify ionic liquid content of product extracts. Long term supply
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of high quality, consistent batches of ionic liquids from manufacturers would 
also be required to ensure consistency of processes over drug product lifetimes.
7.3 Bioprocess management2
The development of new drugs is broadly a well defined process encompassing 
drug discovery and basic research, preclinical testing, clinical testing, regulatory 
review and approval and post-market testing. The rate of attrition of this process 
is well attested and it has recently (2005) been suggested that of 10,000 
compounds screened through basic research only one will be approved as a 
pharmaceutical drug some 16 years later. Faster process development and higher 
yields of product from these processes is therefore a paramount concern to 
determine the potential of a drug candidate as soon as possible 
(http://www.merck.com/).
The work on the bioreduction of 4 ’-Br-2,2,2-trifluoroacetophenone (Section 
5.10) clearly showed an application of ionic liquids that led to a previously 
infeasible process becoming potentially industrially viable. However, there are 
further considerations to be made with respect to ionic liquids in the 
pharmaceutical environment before they are taken up as a standard technology. 
Some of these considerations are related to the regulatory approval of processes 
that employ ionic liquids and were discussed in the Section 7.2. There are other 
considerations to be made on the basis of effective pharmaceutical management.
2The inclusion of this section relates to the University of London EngD requirement for 
consideration of the bioprocess management implications of the research work performed.
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The primary concern here is the relatively much greater cost of ionic liquids 
compared to organic solvents. The ionic liquid [BMP][NTf2] currently sells for 
£370 per kilogram. In contrast 1 litre of high purity toluene retails for £15. 
However, the financial considerations are based not only on the cost of 
purchasing ionic liquids but also of their disposal. As discussed in Section 7.2 a 
chemical degradation process is required to safely dispose of ionic liquids 
significantly increasing the costs of use. This is because either a second plant 
will be required on the manufacturing site to carry out the degradation process, 
or the disposal will need to be contracted out to a second company to dispose of 
the ionic liquids safely.
The greatest advantages with ionic liquids have been observed in this work with 
regard to isolated enzyme processes. These are generally preferred processes due 
to the ability to rapidly develop a process for effective product synthesis. The 
major issue with isolated enzyme redox syntheses, however, is the requirement 
for co-factor, as has been discussed in Section 1.2. In this work, this issue has 
been overcome through the use of a coupled enzyme system converting an inert 
second substrate to regenerate co-factor (Figure 5.1). This has significant 
implications for cost as enzyme preparations are generally the most expensive 
component in the system. Recently, isolated enzyme process development 
requiring co-factor has employed the second recycling system postulated by 
Kroutil and co-workers (Kroutil et al, 2004). This process employs a single 
enzyme that recycles a coupled substrate, often isopropyl alcohol in which the 
substrate can be suspended. This is shown in Figure 7.1. The effect of the 
isopropyl alcohol on the ionic liquid present and the stabilisation or improved
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mass transfer effects observed and discussed in Chapter 5 would be unknown. 
However, through this kind of process improvement significant cost savings can 
be made over a system employing two enzymes.
Single enzyme i
(ADH) N AD(P)NAD(P)H
OH
OH
O
Figure 7.1 The coupled substrate recycling of NAD(P)H cofactor during the enzymatic 
reduction of a ketone to alcohol. (Kroutil et al, 2004).
Long term supply and stability of the ionic liquid co-solvent discussed in the 
previous section would also be a concern here. The process would be reliant on 
consistent batches of ionic liquids that are supplied through a robust chain. As 
yet, there are too few examples of ionic liquids being made and distributed at 
large scale to assuage the concern over security of the supply chain. Long term 
stability studies of the ionic liquids are required to determine the size of batches 
that can be supplied in single loads and kept for use within the drug 
manufacturing company. The ionic liquid [Bmim][PF6] was reported to be 
degrading to hydrogen fluoride (Swatloski, 2003) through a hydrolysis reaction
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which is highly toxic and corrosive indicating the need for robust testing of ionic 
liquid products before widespread use.
Finally, the issue of the high cost of ionic liquids will be resolved as more and 
more groups make use of their unique properties and processing advantages such 
as those outlined in this work. The only major industrial process involving ionic 
liquids to date is the BASF process involving scavenging of acid at the end of the 
process for synthesis of alkoxyphenylphosphine. The ionic liquid that forms at 
the end of this process is an immiscible dense liquid also facilitating product 
recovery (Seddon, 2003). As ionic liquids attract more interest and processing 
advantages become more well known the potential for ionic liquids to be used as 
a cost effective process component may be realised.
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8 Conclusions and future work
8.1 Conclusions
In this work the successful use of ionic liquids as co-solvents in biocatalytic 
redox reactions has been demonstrated. The bioreduction of 6-Br-p-tetralone to 
(iS)-6-Br-P-tetralol by the whole cell strains T. capitatum MY 1890 and R. 
erythropolis MA7213 in the presence of 20% v/v [Emim][TOS] was shown to be 
either comparable in the case of T. capitatum MY1890 (Figures 3.2(a) and 
3.4(a)) or superior in the case of R. erythropolis MA7213 (Figures 3.2(b) and 
3.5) to the base case control reaction involving 10% v/v ethanol as co-solvent. 
The decrease in cell viability of both types of cell upon exposure to ionic liquids 
(Figure 3.3) was found to be intermediate to that determined for cells residing 
purely in fermentation media and cells residing in a two-phase mixture of media 
and organic solvent (toluene). For T. capitatum MY 1890 bioconversions, the 
water miscible hydrophilic ionic liquid [Emim][TOS] gave a reaction profile 
comparable to that observed in the previously studied water-ethanol (10% v/v) 
system (Figure 3.4(a)), in terms of overall rate of reaction (0.2g(prod)L‘1hr'1) and 
conversion (100% w/w). Of the hydrophobic ionic liquids evaluated 
[Oc3MeN][NTf2] gave the best conversion of 60%, but at a much reduced rate 
suggesting solute mass transfer from the ionic liquid phase was rate limiting 
(Figure 3.4(b)). For bioconversions carried out with R. erythropolis MA7213 
employing 20% v/v [Emim][TOS] as a co-solvent the conversion yield doubled 
and a four-fold increase in initial rate was found (Figure 3.5) compared to the 
standard ethanol co-solvent (Figure 3.2(b)). This was attributed to improved cell
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viability and reduced aggregation of the R. erythropolis MA7213 compared to T. 
capitatum MY1890 (Figure 3.6).
Multi parameter flow cytometry was used for the first time to determine the 
biocompatibility of ionic liquids with whole cell biocatalysts in a rapid manner 
(Chapter 4). It was shown that the traditional method of counting viable cell 
colonies on agar plates was equivalent to the polarised live cell counts obtained 
through flow cytometry (Figure 4.4). As suspected, the mechanism of toxicity of 
the ionic liquids appears to be to disrupt the cellular metabolism leading to cell 
death (Figure 4.8(b)). Flow cytometry was successfully used to identify the most 
biocompatible ionic liquid for the gram negative bacterium E. coli TOP 10 
pQR239 (Figure 4.7), and this ionic liquid, [Emim][TOS] was successfully used 
as a co-solvent to double conversion of the substrate 1-indanone into 3,4- 
dihydrocoumarin (Figure 4.9 and Table 4.3).
The work described in Chapter 5 is the first example of the isolated enzyme 
mediated reduction of a ketone with in-situ recycling of the co-factor in the 
presence of ionic liquids at industrially relevant substrate concentrations. The 
enantioselective reduction of 4 ’-Br-2,2,2-trifluoroacetophenone to (/?)-4’-Br-
2,2,2-trifluoroacetophenyl alcohol was limited to a maximum alcohol production 
of 10 gL'1 using traditional organic solvents whereas use of the ionic liquid 
[BMP][NTf2] led to complete conversion of 50 gL'1 substrate at a high rate and 
with excellent enantioselectivity (Figure 5.8). The reduction of 6-Br-P-tetralone 
to (5)-6-Br-p-tetralol was also improved through use of ionic liquids (Figure
5.3). Product recovery and isolation was demonstrated with yields of 85% w/w in
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the case of (i?)-4’-Br-trifluoroacetopheny 1 alcohol (Section 5.11.6) and 88% w/w 
in the case of (S)-6-Br-p-tetralol (Section 5.10) with product ee >99% in favour 
of the desired enantiomer in both cases. The stability of the enzymes employed 
was shown to be increased through the presence of ionic liquid with half lives of 
the two enzymes employed increased to 266 hours in the case of ADH RE and 
>300 hours in the case of GDH 103 compared to 78 hours and 128 hours 
respectively in the presence of buffer alone (Table 5.3).
Finally, based on the preceding experimental results it is proposed that substrate 
solubility in the co-solvent mixture, biocatalyst stability in the presence of the 
co-solvent and mass transfer efficiency of the substrate from the co-solvent phase 
to the aqueous phase in the case of immiscible co-solvents are the key design 
features. A conceptual framework for the identification of ionic liquids as co­
solvents for biocatalytic conversions has been proposed and the potential for 
automation has been shown (Figure 6.1). Design of a bioconversion process 
would thus be based on the identification of the biocatalyst, solubility of the 
substrate in a range of solvents and co-solvent mixtures, stability of the 
biocatalyst in the presence of the substrate in those co-solvent mixtures and the 
subsequent screening of reaction conditions. Such a system has been 
implemented at Merck & Co. Inc. and is currently in use.
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8.2 Future Work
A number of potential areas for further investigation have been identified 
throughout the course of this work. Based upon the experimental results obtained 
here, the immediate follow-up studies should address the following points.
• The whole cell biocatalysts investigated in Chapters 3 and 4 were found to be 
stabilised by some ionic liquids as well- particularly those that form two 
phases. Further investigation should focus on whether this stability is a result 
of changes at a molecular level or whether the cells are simply being protected 
from phase interface effects.
• The effects observed in Chapter 5 of improved mass transfer coefficients 
from the ionic liquid into aqueous phase should be examined further to find 
whether this is a generic effect of ionic liquids. It would also be interesting 
to attempt to determine a molecular basis for the observed effects.
• The improved enzyme stability observed in Section 5.4 should also be 
examined further. It was postulated in Chapter 7 that the presence of ionic 
liquid prompts changes in the enzyme secondary structure from a-helix to p- 
sheet motifs and vice versa. This phenomenon could be examined through 
the use of circular dichroic spectrometry to determine if the stability is 
indeed conferred through structural changes within the enzyme molecule.
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• A conceptual approach has been developed for selection of ionic liquids and 
demonstrated on a small scale in the case of the 1-indanone bioconversion 
covered in Chapter 4. More in-depth study of the factors identified for co­
solvent selection should be carried out and a Design of Experiments matrix 
constructed (Islam et al, 2007) to facilitate rapid co-solvent selection.
Based upon the wider considerations of the use of ionic liquids in bioconversion
processes, especially in an industrial context, the following points could be
addressed.
• The thermal stability of ionic liquids and the stability of enzyme and whole 
cell biocatalysts have not been examined in any depth in this work. Future 
work could explore the effects of higher temperatures on rates of reaction 
and biocatalyst stability for a range of biocatalysts and substrates.
• In Section 7.2 the regulatory environment for solvent usage in 
pharmaceutical development was discussed. Quantification of residual ionic 
liquid concentrations within isolated product preparations should be 
investigated through the use of NMR and mass spectrometry.
• In view of the current high costs of both the ionic liquids and isolated 
enzyme preparations further study of the potential of ionic liquid re-use 
should be investigated to determine the number of times they can be 
recycled. Similarly, since the isolated enzymes investigated in this work 
have been shown to have improved stability in the presence of certain ionic
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liquids the potential for the enzyme preparations to be re-used should be 
investigated. This could lead to a more comprehensive economic evaluation 
of the industrial use of ionic liquids.
• Whilst literature data and the results obtained here show that suitable ionic 
liquids for a particular bioconversion can be identified by screening a small 
range of ionic liquids, in the longer term it would be useful to examine and 
correlate the physico-chemical features of ionic liquids to both substrate 
solubility and biocatalyst stability.
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Appendix A
Appendix A: Reverse phase HPLC analysis
A .l HPLC analysis of the bioreduction of 6-Br-|3-tetralone to 6-Br-|3-tetralol
A. 1.1 Calibration curves
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Figure A .l H PLC  calibration curves for (a) 6-Br-P-tetralone and (b) 6-Br-p-tetralol. Sam ples were
analysed as described in Section 2.8.1.
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A. 1.2 Sample chromatogram
Appendix A
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Figure A.2 Sample chromatogram showing separation of 6-Br-(3-tetralone eluting at 2.7 minutes and 6- 
Br-P-tetralol eluting at 1.98 minutes. Samples were analysed as described in Section 2.8.1 on a short 
column.
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A.2 HPLC analysis of the bioreduction of 4’Br-2,2,2-trifluoroacetohphenone 
to 4’-Br-2,2,2-trifluoroacetophenyl alcohol
A.2.1 Calibration curves
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<^
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Figure A.3 H PLC  calibration  curves for (a) 4 ’-B r-2,2,2-trifluoroacetophenone and (b) 4 ’Br-2,2,2-
trifluoroacetophenyl alcohol. Sam ples w ere analysed as described in Section 2.8.1.
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A.2.2 Sample chromatogram
DAD1 A. S ig=210,4  R eK 360.100 (EPOCH\EPOCH 2007-06-28 12-41-27\021-0101.D)
mAL) I 
1 4 0 -
120-
100-
8 0 -
6 0 -
20-
0-
Figure A.4 Sample chromatogram showing separation of 4’Br-2,2,2-trifluoroacetophenone eluting at 
5.3 minutes and 4 ’-Br-2,2,2-trifluoroacetophenyl alcohol eluting at 3.28 minutes. Samples were 
analysed as described in Section 2.8.1.
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A.3 HPLC analysis of the biocatalytic oxidation of 1-indanone to 3,4- 
dihydrocoumarin
A.3.1 Calibration curves
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Figure A.5 H PLC  calibration curves for (a) 1-indanone and (b) 3,4-dihydrocoum arin. Samples were
analysed as described in Section 2.8.1.
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A.3.2 Sample chromatogram
100 mQthod10check#1
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Figure A.6 Sample chromatogram showing separation of 1-indanone eluting at 5.93 minutes and 3,4- 
dihydrocoumarin eluting at 4.23 minutes. Samples were analysed as described in Section 2.8.1.
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Appendix B: Whole cell bioreduction of 6-Br-p- 
tetr alone by T. capitatum MY1890
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Figure B.l Time course of the bioreduction of 6-Br-P-tetralone to (5)-6-Br-p-tetralol by the yeast T. 
capitatum MY1890 in the presence of 20% v/v (a) [Bmim][BF4]; (b) [CABHEM][MeS04]: (■) 6-Br-p- 
tetralone; ( • )  6-Br- P-tetralol; (-) mass balance. Cultivation was performed as described in Section 2.6. 
Bioconversion was performed as described in Section 2.7.1 and the reaction was monitored by HPLC 
analysis as described in Section 2.8.1.
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Figure B.2 Time course of the bioreduction of 6-Br-P-tetralone to (S)-6-Br-p-tetralol by the yeast T. 
capitatum MY1890 in the presence of 20% v/v (a) [Bmim][MDEGS04]; (b) [Oc3MeN][NTf2]: (■) 6- 
Br-p-tetralone; ( • )  6-Br- P-tetralol; (-) mass balance. Cultivation was performed as described in Section 
2.6. Bioconversion was performed as described in Section 2.7.1 and the reaction was monitored by 
HPLC analysis as described in Section 2.8.1.
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Figure B.3 Time course of the bioreduction of 6-Br-P-tetralone to (5)-6-Br-P-tetralol by the yeast T. 
capitatum MY1890 in the presence of 20% v/v (a) [Bmim][OcS0 4 ]; (b) [Bmim][PF6]: (■) 6-Br-p- 
tetralone; ( • )  6-Br- P-tetralol; (-) mass balance. Cultivation was performed as described in Section 2.6. 
Bioconversion was performed as described in Section 2.7.1 and the reaction was monitored by HPLC 
analysis as described in Section 2.8.1.
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Figure B.4 Time course of the bioreduction of 6-Br-P-tetralone to (*S)-6-Br-P-tetralol by the yeast T. 
capitatum MY 1890 in the presence of 20% v/v [Emim][TOS]: ( • )  6-Br-P-tetralone; (o) 6-Br- P- 
tetralol; (-) mass balance. Cultivation was performed as described in Section 2.6. Bioconversion was 
performed as described in Section 2.7.1 and the reaction was monitored by HPLC analysis as described 
in Section 2.8.1.
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Appendix C: Flow cytometry analysis of 
erythropolis MA7213 in a range of co-solvents.
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Figure C.l Response of R. erythropolis MA7213 cells 
to exposure to 10% v/v Ethanol. Quadrant HI 
corresponds to live, polarized cells, H3 corresponds to 
live cells with depolarized cell membranes and H4 
corresponds to dead cells. Cultivation was performed as 
described in Section 2.6, bioconversion as described in 
Section 2.7.1 and flow cytometry analysis as described 
in Section 2.8.8.
m7i— . rTTniB— ■ t rrrm — r1Q0 101 102 10*
222
Appendix C
rh o b a tc h 1 s2  PI+OI+ 00005183 5 6 2 .LMD : FL3 LOG FL1 LOC
102-=
o  101-  □
10°-=
H 2
t  =  0  m i n
H 4
10° 101 102 103 
PI
rh oB F 4t45m ln  Pl+D1+00005190 569.LMD : FL3 LOG/FL1 LO' 
lO3^
102-
o 10S 
5
9 t = 45 min
H3
10 — H 4
i i n i n r i— i i n  i mi— i—i i i rmr 
10° 101 102 10s
PI
4] rhoB F4t3  PI+DI+ 00005198 57 7 .LMD : FL3 LOG/FL1 LOG
8
O  10' Q
H 4
10°
p i
4] rhoB F 4t5  PI+DI+00005206 585.LMD : FL3 LOG/FL1 LOG
H 2
8
H 4
10°
p i
4] rhoBF4tO PI+OI+00005186 565.LMD : FL3 LOG FL1 LOG 
103-
t = 1 min
i i 11111d|’— i1 . i r im i— i i r r m ii— i i i m u  10° 101 102 10*
PI
rhoB F4t90m in  PI+DH-00005194 573.LMD : FL3 L0G/FL1 LO'
103-
102-
o  101-Q
H2
t = 90 min
H3
10° — H 4
I I I I llll' 1 I I I i i il |-- 1 I TTTTTTj---1—TT10° 101 102 103
4] rhoB F4t4  PKK3I+ 00005202 581 .LMD : FL3 LOG/FL1 LOG -
t = 4 h
8oQ
H 4
10°
pi
Figure C.2 Response of R. erythropolis MA7213 cells 
to exposure to 20% v/v [Bmim][BF4]. Quadrant HI 
corresponds to live, polarized cells, H3 corresponds to 
live cells with depolarized cell membranes and H4 
corresponds to dead cells. Cultivation was performed as 
described in Section 2.6, bioconversion as described in 
Section 2.7.1 and flow cytometry analysis as described 
in Section 2.8.8.
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Figure C.3 Response of R. erythropolis MA7213 cells 
to exposure to 20% v/v [Emim][TOS], Quadrant HI 
corresponds to live, polarized cells, H3 corresponds to 
live cells with depolarized cell membranes and H4 
corresponds to dead cells. Cultivation was performed as 
described in Section 2.6, bioconversion as described in 
Section 2.7.1 and flow cytometry analysis as described 
in Section 2.8.8.
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Figure C.4 Response of R. erythropolis MA7213 cells 
to exposure to 20% v/v [CABHEM][MeS04]. Quadrant 
H1 corresponds to live, polarized cells, H3 corresponds 
to live cells with depolarized cell membranes and H4 
corresponds to dead cells. Cultivation was performed as 
described in Section 2.6, bioconversion as described in 
Section 2.7.1 and flow cytometry analysis as described 
in Section 2.8.8.
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Appendix D: Flow cytometry analysis of 
TOPIO pQR239 in a range of co-solvents
PI 630nm
Figure D.l Response of E. coli TOPIO pQR239 cells to exposure to 20% v/v [Bmim][BF4]. Quadrant K3 
corresponds to live, polarized cells, K1 corresponds to live cells with depolarized cell membranes and K2 
corresponds to dead cells. Cultivation was perfonned as described in Section 2.6, bioconversion as described in 
Section 2.7.1 and flow cvtometrv analvsis as described in Section 2.8.8.
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Figure D.2 Response of E. coli TOPIO pQR239 cells to exposure to 20% v/v [Bmim][MDEGS04]. Quadrant 
K3 corresponds to live, polarized cells, K1 corresponds to live cells with depolarized cell membranes and K2 
corresponds to dead cells. Cultivation was performed as described in Section 2.6, bioconversion as described in 
Section 2.7.1 and flow cvtometrv analvsis as described in Section 2.8.8.
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Figure D.3 Response of E. coli TOPIO pQR239 cells to exposure to 20% v/v [Bmim][0cS04]. Quadrant K3 
corresponds to live, polarized cells, K1 corresponds to live cells with depolarized cell membranes and K2 
corresponds to dead cells. Cultivation was performed as described in Section 2.6, bioconversion as described in 
Section 2.7.1 and flow cvtometrv analvsis as described in Section 2.8.8.
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Figure D.4 Response of E. coli TOPIO pQR239 cells to exposure to 20% v/v [CABHEM][MeS04]. Quadrant 
K3 corresponds to live, polarized cells, K1 corresponds to live cells with depolarized cell membranes and K2 
corresponds to dead cells. Cultivation was performed as described in Section 2.6, bioconversion as described in 
Section 2.7.1 and flow cvtometrv analvsis as described in Section 2.8.8.
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Figure D.5 Response of E. coli TOPIO pQR239 cells to exposure to 20% v/v [Emim][TOS]. Quadrant K3 
corresponds to live, polarized cells, K1 corresponds to live cells with depolarized cell membranes and K2 
corresponds to dead cells. Cultivation was performed as described in Section 2.6, bioconversion as described in 
Section 2.7.1 and flow cvtometrv analvsis as described in Section 2.8.8.
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Figure D.6 Response of E. coli TOPIO pQR239 cells to exposure to 20% v/v [Oc3MeN][NTf2]. Quadrant K3 
corresponds to live, polarized cells, K1 corresponds to live cells with depolarized cell membranes and K2 
corresponds to dead cells. Cultivation was performed as described in Section 2.6, bioconversion as described in 
Section 2.7.1 and flow cvtometrv analvsis as described in Section 2.8.8.
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Figure D.7 Response of E. coli TOPIO pQR239 cells to exposure to 10% v/v ethanol. Quadrant K3 
corresponds to live, polarized cells, K1 corresponds to live cells with depolarized cell membranes and K2 
corresponds to dead cells. Cultivation was performed as described in Section 2.6, bioconversion as described in 
Section 2.7.1 and flow cvtometrv analvsis as described in Section 2.8.8.
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Figure D.8 Response of E. coli TOPIO pQR239 cells to exposure to 10% v/v toluene. Quadrant K3 
corresponds to live, polarized cells, K1 corresponds to live cells with depolarized cell membranes and K2 
corresponds to dead cells. Cultivation was performed as described in Section 2.6, bioconversion as described in 
Section 2.7.1 and flow cvtometrv analvsis as described in Section 2.8.8.
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Appendix E: Stability of ADH RE and GDH 103 in 
a range of co-solvents
Co-Solvent ADH RE relative activity (%) GDH 103 relative activity (%)
Time (hr) Time (hr)
15 40 64 15 40 64
[BMPl[NTf2] 90.1 93.8 80.5 95.5 111.3 90.6
[Bmim][PF6] 102.7 71.6 78.4 94.4 101.7 78.7
AmmoEng™ 102 5.8 4.1 1.2 99.8 116.1 85.7
AmmoEng™ 110 97.4 66.7 58.8 105.6 118.6 88.0
AmmoEng™ 120 36.0 29.1 28.0 77.0 89.3 77.9
[Emiml[TOSl 61.8 66.4 50.9 62.7 46.8 31.3
[Bmim][BF4 l 47.4 48.1 31.1 91.7 106.7 82.4
EcoEng™ 212 79.7 96.7 65.8 101.3 121.6 86.9
EcoEng™ 1111P 90.1 102.2 72.8 101.3 90.5 66.1
TEMPirES] 87.7 85.8 70.8 61.0 42.1 18.7
EcoEng™ 21M 5.6 10.4 6.6 79.3 89.5 61.8
Buffer 83.3 65.8 56.7 101.1 86.5 72.0
Table E .l Relative activity of ADH RE and GDH 103 over time in the library of ionic liquids and buffer. 
Enzyme activity was determined as described in Section 2.8.2.
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